{"meta":{"query_hash":"5da7a42e9d2d","filters":{"venue":"JHEP Reports"},"cohort_total":114,"direct_labels_cover":2,"predictions_cover":114,"exported":114,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5da7a42e9d2d","api":"https://metacan.xera.ac/api/v1/cohort?venue=JHEP+Reports"},"results":[{"id":"W2923998330","doi":"10.1016/j.jhepr.2019.03.001","title":"JHEP Reports: A new EASL open access journal","year":2019,"lang":"en","type":"editorial","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatology; Publication; Outreach; Impact factor; Audience measurement; Medicine; Internal medicine; Publishing; Political science; Public relations; Medical education; Family medicine; Law","score_opus":0.03957957871228053,"score_gpt":0.40626750418538915,"score_spread":0.36668792547310863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923998330","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002966569,0.0047743428,0.0000071242457,0.00096032483,0.9518125,0.002659044,0.000057111043,0.0001000308,0.03666296],"genre_scores_gemma":[0.0044309883,0.0018121039,0.00024536476,0.0004558993,0.92170227,0.00021139701,0.0020207043,0.00021359668,0.06890766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374545,0.000080299724,0.0019292136,0.0014178205,0.002164869,0.00066233455],"domain_scores_gemma":[0.99221617,0.00027784833,0.0030970264,0.002301525,0.0008315089,0.0012758973],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092913135,0.00074352935,0.0017991092,0.00029860713,0.00023189349,0.0023347426,0.0007965919,0.00090511364,0.002426994],"category_scores_gemma":[0.0019332885,0.0005750057,0.00079173973,0.00026074811,0.000056513083,0.0011232379,0.0012280621,0.0012909959,0.00014513211],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001767047,0.0007202472,0.04188241,0.00020877086,0.0012323376,0.11432191,0.00006397034,0.0000020379725,0.0000019752563,0.0000037646694,0.8387705,0.0026153415],"study_design_scores_gemma":[0.001734721,0.00041306813,0.009454251,0.0015900128,0.002587401,0.0074908477,0.000021099777,8.257523e-7,0.00004338497,0.0006362567,0.9754748,0.0005533654],"about_ca_topic_score_codex":0.0025365378,"about_ca_topic_score_gemma":0.0000515796,"teacher_disagreement_score":0.13670424,"about_ca_system_score_codex":0.0010037329,"about_ca_system_score_gemma":0.011378638,"threshold_uncertainty_score":0.99967015},"labels":[{"model":"gemma","categories":["scholarly_communication"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["scholarly_communication","open_science"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2925188819","doi":"10.1016/j.jhepr.2019.02.005","title":"Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Decompensation; Hepatorenal syndrome; Intensive care unit; Cirrhosis; Portopulmonary hypertension; Intensive care medicine; Liver transplantation; Hepatic encephalopathy; Intensive care; Transplantation; Internal medicine","score_opus":0.047675907830002695,"score_gpt":0.3648379389039142,"score_spread":0.3171620310739115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925188819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00171827,0.9932824,0.0000018797001,0.000059839174,0.000320014,0.0023390187,0.000082031554,0.000027015194,0.002169564],"genre_scores_gemma":[0.022150207,0.97487974,0.00000986233,0.00033022207,0.00018892346,0.000119037264,0.0018551335,0.000041635358,0.00042523022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831504,0.00013965587,0.0005003546,0.0005189278,0.00031585665,0.0002101557],"domain_scores_gemma":[0.9986198,0.00013088604,0.00032044956,0.00052620954,0.00028724555,0.00011544136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015016792,0.000340371,0.0009743648,0.00020060259,0.000053695625,0.0000354002,0.00007251472,0.00025453704,0.0002103493],"category_scores_gemma":[0.00004106025,0.00020242592,0.00024156971,0.00019315761,0.00004608107,0.00009596849,0.000031297852,0.00045670648,0.000053506512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041140078,0.00021083702,0.0040080203,0.15960301,0.0030022552,0.12568486,0.03302392,3.9791288e-7,0.000010028078,0.00006515022,0.006618218,0.6673619],"study_design_scores_gemma":[0.001097197,0.00140512,0.0040921858,0.04304076,0.018109392,0.015905194,0.0036524758,0.0000027422925,0.000019686408,0.000026626096,0.9120481,0.0006005402],"about_ca_topic_score_codex":0.0000385711,"about_ca_topic_score_gemma":0.000026901162,"teacher_disagreement_score":0.90542984,"about_ca_system_score_codex":0.00017379099,"about_ca_system_score_gemma":0.001050333,"threshold_uncertainty_score":0.8254689},"labels":[],"label_agreement":null},{"id":"W2940105550","doi":"10.1016/j.jhepr.2019.02.001","title":"Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Adverse effect; Immune checkpoint; Internal medicine; Immune system; Common Terminology Criteria for Adverse Events; Cancer; Oncology; Immunology; Immunotherapy; Cancer research","score_opus":0.010726329060093267,"score_gpt":0.2735513881588859,"score_spread":0.26282505909879267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940105550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894383,0.0035794685,0.000016261089,0.0009676056,0.0013392569,0.0024255894,0.000016428909,0.00004808402,0.002169012],"genre_scores_gemma":[0.99128866,0.00025917706,0.00020884081,0.00016989849,0.00013830034,0.0002527298,0.00005865991,0.00003665259,0.0075871046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800175,0.00001885998,0.001184894,0.0003564726,0.00022034533,0.00021768648],"domain_scores_gemma":[0.99801123,0.00010584598,0.00064666255,0.0009917209,0.00015999142,0.000084541636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004909578,0.00019151744,0.00045754673,0.00009763327,0.0000734382,0.000013981621,0.00003855278,0.000120528224,0.00052781746],"category_scores_gemma":[0.00008324523,0.00012382209,0.0004461091,0.00018569827,0.000084380634,0.00006686185,0.0000193891,0.000091101356,0.000008174662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008957367,0.0034994993,0.12326207,0.0007867339,0.005123946,0.26434812,0.01333685,0.000044972247,0.24183817,0.000023862007,0.011901021,0.32687736],"study_design_scores_gemma":[0.005553607,0.0059381383,0.046930797,0.00033441623,0.00042168953,0.20750046,0.0007983989,0.00006113614,0.12009312,0.00004895926,0.611949,0.00037021606],"about_ca_topic_score_codex":0.0047542104,"about_ca_topic_score_gemma":0.00020032671,"teacher_disagreement_score":0.600048,"about_ca_system_score_codex":0.00033359727,"about_ca_system_score_gemma":0.00035125721,"threshold_uncertainty_score":0.7186976},"labels":[],"label_agreement":null},{"id":"W2946374695","doi":"10.1016/j.jhepr.2019.05.004","title":"Radiotherapy for HCC: Ready for prime time?","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Bridging (networking); Radiation therapy; Radiology; Oncology; Medical physics; Internal medicine; Computer science","score_opus":0.24115940712736844,"score_gpt":0.38754633542407724,"score_spread":0.1463869282967088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946374695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001786008,0.9844039,0.0002459723,0.00010803796,0.0006126852,0.012628519,0.00010110984,0.00011640467,0.0017654904],"genre_scores_gemma":[0.000009462731,0.9361292,0.004584226,0.00008380538,0.0009827868,0.0028246935,0.004178074,0.00021922412,0.050988514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752104,0.000044204513,0.0009991532,0.00076917576,0.00023723571,0.00042919017],"domain_scores_gemma":[0.997557,0.00030034967,0.00080019375,0.0010140917,0.00015171283,0.00017666255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005428505,0.00053628016,0.002967664,0.00018737568,0.000072592586,0.000037518712,0.00008910135,0.0005481303,0.00022574542],"category_scores_gemma":[0.00011742132,0.00038910005,0.0016543675,0.00013267514,0.000028577113,0.000047513422,0.000019135648,0.00016192255,0.00010350589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053920463,0.00016662412,0.00081821624,0.02252574,0.00126389,0.00045192952,0.000021318909,8.169895e-9,0.0000068188356,0.000019734282,0.02171145,0.9529604],"study_design_scores_gemma":[0.0006741708,0.00068906834,0.000004695154,0.0038821127,0.005214067,0.0013642508,6.9932e-7,0.00004458052,0.000029652629,0.000033690503,0.98769593,0.0003671009],"about_ca_topic_score_codex":0.000009464099,"about_ca_topic_score_gemma":3.73169e-7,"teacher_disagreement_score":0.96598446,"about_ca_system_score_codex":0.00028634546,"about_ca_system_score_gemma":0.0007804167,"threshold_uncertainty_score":0.9998561},"labels":[],"label_agreement":null},{"id":"W2954121849","doi":"10.1016/j.jhepr.2019.06.001","title":"HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"AstraZeneca","keywords":"HBeAg; Medicine; Seroconversion; Immunology; Hepatitis B virus; Blockade; Hepatocellular carcinoma; T cell; Virology; Hepatitis B; Antibody; Viral load; HBsAg; Immune system; Virus; Internal medicine; Receptor","score_opus":0.004777561713862955,"score_gpt":0.2349294680056037,"score_spread":0.23015190629174073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954121849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503106,0.00017932334,0.000009716323,0.00025776372,0.00040244698,0.0015741435,0.0000060361563,0.00024744475,0.0022920587],"genre_scores_gemma":[0.99563104,0.00017353406,0.000026248756,0.00018792762,0.00017874969,0.00013997704,0.000038591723,0.000053207197,0.0035707015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981246,0.000052459727,0.00038108428,0.0005430653,0.0005060538,0.00039274586],"domain_scores_gemma":[0.998725,0.00006696945,0.00038461763,0.0004485057,0.0002485148,0.00012638592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021302246,0.00026456424,0.0005494114,0.00015470896,0.00018096449,0.000020199319,0.000030387695,0.0001711957,0.00037672598],"category_scores_gemma":[0.00023988164,0.00022405952,0.0001323716,0.00034842378,0.0000691564,0.00018696325,0.00008365592,0.00031313943,0.00012945234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008141863,0.000102308186,0.98842126,0.00023023663,0.00041740172,0.0016565772,0.00074191927,0.000018035744,0.0071859453,6.5582145e-7,0.0006305989,0.0005136646],"study_design_scores_gemma":[0.0013549826,0.00075553136,0.96667194,0.00083795586,0.00021750545,0.0008022154,0.000014160922,0.00017696906,0.027402509,0.000009311833,0.0015122149,0.00024471935],"about_ca_topic_score_codex":0.0079461085,"about_ca_topic_score_gemma":0.0030150549,"teacher_disagreement_score":0.021749314,"about_ca_system_score_codex":0.0011942737,"about_ca_system_score_gemma":0.0001595073,"threshold_uncertainty_score":0.9986601},"labels":[],"label_agreement":null},{"id":"W2964431599","doi":"10.1016/j.jhepr.2019.07.004","title":"Recent advances in liver transplantation for cancer: The future of transplant oncology","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Liver transplantation; Hepatocellular carcinoma; Transplantation; Colorectal cancer; Neuroendocrine tumors; Internal medicine; Cancer; Oncology","score_opus":0.047805966528124674,"score_gpt":0.3699732112463504,"score_spread":0.3221672447182257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964431599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000432614,0.9939361,0.000010765772,0.000389828,0.0015828727,0.0024074598,0.00011445541,0.000012392314,0.0015028515],"genre_scores_gemma":[0.0001193107,0.9979329,0.0000423586,0.00008871709,0.0005870323,0.0007446266,0.00024632024,0.000030492156,0.00020823599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833095,0.00005839591,0.0008242645,0.00037434103,0.00019857923,0.0002134723],"domain_scores_gemma":[0.99875677,0.00017663675,0.00061446056,0.0003157516,0.00009825043,0.000038132297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027417095,0.00026140013,0.0016645258,0.00011329915,0.000036343325,0.0000038700305,0.00007959699,0.00023732775,0.00004315437],"category_scores_gemma":[0.00000987415,0.0001515446,0.00042952955,0.00019202394,0.00005438832,0.00004993476,0.000008809268,0.00027705883,0.0000011898883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011609818,0.000054569657,0.00050562894,0.04024852,0.00016038859,0.00064963085,0.0007880198,0.0000012505034,3.582095e-7,0.000014336126,0.0006366731,0.95682454],"study_design_scores_gemma":[0.00040655563,0.00020443644,0.00075250113,0.007600672,0.0027197888,0.0015235349,0.000075163465,0.0000010275088,0.000003988224,0.00001080557,0.98655504,0.00014649676],"about_ca_topic_score_codex":0.000051418006,"about_ca_topic_score_gemma":0.0014024741,"teacher_disagreement_score":0.98591834,"about_ca_system_score_codex":0.00022574136,"about_ca_system_score_gemma":0.000721724,"threshold_uncertainty_score":0.617981},"labels":[],"label_agreement":null},{"id":"W2965251010","doi":"10.1016/j.jhepr.2019.04.004","title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Intestinal permeability; Intestinal Microbiome; Microbiome; Pathogenesis; Liver disease; Gut flora; Disease; Gut microbiome; Fatty liver; Chronic liver disease; Immunology; Biology; Inflammatory bowel disease; Inflammation; Medicine; Gastroenterology; Bioinformatics; Internal medicine; Cirrhosis","score_opus":0.0963577682362618,"score_gpt":0.4091114852073539,"score_spread":0.3127537169710921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965251010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005649847,0.99404514,5.3319475e-8,0.00040156938,0.00057389616,0.004081403,0.000025840796,0.000012624898,0.00029451647],"genre_scores_gemma":[0.009285585,0.9884738,0.0000027213764,0.0001089909,0.0003506845,0.00040262422,0.000036483994,0.000040554594,0.0012985907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652255,0.00054388464,0.0015698937,0.00059607235,0.0004620231,0.00030557395],"domain_scores_gemma":[0.99447745,0.001308633,0.0013745368,0.0025822567,0.000104870414,0.00015227895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012417412,0.00035868768,0.0014071839,0.000047564696,0.000118836564,0.000040722553,0.00041855997,0.00017334551,0.00010012315],"category_scores_gemma":[0.00071760814,0.00013244635,0.0016855618,0.00032143886,0.0002936147,0.000050282146,0.0003062174,0.00046245696,0.00008148522],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004137367,0.00048497264,0.037353046,0.012051866,0.00076585816,0.0010180298,0.000031946118,5.650604e-7,0.0000011124072,0.00006590293,0.005242521,0.9429428],"study_design_scores_gemma":[0.00017138656,0.00006624905,0.048664693,0.041788902,0.004528825,0.00012983389,0.0000047291123,0.0000032895355,0.000001263094,0.000029250614,0.90448046,0.00013110512],"about_ca_topic_score_codex":0.00010886981,"about_ca_topic_score_gemma":0.000029494051,"teacher_disagreement_score":0.9428117,"about_ca_system_score_codex":0.00049270503,"about_ca_system_score_gemma":0.0030619395,"threshold_uncertainty_score":0.5431749},"labels":[],"label_agreement":null},{"id":"W2985497014","doi":"10.1016/j.jhepr.2019.10.007","title":"How to improve HCC surveillance outcomes","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Computer science; Internal medicine","score_opus":0.11992296774698413,"score_gpt":0.3296167892671368,"score_spread":0.20969382152015265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985497014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031838106,0.99019134,0.000011402874,0.0005112845,0.0015404794,0.003746123,0.00003712605,0.00013231047,0.0035115392],"genre_scores_gemma":[0.0021858339,0.93760455,0.0003061631,0.00015374988,0.00041852897,0.0004777327,0.0004756745,0.00013538051,0.058242384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972598,0.00008038625,0.0007969264,0.0009343464,0.00046502007,0.00046351476],"domain_scores_gemma":[0.99723697,0.00013363833,0.00061809743,0.0015457702,0.000119753975,0.00034579687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039840676,0.00063549535,0.0035509241,0.0002384739,0.000047199846,0.00010273588,0.00011526131,0.00042098472,0.000105966064],"category_scores_gemma":[0.00032665694,0.0004249817,0.001330322,0.000308676,0.000022592312,0.000059543243,0.000115805,0.0003254418,0.0003647903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004838528,0.00007771479,0.16669768,0.012491522,0.00056248996,0.005554269,0.0000152421735,3.8312744e-9,0.0000011666477,0.0000049738514,0.003741263,0.81084883],"study_design_scores_gemma":[0.00016509753,0.0001978892,0.00090585696,0.0023874715,0.0013572472,0.001023625,0.000002498411,7.900475e-7,0.000007288499,0.000004651562,0.9935384,0.00040919485],"about_ca_topic_score_codex":0.00003946416,"about_ca_topic_score_gemma":0.000007144283,"teacher_disagreement_score":0.9897971,"about_ca_system_score_codex":0.00023883655,"about_ca_system_score_gemma":0.0004809188,"threshold_uncertainty_score":0.9998202},"labels":[],"label_agreement":null},{"id":"W2988141874","doi":"10.1016/j.jhepr.2019.10.003","title":"Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Liver Centre; University of Toronto","funders":"Manchester Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; Department of Health and Social Care; Medical Research Council; University of Birmingham; National Institute for Health and Care Research; Birmingham Biomedical Research Centre; University Hospitals Birmingham NHS Foundation Trust","keywords":"Primary sclerosing cholangitis; CD68; Steatohepatitis; CD14; Fatty liver; Medicine; Internal medicine; Gastroenterology; Pathology; Liver disease; Primary biliary cirrhosis; Liver transplantation; Chronic liver disease; Macrophage; Biology; Immunohistochemistry; Transplantation; Receptor; Disease; Cirrhosis","score_opus":0.030673995109366036,"score_gpt":0.27338421958483305,"score_spread":0.24271022447546703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988141874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553466,0.0003380278,0.0000049555338,0.00010633277,0.00017527521,0.0003308611,0.00000383648,0.000010382028,0.0034956676],"genre_scores_gemma":[0.9991176,0.000031574826,0.00017357038,0.00043574366,0.000037438327,0.0000078899875,0.00006980914,0.0000072228386,0.00011911434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993177,0.000057820613,0.0002769558,0.00011322924,0.00012692777,0.000107343076],"domain_scores_gemma":[0.99935776,0.000031019896,0.00013227592,0.0004181298,0.0000337043,0.000027092363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017365924,0.000059102706,0.00019088913,0.000048724232,0.000027977458,0.0000062011977,0.0000431146,0.000038266775,0.00014120006],"category_scores_gemma":[0.000056953773,0.000040564883,0.00006941815,0.00013383421,0.0000321239,0.000062705796,0.000031082727,0.00012083887,0.00000922365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027441836,0.0002072393,0.960333,0.00013408021,0.000012369976,0.00027763128,0.0004337673,0.000009150801,0.03351353,0.00006170702,0.00018873498,0.004801378],"study_design_scores_gemma":[0.0002328854,0.000094244715,0.99830925,0.0000879973,0.000034916204,0.00010917759,0.00008601388,0.000040299215,0.0001688748,0.0006701974,0.00012540283,0.000040762174],"about_ca_topic_score_codex":0.00043978813,"about_ca_topic_score_gemma":0.000004581541,"teacher_disagreement_score":0.037976258,"about_ca_system_score_codex":0.00003645981,"about_ca_system_score_gemma":0.000056453126,"threshold_uncertainty_score":0.1654188},"labels":[],"label_agreement":null},{"id":"W2988581613","doi":"10.1016/j.jhepr.2019.10.009","title":"Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute; McMaster University; Université de Montréal; Montreal Clinical Research Institute; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Amgen Canada; Amgen; Fondation Leducq; McMaster University; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Steatohepatitis; Steatosis; Fatty liver; CD36; Internal medicine; Endocrinology; Liver injury; PCSK9; Hepatocyte; Biology; Alcoholic liver disease; LDL receptor; Chemistry; Lipoprotein; Medicine; Cholesterol; Biochemistry; Receptor; Cirrhosis","score_opus":0.009694823089765093,"score_gpt":0.25286993859812845,"score_spread":0.24317511550836335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988581613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940502,0.0012516419,2.0156297e-7,0.00018819157,0.00023078367,0.00091918575,0.000012671966,0.000043510176,0.0033036096],"genre_scores_gemma":[0.99801004,0.0005092888,0.00009176545,0.00028149196,0.000078136036,0.00012025987,0.000056370875,0.000031930627,0.0008207344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985265,0.00002843742,0.00038897234,0.00051563943,0.0002542588,0.00028617843],"domain_scores_gemma":[0.99908507,0.000057470785,0.00015835532,0.00042094407,0.000059164984,0.0002190068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012526786,0.00022078397,0.0004299346,0.0001325305,0.000042211,0.0000362176,0.000036865596,0.00011264713,0.0003188206],"category_scores_gemma":[0.000036410198,0.00018599191,0.0001035414,0.000152333,0.000027217013,0.00015665835,0.00008245001,0.00012359496,0.00010710101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001245347,0.0004401579,0.9854207,0.0001631169,0.0001096751,0.001715976,0.0003933798,5.647649e-7,0.0048419875,0.000009468847,0.00093870214,0.00584172],"study_design_scores_gemma":[0.0009988006,0.0006390011,0.97816724,0.00036843476,0.0001799499,0.0001285047,0.00006344287,0.000053294792,0.017054426,0.000031860785,0.0021102065,0.00020483856],"about_ca_topic_score_codex":0.0018440558,"about_ca_topic_score_gemma":0.00006551675,"teacher_disagreement_score":0.0122124385,"about_ca_system_score_codex":0.00013654646,"about_ca_system_score_gemma":0.00010244284,"threshold_uncertainty_score":0.758453},"labels":[],"label_agreement":null},{"id":"W2988855473","doi":"10.1016/j.jhepr.2019.10.005","title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of Calgary; University of Alberta","funders":"Sir Jules Thorn Charitable Trust; Medical Research Council; National Institute for Health and Care Research","keywords":"Autoimmune hepatitis; Medicine; Rituximab; Prednisolone; Internal medicine; Hepatitis; Retrospective cohort study; Cohort; Adverse effect; Gastroenterology; Immunology; Pediatrics; Lymphoma","score_opus":0.00919909392241031,"score_gpt":0.24088738759176556,"score_spread":0.23168829366935526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988855473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084836,0.0005390605,0.000021089032,0.001635402,0.0012033214,0.00094876956,0.00013653543,0.00007503505,0.004592419],"genre_scores_gemma":[0.9955955,0.00027171607,0.00027727758,0.0004890819,0.00012304443,0.000032165124,0.00091589877,0.000030282426,0.002264997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974971,0.000082379636,0.001089093,0.00046288056,0.00059977255,0.0002688074],"domain_scores_gemma":[0.9976532,0.00028331362,0.0004692282,0.0013299924,0.00017098109,0.00009328414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046998556,0.00021640689,0.00053776684,0.00012782105,0.00006328093,0.000043837852,0.00032673727,0.00009906925,0.00052167935],"category_scores_gemma":[0.00081301166,0.00016160843,0.0002043469,0.0003634408,0.00007248495,0.00016655632,0.00034336903,0.00031181256,0.00011606838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011072061,0.0022484818,0.97667944,0.000047602178,0.00032506927,0.0009867206,0.0021896262,0.000052070787,0.0056711393,0.00014486545,0.0032881733,0.007259615],"study_design_scores_gemma":[0.004997126,0.00018288018,0.97943413,0.0005226174,0.0000882789,0.000055765384,0.00012266671,0.000690376,0.0002288128,0.00006390429,0.013439098,0.0001743351],"about_ca_topic_score_codex":0.042799134,"about_ca_topic_score_gemma":0.0004244772,"teacher_disagreement_score":0.042374656,"about_ca_system_score_codex":0.00017778775,"about_ca_system_score_gemma":0.00009426634,"threshold_uncertainty_score":0.96357495},"labels":[],"label_agreement":null},{"id":"W2991772886","doi":"10.1016/j.jhepr.2019.11.004","title":"Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Target Real-world evidence; Intercept Pharmaceuticals; Gilead Sciences; Novartis; Meso Scale Diagnostics; Merck; Dr. Falk Pharma; GlaxoSmithKline; Allergan; Bristol-Myers Squibb","keywords":"Primary sclerosing cholangitis; Medicine; Internal medicine; Gastroenterology; Cohort; Hazard ratio; Cirrhosis; Liver biopsy; Confidence interval; Biopsy; Disease","score_opus":0.007678889443100779,"score_gpt":0.22518395467060626,"score_spread":0.21750506522750548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991772886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837273,0.00027560748,0.000001727103,0.00004139807,0.00003461651,0.0009489598,0.0000054145285,0.00002716125,0.0002923677],"genre_scores_gemma":[0.9992022,0.00000843105,0.0000805129,0.000098558,0.000013933343,0.000023320426,0.00044968625,0.000018148054,0.000105194886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901676,0.00007260154,0.00021347342,0.000246917,0.00030390764,0.00014632917],"domain_scores_gemma":[0.9993745,0.000018660152,0.00022732589,0.00018583558,0.000081789105,0.000111856694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015256839,0.000120413395,0.00021378684,0.00009161,0.0000447879,0.000049977338,0.000018705981,0.000062587635,0.000037455775],"category_scores_gemma":[0.00010043152,0.000086261156,0.00002077217,0.00017651918,0.000025866286,0.00033566446,0.000025307849,0.0001716549,1.6656853e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008570691,0.0005862876,0.9958614,0.000088567795,0.000031019812,0.00045107832,0.00015864363,0.000030626765,0.00042383865,4.771655e-7,0.00001555694,0.0014954524],"study_design_scores_gemma":[0.0032686894,0.00030420517,0.9947208,0.0012838579,0.00008497531,0.000002910203,0.00003252401,0.00012221283,0.00004218991,0.000010354192,0.000006562387,0.00012067526],"about_ca_topic_score_codex":0.00005219693,"about_ca_topic_score_gemma":0.000031321364,"teacher_disagreement_score":0.0024116202,"about_ca_system_score_codex":0.00011921267,"about_ca_system_score_gemma":0.00009638603,"threshold_uncertainty_score":0.3517628},"labels":[],"label_agreement":null},{"id":"W3002581322","doi":"10.1016/j.jhepr.2020.100067","title":"Limitations of non-invasive tests for assessment of liver fibrosis","year":2020,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Toronto General Hospital; University Health Network","funders":"Fonds de Recherche du Québec - Santé; Faculty of Medicine, McGill University","keywords":"Medicine; Liver biopsy; Steatohepatitis; Context (archaeology); Fibrosis; Fatty liver; Chronic liver disease; Biomarker; Biopsy; Hepatic fibrosis; Pathology; Disease; Gastroenterology; Cirrhosis; Biology","score_opus":0.1903950336497323,"score_gpt":0.40080223329310644,"score_spread":0.21040719964337415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002581322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012632563,0.9945578,0.00003623635,0.00005729907,0.00014638789,0.003237764,0.0003219582,0.000017402403,0.0014988194],"genre_scores_gemma":[0.004618781,0.9885451,0.0045305816,0.000027087266,0.000111079404,0.0010902324,0.0008986957,0.000045112607,0.00013328569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981152,0.000028146154,0.0010045659,0.00040480352,0.00030405793,0.00014325712],"domain_scores_gemma":[0.9968896,0.0008474186,0.0012818038,0.0005024902,0.0003037377,0.00017498061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093354734,0.00027876065,0.001899117,0.00012510284,0.000029879355,0.0000072849152,0.000056583885,0.00013918629,0.000043714455],"category_scores_gemma":[0.00040039042,0.00020857097,0.001140769,0.00019974135,0.000045971665,0.000036968722,0.00005027033,0.00008955007,0.000003755698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013107247,0.0018920031,0.005176621,0.08356094,0.0033052946,0.00179058,0.00014298498,0.0000011841473,0.0000109482635,0.00009602512,0.008776368,0.8952339],"study_design_scores_gemma":[0.00048241531,0.0010610883,0.017377155,0.024857948,0.017513296,0.00017670891,0.000021591868,0.000009476714,0.00008691486,0.000028195172,0.93814194,0.00024328106],"about_ca_topic_score_codex":0.000035591678,"about_ca_topic_score_gemma":0.0000066833672,"teacher_disagreement_score":0.9293656,"about_ca_system_score_codex":0.00015516146,"about_ca_system_score_gemma":0.0016642986,"threshold_uncertainty_score":0.8505277},"labels":[],"label_agreement":null},{"id":"W3003672419","doi":"10.1016/j.jhepr.2020.100081","title":"Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Liver Centre; University of Toronto; University Health Network","funders":"Novartis Pharma; Gilead Sciences; Novartis","keywords":"Steatohepatitis; Medicine; Intensive care medicine; Fatty liver; Disease; Internal medicine","score_opus":0.05752884116265664,"score_gpt":0.3466541766515822,"score_spread":0.28912533548892555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003672419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894257,0.0016176051,0.0000025121872,0.005014229,0.00012654615,0.0005284792,0.0000047056715,0.000030405698,0.0032498057],"genre_scores_gemma":[0.9960975,0.0011203459,0.00008804077,0.002162082,0.0003329801,0.00013531819,0.000033506003,0.000015264597,0.000014944235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989793,0.000046882225,0.00023383363,0.00036685631,0.00021912418,0.00015404315],"domain_scores_gemma":[0.9990717,0.00023329632,0.00029639606,0.00019390858,0.00003726342,0.000167404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007026246,0.00014830039,0.0002550838,0.00005230143,0.000074197356,0.00010302115,0.000027300403,0.00005253548,0.000034491346],"category_scores_gemma":[0.0001678919,0.000113002425,0.000054680968,0.00016195697,0.000030300855,0.00022239941,0.000022243968,0.00014211735,0.0000092404025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021673115,0.00074106443,0.94570595,0.00010111263,0.00012908262,0.002360433,0.0009287094,0.000009555406,0.00019975952,0.0000732563,0.00023138837,0.049498018],"study_design_scores_gemma":[0.00046620058,0.0003515689,0.9956534,0.00025597453,0.00028711942,0.000046331726,0.0006371014,0.000072858245,0.00049558724,0.0001528443,0.0014674454,0.00011356539],"about_ca_topic_score_codex":0.00014394466,"about_ca_topic_score_gemma":0.000039306382,"teacher_disagreement_score":0.049947456,"about_ca_system_score_codex":0.000045769983,"about_ca_system_score_gemma":0.00009226701,"threshold_uncertainty_score":0.4608105},"labels":[],"label_agreement":null},{"id":"W3009714532","doi":"10.1016/j.jhepr.2020.100095","title":"The second volume","year":2020,"lang":"en","type":"editorial","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Publication; Computer science; Political science; Law","score_opus":0.005978280017988083,"score_gpt":0.26743334455638246,"score_spread":0.2614550645383944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009714532","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014015278,0.000644798,0.000048923743,0.0024467343,0.97887343,0.0004828444,0.0000723143,0.00034347086,0.016947314],"genre_scores_gemma":[0.00066718645,0.0007642717,0.00024304492,0.0004018758,0.8131721,0.000033162614,0.0006068706,0.0000721371,0.18403932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982923,0.000018389313,0.0005341896,0.00034267915,0.00061762874,0.00019478165],"domain_scores_gemma":[0.9986765,0.00018323072,0.0003427909,0.0005138915,0.00014784954,0.00013577286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002339677,0.00020410278,0.00040257676,0.000034797224,0.00012543274,0.000063351006,0.00009203564,0.00046097845,0.0008697902],"category_scores_gemma":[0.00039516127,0.00013226703,0.00020810936,0.00008307138,0.000056498266,0.000031059262,0.000027487407,0.00076715124,0.0000758003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030160545,0.000008830343,0.0011079159,0.00040545597,0.00005833469,0.0029699483,0.000044764452,7.032292e-9,0.000018813324,0.00000507354,0.9949456,0.00040510236],"study_design_scores_gemma":[0.00014418316,0.0001013801,0.0008256741,0.000067395005,0.00016977328,0.00023924984,0.000008732115,8.198468e-7,0.0006925778,0.00011407461,0.9974967,0.00013940866],"about_ca_topic_score_codex":0.000016608516,"about_ca_topic_score_gemma":0.00002695486,"teacher_disagreement_score":0.16709201,"about_ca_system_score_codex":0.000065191125,"about_ca_system_score_gemma":0.00044374747,"threshold_uncertainty_score":0.95235926},"labels":[],"label_agreement":null},{"id":"W3018166881","doi":"10.1016/j.jhepr.2020.100117","title":"Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Immune system; Biology; Medicine; Pathology; Immunology","score_opus":0.018518186571138608,"score_gpt":0.2675152929266799,"score_spread":0.24899710635554131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018166881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979123,0.012526374,0.0000011647428,0.0075322352,0.000038013677,0.00053106237,0.000004444656,0.000008363763,0.00023535226],"genre_scores_gemma":[0.997954,0.00033943346,0.000015160007,0.0015352275,0.000042728283,0.00008766918,0.000008526766,0.000009436696,0.000007819927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896,0.00016458945,0.000316592,0.00019007965,0.00022465011,0.00014409683],"domain_scores_gemma":[0.99921113,0.00026965636,0.000151965,0.00030576537,0.000025395526,0.000036059653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061400986,0.00011047844,0.00026127687,0.000077587574,0.000037691927,0.000026924761,0.00006375403,0.000017943927,0.00002579714],"category_scores_gemma":[0.00026904652,0.00006122081,0.00005913372,0.00028531603,0.000053934666,0.0000707958,0.000034058707,0.000099976445,0.0000011428205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078674924,0.000490991,0.96875966,0.00008028323,0.00006969284,0.00313266,0.01774198,0.0000029023206,0.003294667,0.00003099915,0.0000704647,0.005538968],"study_design_scores_gemma":[0.0008494617,0.0001609111,0.99534273,0.0001475808,0.00013747676,0.00011254251,0.0015641124,0.000040898674,0.00088059314,0.00006412266,0.0006379811,0.00006158749],"about_ca_topic_score_codex":0.0008542205,"about_ca_topic_score_gemma":0.000024372299,"teacher_disagreement_score":0.026583089,"about_ca_system_score_codex":0.000023811655,"about_ca_system_score_gemma":0.000058369398,"threshold_uncertainty_score":0.24965122},"labels":[],"label_agreement":null},{"id":"W3023556837","doi":"10.1016/j.jhepr.2020.100119","title":"Adding the oxygen carrier M101 to a cold-storage solution could be an alternative to HOPE for liver graft preservation","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Machine perfusion; Viaspan; Hepatocyte; Cold storage; Medicine; Liver transplantation; Chemistry; Transplantation; Surgery; Biology; Biochemistry","score_opus":0.058892949149424334,"score_gpt":0.3246540398878067,"score_spread":0.2657610907383824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023556837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84738696,0.00008188349,0.10426161,0.040697,0.000367167,0.005520632,0.00023179699,0.00039501535,0.00105793],"genre_scores_gemma":[0.9776623,0.000020665462,0.0058256923,0.01459859,0.00036157024,0.0002409188,0.00012232106,0.00003190569,0.0011359833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989253,0.000024463934,0.0002993578,0.00030189694,0.0002772885,0.00017165378],"domain_scores_gemma":[0.9991696,0.000042211912,0.00012652932,0.00025081713,0.00018437312,0.00022646412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024454555,0.000118271724,0.00018606364,0.000052847176,0.00012515666,0.000034891047,0.00007676565,0.00006152707,0.00010373754],"category_scores_gemma":[0.00020293274,0.00008920898,0.00007313498,0.00017771784,0.000014565391,0.00017630415,0.000029695026,0.000095719864,0.0000039037677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033490243,0.00049405807,0.07773816,0.0019169112,0.000654405,0.003675228,0.09294987,0.0012863498,0.33111894,0.0038368632,0.47602442,0.0069558015],"study_design_scores_gemma":[0.0011905646,0.0022456958,0.104573905,0.00023408607,0.00042759738,0.0002178021,0.00071079825,0.005451528,0.14131054,0.00014822051,0.74294806,0.00054122065],"about_ca_topic_score_codex":0.0002650778,"about_ca_topic_score_gemma":0.000087239394,"teacher_disagreement_score":0.26692364,"about_ca_system_score_codex":0.000080239064,"about_ca_system_score_gemma":0.00006612672,"threshold_uncertainty_score":0.36378366},"labels":[],"label_agreement":null},{"id":"W3091107552","doi":"10.1016/j.jhepr.2020.100191","title":"Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital","funders":"Dr. Falk Pharma; Gilead Sciences","keywords":"Medicine; Obeticholic acid; Internal medicine; Ursodeoxycholic acid; Gastroenterology; Placebo; Pathology","score_opus":0.008873080547713833,"score_gpt":0.21300129425023084,"score_spread":0.20412821370251702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091107552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980041,0.000079768884,0.0000071712925,0.00036981096,0.00003350465,0.00102901,0.00003229384,0.000032023287,0.00041232957],"genre_scores_gemma":[0.9956776,0.0000095248415,0.000052113184,0.003857077,0.000024660183,0.000033961252,0.00026005448,0.000026563865,0.00005846097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985531,0.000035525954,0.00036771098,0.00038758756,0.00039726903,0.00025883032],"domain_scores_gemma":[0.9991589,0.000012129379,0.00018188315,0.00028075755,0.00010793144,0.00025835988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000122712,0.0001822154,0.0003632779,0.00010435766,0.000039766124,0.0000343013,0.00004908029,0.000077731616,0.000051889434],"category_scores_gemma":[0.00012482253,0.00013980789,0.000025827307,0.00047241565,0.000038936298,0.00021883438,0.000088782384,0.00025368057,0.0000027531232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062652596,0.0003928726,0.9931525,0.00007313192,0.00007263536,0.0009796311,0.0007524229,0.0000023390444,0.00027948886,1.8092288e-7,0.00027386818,0.0033943767],"study_design_scores_gemma":[0.004064647,0.0010693683,0.99363226,0.0002997821,0.00005167719,0.000019768087,0.000055560424,0.00003216708,0.00039691656,0.0000058341134,0.00020095478,0.00017105082],"about_ca_topic_score_codex":0.00044600162,"about_ca_topic_score_gemma":0.000072462055,"teacher_disagreement_score":0.0034872661,"about_ca_system_score_codex":0.00016525925,"about_ca_system_score_gemma":0.00016454255,"threshold_uncertainty_score":0.57012004},"labels":[],"label_agreement":null},{"id":"W3110042762","doi":"10.1016/j.jhepr.2020.100217","title":"Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"European Commission; National Institute for Health and Care Research; Takeda Pharmaceutical Company","keywords":"Steatosis; Fatty liver; Fructose; Endocrinology; Internal medicine; Glycolysis; Medicine; Biology; Biochemistry; Metabolism; Disease","score_opus":0.015840538796458567,"score_gpt":0.24540463565255863,"score_spread":0.22956409685610007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110042762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342585,0.002255293,0.0000120470695,0.0012426007,0.00022151579,0.00041659392,0.00001720205,0.00016981958,0.0022390862],"genre_scores_gemma":[0.99719906,0.00009595089,0.00022423777,0.0015925887,0.0004119565,0.000032672197,0.00008918212,0.000043426946,0.0003109352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830115,0.000035413585,0.00047766208,0.000587761,0.00033018694,0.0002678554],"domain_scores_gemma":[0.99865884,0.000022666505,0.00022613438,0.00035320004,0.000092182134,0.0006469965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015697558,0.00021829313,0.00040357755,0.0000663858,0.00010618043,0.000056477154,0.000027775268,0.0001134275,0.000099009754],"category_scores_gemma":[0.00041995244,0.00020002779,0.00012999997,0.00021211767,0.00004665445,0.00020189752,0.0000631436,0.0001253447,0.000010469185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016435079,0.00018394606,0.016104814,0.0003851124,0.00008430054,0.0015292423,0.00066630513,5.3650587e-7,0.9445298,0.000022652013,0.016144566,0.020184427],"study_design_scores_gemma":[0.0028591137,0.0006764608,0.08250838,0.00031551346,0.0010912056,0.00087972154,0.0013781611,0.00014212924,0.8775237,0.00021691048,0.031586576,0.0008221174],"about_ca_topic_score_codex":0.00011685535,"about_ca_topic_score_gemma":0.0000015575214,"teacher_disagreement_score":0.06700604,"about_ca_system_score_codex":0.000028703262,"about_ca_system_score_gemma":0.0001631845,"threshold_uncertainty_score":0.8156897},"labels":[],"label_agreement":null},{"id":"W3122013602","doi":"10.1016/j.jhepr.2021.100234","title":"European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Allergan; European Association for the Study of the Liver; National Institute for Health and Care Research; Generalitat de Catalunya; European Social Fund; Gilead Sciences; Centres de Recerca de Catalunya; NIHR Newcastle Biomedical Research Centre; Ministerio de Ciencia, Innovación y Universidades; Instituto de Salud Carlos III; European Commission; Pfizer","keywords":"Preparedness; Epidemiology; Medicine; Fatty liver; Environmental health; Disease; Index (typography); Metabolic syndrome; Obesity; Family medicine; Political science; Pathology; Computer science","score_opus":0.029273893850933482,"score_gpt":0.27670722367827205,"score_spread":0.24743332982733857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122013602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90197724,0.0041605467,0.0000123919535,0.005765803,0.0003995279,0.0009205317,0.00009504923,0.00008225574,0.086586654],"genre_scores_gemma":[0.99553156,0.00039993995,0.000039669714,0.0014833781,0.00017733852,0.00005931754,0.000058150872,0.00004206613,0.0022085987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981967,0.00013244784,0.00043923652,0.00053631084,0.0004758052,0.00021950013],"domain_scores_gemma":[0.99772525,0.000047370304,0.00019884984,0.0012400253,0.00038796826,0.0004005131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022117584,0.00019002825,0.00030645155,0.00004289918,0.00008028915,0.000026529535,0.00008928612,0.000028258766,0.0005390916],"category_scores_gemma":[0.00021050253,0.00012537253,0.0001702236,0.00022658495,0.00005223106,0.000059055492,0.00020259176,0.000067325636,0.00005786378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030462854,0.0042573255,0.8199821,0.0004837438,0.00094143255,0.08231408,0.005371855,0.000021596263,0.00021156495,0.0011086043,0.07620187,0.008801213],"study_design_scores_gemma":[0.00046839143,0.00016561341,0.9198456,0.00028722355,0.0006198733,0.00018818582,0.00015092551,0.000014123375,0.0018411954,0.000099605364,0.0761392,0.00018011502],"about_ca_topic_score_codex":0.00009389566,"about_ca_topic_score_gemma":0.0000344433,"teacher_disagreement_score":0.09986347,"about_ca_system_score_codex":0.00005720265,"about_ca_system_score_gemma":0.00024970018,"threshold_uncertainty_score":0.59026754},"labels":[],"label_agreement":null},{"id":"W3130529097","doi":"10.1016/j.jhepr.2021.100260","title":"Assessing the impact of COVID-19 on liver cancer management (CERO-19)","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Toronto General Hospital; McMaster University; University of Toronto; University Health Network","funders":"UCLH Biomedical Research Centre; Sanofi Genzyme; EMD Serono; Imperial Experimental Cancer Medicine Centre; Cancer Treatment and Research Trust; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ipsen; University College London Hospitals NHS Foundation Trust; Basilea Pharmaceutica; Eisai; Daiichi-Sankyo; National Institute for Health and Care Research; Incyte; BTG; AbbVie; Worldwide Cancer Research; Societat Catalana de Digestologia; Association for International Cancer Research; Sirtex Medical; Wellcome Trust; Cancer Research UK; European Cooperation in Science and Technology; Boston Scientific Corporation; Albert Einstein Cancer Center; Exelixis; Meso Scale Diagnostics; Bayer; Gilead Sciences; Roche; Celgene; Novartis; NIHR Imperial Biomedical Research Centre; Merck; Imperial College London; GlaxoSmithKline; Agència de Gestió d'Ajuts Universitaris i de Recerca; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Instituto de Salud Carlos III; Amgen","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Liver cancer; Virology; Cancer; Internal medicine; Infectious disease (medical specialty)","score_opus":0.1496123350925475,"score_gpt":0.5073078806710404,"score_spread":0.35769554557849287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130529097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554515,0.0025133127,0.00021681044,0.023921417,0.0005467919,0.00072451663,0.0000104772525,0.000087543274,0.016527643],"genre_scores_gemma":[0.9881,0.00067266356,0.000102482954,0.008568654,0.00022781546,0.000024943816,0.000019263387,0.000023591994,0.0022605823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983498,0.00008149794,0.00044677412,0.0003455215,0.0004734651,0.0003029373],"domain_scores_gemma":[0.9981543,0.00018781921,0.00031872428,0.00075484556,0.00014494198,0.00043938577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055641937,0.0001569001,0.0003312404,0.000101881764,0.0001507817,0.000048318998,0.000054982964,0.00007865954,0.0012346214],"category_scores_gemma":[0.00078481494,0.00009958049,0.00022491712,0.00032803215,0.00005613686,0.000083705745,0.00007744669,0.00021994468,0.0000074710624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032343686,0.0009355547,0.6450559,0.003989745,0.0011192964,0.071816,0.0041511147,0.0020766195,0.0027136796,0.00046912095,0.17067777,0.09667178],"study_design_scores_gemma":[0.0006891862,0.00022894757,0.9007357,0.00042239012,0.00022446876,0.0013644804,0.000625396,0.00014427565,0.0009266563,0.0003855117,0.0940852,0.00016779243],"about_ca_topic_score_codex":0.00864468,"about_ca_topic_score_gemma":0.0002498897,"teacher_disagreement_score":0.2556798,"about_ca_system_score_codex":0.0010976305,"about_ca_system_score_gemma":0.003004634,"threshold_uncertainty_score":0.9996784},"labels":[],"label_agreement":null},{"id":"W3132063234","doi":"10.1016/j.jhepr.2021.100255","title":"Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Bile acid; Internal medicine; Ursodeoxycholic acid; FGF19; Taurine; Deoxycholic acid; Endocrinology; Lithocholic acid; Glycocholic acid; Cirrhosis; Cholic acid; Chemistry; Medicine; Gastroenterology; Biochemistry; Amino acid; Receptor; Fibroblast growth factor","score_opus":0.010647121669061873,"score_gpt":0.2859448023548816,"score_spread":0.2752976806858197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132063234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97886616,0.020162692,0.0000028137372,0.0001354825,0.00012655047,0.00031673769,0.00023593906,0.000034352845,0.000119257806],"genre_scores_gemma":[0.9958944,0.0022554668,0.00009401871,0.00022687415,0.00005307837,0.00006573804,0.00094365893,0.000026273288,0.0004405249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838895,0.000065993634,0.00041732762,0.0005085061,0.0003619369,0.00025729384],"domain_scores_gemma":[0.99855816,0.00004200288,0.0002043638,0.00060129876,0.00015364257,0.00044050495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081612736,0.00020135911,0.0004841042,0.000045392753,0.000091726186,0.00003469377,0.000037180907,0.00006503296,0.00020824274],"category_scores_gemma":[0.00006124993,0.00015338056,0.00015457819,0.00016029124,0.000102553255,0.00016088928,0.00009158589,0.0000721856,0.0000045177744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009802337,0.004126695,0.944996,0.00032606185,0.00040126726,0.016463198,0.00080344523,0.000006599543,0.015478851,0.000015102996,0.0032454454,0.014039291],"study_design_scores_gemma":[0.0010849586,0.00026462908,0.94537526,0.0001752358,0.0009900037,0.00070919737,0.00026388842,0.00007889508,0.04661897,0.000061437546,0.0042016804,0.00017585397],"about_ca_topic_score_codex":0.00023156978,"about_ca_topic_score_gemma":0.000014116687,"teacher_disagreement_score":0.031140115,"about_ca_system_score_codex":0.000032616543,"about_ca_system_score_gemma":0.00014660085,"threshold_uncertainty_score":0.6254678},"labels":[],"label_agreement":null},{"id":"W3135464417","doi":"10.1016/j.jhepr.2021.100259","title":"The third year","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Cirrhosis; Viral hepatitis; microRNA; Medicine; Liver disease; Scopus; Chronic hepatitis; Disease; Internal medicine; Gastroenterology; Bioinformatics; MEDLINE; Immunology; Political science; Biology; Virus; Gene","score_opus":0.008265417441087861,"score_gpt":0.22760232315784873,"score_spread":0.21933690571676087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135464417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91289407,0.007078619,0.00009886282,0.001576244,0.008192559,0.00019597234,0.000007998222,0.00018065776,0.06977503],"genre_scores_gemma":[0.8930436,0.000027374816,0.00003544905,0.00016514698,0.00006954686,0.000012316667,0.000032008465,0.0000074246327,0.106607154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933034,0.00008100368,0.00022816833,0.00017705535,0.000028605902,0.00015482241],"domain_scores_gemma":[0.9993114,0.0000776872,0.000103337494,0.00040928234,0.00008711896,0.000011202226],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001745898,0.00006540283,0.00008447875,0.000010982016,0.0002663858,0.000030184336,0.00005349514,0.00008994934,0.0016223874],"category_scores_gemma":[0.00023178976,0.000044823908,0.000064239925,0.00006246503,0.00007858568,0.00003325855,0.00005086881,0.00014115656,0.00079009094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016094527,0.00005180189,0.014846177,0.0000056705026,0.00009993998,0.00089174235,0.00033083075,0.000001428247,0.5080944,0.0021934556,0.47071755,0.0027509332],"study_design_scores_gemma":[0.00008042511,0.000008787317,0.004391066,0.000002940115,0.0000067706883,0.00065535575,0.00012830817,1.4469393e-7,0.21003394,0.0002776056,0.7843616,0.000053059175],"about_ca_topic_score_codex":0.000012836005,"about_ca_topic_score_gemma":0.00004679167,"teacher_disagreement_score":0.31364405,"about_ca_system_score_codex":0.0000169074,"about_ca_system_score_gemma":0.000094699695,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W3137209623","doi":"10.1016/j.jhepr.2021.100265","title":"Defatting strategies in the current era of liver steatosis","year":2021,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Steatosis; Defatting; Medicine; Fatty liver; Liver transplantation; Liver disease; Internal medicine; Disease; Transplantation; Biology","score_opus":0.07248006118339424,"score_gpt":0.3787049822383436,"score_spread":0.30622492105494936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137209623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009472513,0.99612,7.0771017e-7,0.000033218315,0.00020081652,0.0010067568,0.000014132851,0.000011997263,0.001665143],"genre_scores_gemma":[0.0070030256,0.9921777,0.000041069277,0.000020944886,0.00013192008,0.00032647056,0.00025364567,0.000024141782,0.000021068683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800056,0.000159488,0.0008712543,0.00038952465,0.0003925317,0.0001866599],"domain_scores_gemma":[0.9983938,0.00019582568,0.00059703004,0.00066097314,0.000084792955,0.00006759958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030152206,0.00028128325,0.0014318674,0.00008249921,0.000032254393,0.000042674386,0.000076438766,0.00009163338,0.0001089489],"category_scores_gemma":[0.00007041924,0.000158607,0.0007082583,0.00027899625,0.00003708457,0.000054018372,0.000058836064,0.0004575001,0.000006679754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011748277,0.0007307501,0.0033438054,0.014585445,0.0002914283,0.0066921185,0.00020222594,2.5951073e-7,1.909353e-8,0.000112871094,0.00059216714,0.97344774],"study_design_scores_gemma":[0.00016822829,0.0000713809,0.0065200855,0.060316883,0.0049389084,0.00091171457,0.00020354115,6.3613356e-7,0.0000017212624,0.000029702373,0.9266402,0.00019695741],"about_ca_topic_score_codex":0.00015774705,"about_ca_topic_score_gemma":0.000020317977,"teacher_disagreement_score":0.9732508,"about_ca_system_score_codex":0.000115781,"about_ca_system_score_gemma":0.0011713277,"threshold_uncertainty_score":0.6467806},"labels":[],"label_agreement":null},{"id":"W3154594411","doi":"10.1016/j.jhepr.2021.100290","title":"Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Merck Sharp and Dohme; Janssen Pharmaceuticals; Gilead Sciences; Roche; Ipsen; Novartis; AbbVie; Merck; GlaxoSmithKline; Bayer; Siemens; Bristol-Myers Squibb","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Cirrhosis; Entecavir; Gastroenterology; Chronic hepatitis; Predictability; Hepatitis B; Hepatitis B virus; Immunology; Virus","score_opus":0.009296919915915636,"score_gpt":0.22336198892904,"score_spread":0.21406506901312436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154594411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096024,0.0016717275,0.000033547556,0.00013036758,0.00013155275,0.0006255088,0.000031264393,0.00006470868,0.00635109],"genre_scores_gemma":[0.9974334,0.0010409536,0.00028476,0.00003294717,0.00011593772,0.000108837645,0.00006939688,0.000049205613,0.00086456514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977998,0.00008272032,0.00070196664,0.0005385428,0.00047175854,0.00040520466],"domain_scores_gemma":[0.99839795,0.000032824562,0.00039028536,0.0006725517,0.0003666864,0.0001397181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019674198,0.00026466476,0.000705452,0.0001762088,0.00009405975,0.000011127335,0.000048242004,0.00011937142,0.0001620067],"category_scores_gemma":[0.00020740692,0.00022300475,0.00010235628,0.0005846475,0.00019076322,0.0001348235,0.000065905486,0.0003048335,0.000007068816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013272912,0.00018700812,0.9760844,0.00024093027,0.00017582896,0.0192674,0.0011215564,0.00003748105,0.0007594048,0.0000034618545,0.000214352,0.0017754349],"study_design_scores_gemma":[0.00092169974,0.001125458,0.96483094,0.0005975716,0.00022423943,0.0017369034,0.000065497676,0.001986977,0.027703054,0.000010257956,0.00060064724,0.00019676948],"about_ca_topic_score_codex":0.025756694,"about_ca_topic_score_gemma":0.038160518,"teacher_disagreement_score":0.02694365,"about_ca_system_score_codex":0.00044065827,"about_ca_system_score_gemma":0.00084661116,"threshold_uncertainty_score":0.9807309},"labels":[],"label_agreement":null},{"id":"W3187281785","doi":"10.1016/j.jhepr.2021.100350","title":"Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Fujirebio Europe; Gilead Sciences","keywords":"Medicine; Fatty liver; Steatosis; Steatohepatitis; Disease; Diabetes mellitus; Internal medicine; Adverse effect; Type 2 diabetes; Overweight; Metabolic syndrome; Gastroenterology; Clinical significance; Obesity; Endocrinology","score_opus":0.005151699342772957,"score_gpt":0.21307036498006576,"score_spread":0.2079186656372928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187281785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997279,0.0016930122,0.0000019276104,0.000039261973,0.00011439858,0.00053328776,0.00018317581,0.00003384492,0.00012209888],"genre_scores_gemma":[0.99818295,0.00071470946,0.00004778893,0.00008610811,0.000025058518,0.00010554939,0.0006391924,0.000022070886,0.00017657284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984621,0.00008870935,0.00042512084,0.0003673462,0.00045290397,0.000203856],"domain_scores_gemma":[0.99853426,0.00007652212,0.00037202955,0.0004673839,0.00029562926,0.00025416035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008214809,0.00018769356,0.00050761027,0.00009484102,0.000050230858,0.0000058548217,0.000024370716,0.000047392215,0.00045798885],"category_scores_gemma":[0.00044991888,0.00013791097,0.00020056927,0.0002530493,0.000046416768,0.00012232686,0.000042283584,0.00008661866,0.000008882089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014365185,0.0048825582,0.98889965,0.00006152492,0.0008491661,0.004233601,0.000039703646,0.000028810717,0.000001545016,0.000008821748,0.00009849838,0.0007524879],"study_design_scores_gemma":[0.003232517,0.00020562828,0.99403304,0.00019772643,0.0018188256,0.000006606574,0.000009068461,0.000020118368,0.00018780978,0.00001915119,0.00013608985,0.00013339298],"about_ca_topic_score_codex":0.007149034,"about_ca_topic_score_gemma":0.0024663985,"teacher_disagreement_score":0.005133435,"about_ca_system_score_codex":0.00024605935,"about_ca_system_score_gemma":0.000504836,"threshold_uncertainty_score":0.9994624},"labels":[],"label_agreement":null},{"id":"W3187685128","doi":"10.1016/j.jhepr.2021.100343","title":"External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Radiumhemmets Forskningsfonder; Cancerfonden; Swedish Cancer Foundation","keywords":"Hepatocellular carcinoma; Index (typography); Population; Medicine; Oncology; Environmental health; Internal medicine; Computer science; World Wide Web","score_opus":0.027049601423744806,"score_gpt":0.2456920297140943,"score_spread":0.2186424282903495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187685128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963122,0.0014716403,0.00006430306,0.00009466937,0.00030489007,0.00047071488,0.0000037413279,0.000019013749,0.0012588188],"genre_scores_gemma":[0.999016,0.000042210577,0.00020473085,0.000031487725,0.00010652075,0.000037563543,0.00008194642,0.000018793206,0.00046075974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842364,0.0001310751,0.00056777534,0.00030101457,0.0004058461,0.00017063535],"domain_scores_gemma":[0.9988757,0.000025932211,0.00035211974,0.00054715504,0.00012664024,0.00007250102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033402024,0.00013415558,0.0002868477,0.000041102405,0.000054747063,0.000016070775,0.000042816446,0.000096369615,0.00028595],"category_scores_gemma":[0.00016642935,0.00010302239,0.00020316288,0.00021431937,0.00002229522,0.00012596641,0.000052716136,0.00012872486,0.0000021586059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003082981,0.00017011682,0.99295545,0.000048847898,0.000027294538,0.001833908,0.00024418274,0.0000045016627,0.002806181,0.0000145044,0.00003531401,0.0018288931],"study_design_scores_gemma":[0.0005056788,0.000042599244,0.9365748,0.000101847756,0.00013868386,0.000514875,0.00006805853,0.0015646075,0.059877016,0.0003146675,0.00020970755,0.000087466484],"about_ca_topic_score_codex":0.007459849,"about_ca_topic_score_gemma":0.00069088343,"teacher_disagreement_score":0.057070836,"about_ca_system_score_codex":0.00023588462,"about_ca_system_score_gemma":0.00014893513,"threshold_uncertainty_score":0.99914956},"labels":[],"label_agreement":null},{"id":"W3199692770","doi":"10.1016/j.jhepr.2021.100364","title":"Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Horizon 2020 Framework Programme; Ministerio de Ciencia e Innovación; Fundación Científica Asociación Española Contra el Cáncer; European Commission; Samuel Waxman Cancer Research Foundation; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Generalitat de Catalunya; Cancer Research UK; U.S. Department of Defense","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Biopsy; Radiology; Gastroenterology; Internal medicine; Liver biopsy","score_opus":0.023563533847907932,"score_gpt":0.24478321405552755,"score_spread":0.22121968020761962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199692770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942729,0.002326178,0.0001515747,0.00044841622,0.00029330238,0.0021655255,0.000025641022,0.000019780344,0.00029666806],"genre_scores_gemma":[0.99757254,0.00016412347,0.00046765705,0.00013168715,0.00013141653,0.001046757,0.00026210208,0.000070867056,0.00015286311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978909,0.00004194895,0.00068943895,0.0005653845,0.0003825265,0.00042983284],"domain_scores_gemma":[0.998069,0.00021087714,0.00034108644,0.0007735427,0.0004719227,0.00013357436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026506864,0.00029207315,0.0006096371,0.0001344282,0.00009606097,0.000035807858,0.00008280577,0.00008566662,0.0001959657],"category_scores_gemma":[0.00017258567,0.00020998521,0.00026196978,0.00039058895,0.00010446527,0.0001280306,0.00006806213,0.00014706876,0.000005750438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081284714,0.00042135638,0.9902465,0.0005114195,0.00014909785,0.0055181175,0.00042875163,0.0000022837119,0.0005219307,0.0000027632861,0.00058345136,0.001533083],"study_design_scores_gemma":[0.0023038143,0.00045727324,0.9399419,0.0005035847,0.00052667514,0.00020629347,0.000060340775,0.003371471,0.05182806,0.00004839013,0.0005258834,0.00022632765],"about_ca_topic_score_codex":0.0014780535,"about_ca_topic_score_gemma":0.000507174,"teacher_disagreement_score":0.05130613,"about_ca_system_score_codex":0.0002514265,"about_ca_system_score_gemma":0.00050528493,"threshold_uncertainty_score":0.8562948},"labels":[],"label_agreement":null},{"id":"W3202725809","doi":"10.1016/j.jhepr.2021.100368","title":"Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Regional Development Fund; Ministerio de Ciencia e Innovación; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ministerio de Ciencia, Innovación y Universidades; Instituto de Salud Carlos III; Gilead Sciences","keywords":"Ascites; Cirrhosis; Medicine; Internal medicine; Gastroenterology; Portal venous pressure; Biomarker; Portal hypertension; Placebo; Pathology","score_opus":0.0059691491366808454,"score_gpt":0.21047642299185915,"score_spread":0.2045072738551783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202725809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781185,0.00009302894,0.00000709129,0.00016968956,0.00013487208,0.00033036742,0.000055343935,0.000058288388,0.0013394421],"genre_scores_gemma":[0.9979783,0.000017333707,0.00015291886,0.0002622126,0.000027367563,0.000014645886,0.0012676574,0.000017743776,0.00026180374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988219,0.00003469862,0.00029858228,0.00030635318,0.0003520369,0.00018641121],"domain_scores_gemma":[0.99925584,0.000028268283,0.00010588749,0.0002920186,0.00018218569,0.00013581796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007650991,0.000120590026,0.00022104384,0.000084283056,0.000038802154,0.000018259492,0.000021720405,0.000058430403,0.0002444758],"category_scores_gemma":[0.000019718851,0.00010032234,0.00004551339,0.00027702778,0.00002763825,0.00012082083,0.000012474036,0.00010429754,0.000013468157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020343572,0.0003215144,0.9926093,0.0001084656,0.00014754305,0.005943206,0.00024247853,0.0000063612033,0.00008650611,0.000002902266,0.00016349534,0.00016476793],"study_design_scores_gemma":[0.0018948985,0.00014152424,0.99397886,0.0003581447,0.00031969688,0.0002172846,0.000035055575,0.000021504718,0.0027423122,0.00003490393,0.00014377039,0.00011202219],"about_ca_topic_score_codex":0.00009150218,"about_ca_topic_score_gemma":0.00010538976,"teacher_disagreement_score":0.0057259216,"about_ca_system_score_codex":0.000046202444,"about_ca_system_score_gemma":0.00019019992,"threshold_uncertainty_score":0.40910262},"labels":[],"label_agreement":null},{"id":"W3214836651","doi":"10.1016/j.jhepr.2021.100411","title":"Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"NIHR Newcastle Biomedical Research Centre; Horizon 2020 Framework Programme; Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations; National Institute for Health and Care Research; Gilead Sciences","keywords":"Steatohepatitis; Guideline; Medicine; Transient elastography; Fatty liver; Disease; Clinical Practice; Family medicine; Internal medicine; Pathology; Fibrosis","score_opus":0.04486728041178561,"score_gpt":0.42644043853230706,"score_spread":0.38157315812052145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214836651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619152,0.0007642369,0.00013894946,0.01765308,0.00054421934,0.0005936457,0.00013878582,0.000045858684,0.018206054],"genre_scores_gemma":[0.9526757,0.015621639,0.025992943,0.0020278182,0.00019076258,0.00010960676,0.0012069846,0.000029760511,0.0021447937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795395,0.00007624918,0.0010318693,0.00048536054,0.00027135442,0.00018119808],"domain_scores_gemma":[0.998005,0.00027515987,0.0004605787,0.0007247737,0.0002953025,0.00023919449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003276307,0.00014496449,0.0004205473,0.000039545725,0.00009785212,0.000027178765,0.00003232871,0.000057608464,0.00021925714],"category_scores_gemma":[0.00018147947,0.00012890076,0.00016986023,0.00020068415,0.00006866594,0.0001444594,0.00014089813,0.00011052272,0.0000069457146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066851935,0.0023005838,0.87701166,0.00007647508,0.001749483,0.012077974,0.0002781686,0.0000013129787,0.000022667293,0.00024632973,0.060626734,0.04554174],"study_design_scores_gemma":[0.001286771,0.00009419272,0.88216084,0.0003928692,0.0011832168,0.00016941354,0.0007384796,0.000035049932,0.00025286395,0.00021175061,0.11335751,0.00011705186],"about_ca_topic_score_codex":0.0019142487,"about_ca_topic_score_gemma":0.0002388425,"teacher_disagreement_score":0.052730773,"about_ca_system_score_codex":0.0000795224,"about_ca_system_score_gemma":0.00010552891,"threshold_uncertainty_score":0.52564204},"labels":[],"label_agreement":null},{"id":"W3216774526","doi":"10.1016/j.jhepr.2021.100398","title":"Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV","year":2021,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Institutes of Health; Fonds Wetenschappelijk Onderzoek","keywords":"HBcAg; HBsAg; Hepatitis B virus; Immunology; Humoral immunity; Hepatitis B; Immune system; Virology; B cell; Biology; Antibody; Immunity; Medicine; Virus","score_opus":0.06430622315871269,"score_gpt":0.38134827861304305,"score_spread":0.31704205545433034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216774526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021760438,0.9710085,0.0000012126244,0.00011419114,0.0008308521,0.0015379796,0.000009133626,0.0000616986,0.0046759946],"genre_scores_gemma":[0.003964039,0.99412596,0.00016628075,0.00010133542,0.0002717788,0.00075501186,0.000105401436,0.00006951488,0.00044069477],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567723,0.00078406127,0.002050085,0.0006147496,0.00043589238,0.0004379638],"domain_scores_gemma":[0.99711126,0.0007080088,0.0007522337,0.0011917844,0.00015849744,0.00007820822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001964381,0.00045376105,0.002659221,0.00034137612,0.0001631417,0.000042485524,0.000096862066,0.00032015605,0.00023206971],"category_scores_gemma":[0.00495194,0.00033023005,0.00055890006,0.0012311036,0.00016779285,0.00009463636,0.00030970195,0.001514904,0.00002806918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020546347,0.00017773217,0.5461577,0.0067095524,0.000108598586,0.0074971006,0.0007125865,9.933314e-7,4.852637e-7,0.000017726321,0.0006462568,0.43796918],"study_design_scores_gemma":[0.00012667778,0.00008868685,0.12918116,0.025160072,0.0002628417,0.0019516275,0.000029984561,0.0000017644869,0.0000010727894,0.000058517267,0.8428442,0.00029343282],"about_ca_topic_score_codex":0.13403098,"about_ca_topic_score_gemma":0.18112941,"teacher_disagreement_score":0.8421979,"about_ca_system_score_codex":0.00095935346,"about_ca_system_score_gemma":0.0008579844,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W4213412991","doi":"10.1016/j.jhepr.2022.100462","title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis C virus research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Centre for Disease Control","funders":"National Health and Medical Research Council; Ministero dell’Istruzione, dell’Università e della Ricerca; Ministero della Salute; Gilead Sciences; University of Sydney; Department of Health and Ageing, Australian Government; Genome British Columbia; Merck","keywords":"NS5A; NS5B; Medicine; Hepatitis C virus; Sofosbuvir; Drug resistance; Virology; NS3; Internal medicine; Ribavirin; Virus; Hepacivirus; Biology; Microbiology","score_opus":0.023632290323086683,"score_gpt":0.33304164089867544,"score_spread":0.30940935057558877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213412991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816412,0.00009211683,0.000011522226,0.00010728028,0.00024773108,0.0003637491,0.00013011353,0.000018804516,0.017387496],"genre_scores_gemma":[0.99823433,0.00022514861,0.00048292204,0.00007812495,0.000060482318,0.00014519815,0.000089040936,0.00002620537,0.0006585503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976193,0.0001333947,0.000867287,0.0003167693,0.0008567864,0.00020651834],"domain_scores_gemma":[0.9987416,0.00007050444,0.00046211312,0.00044482565,0.00020255226,0.000078366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009205441,0.000103247214,0.00043213004,0.00028165654,0.000036347603,0.000010387435,0.00010700982,0.000046233716,0.00091054576],"category_scores_gemma":[0.0007158062,0.000113372225,0.000072311756,0.00030253959,0.00007269529,0.00016278414,0.0001530525,0.00026990002,0.0000015594534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028511172,0.00025718624,0.97948635,0.00007664645,0.000043575794,0.0039252527,0.00044326854,0.0000015426797,0.0105556995,0.000010237562,0.0001179625,0.004797191],"study_design_scores_gemma":[0.00020429825,0.000121440426,0.9720085,0.00010591852,0.000016443239,0.00003619476,0.000019165742,0.000083046114,0.006729671,0.00002341239,0.020560862,0.00009101191],"about_ca_topic_score_codex":0.0015313327,"about_ca_topic_score_gemma":0.0014182163,"teacher_disagreement_score":0.0204429,"about_ca_system_score_codex":0.0002185803,"about_ca_system_score_gemma":0.00019737269,"threshold_uncertainty_score":0.99698377},"labels":[],"label_agreement":null},{"id":"W4214591600","doi":"10.1016/j.jhepr.2022.100461","title":"Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of British Columbia; University of Ottawa; University of Toronto; University of Alberta; McGill University; University of Calgary; University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Medicine; Hepatitis D virus; HBsAg; Internal medicine; Cohort; Epidemiology; Cirrhosis; Hepatitis D; Hepatitis B virus; Liver disease; Genotype; Virology; Virus; Biology","score_opus":0.03231127326058857,"score_gpt":0.3279446422088672,"score_spread":0.29563336894827863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214591600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982148,0.00027004725,0.000024055622,0.00029507288,0.00056800107,0.00019975238,0.000017742264,0.000009332674,0.00040123973],"genre_scores_gemma":[0.9974666,0.0015285751,0.000088063156,0.0007780835,0.000037155096,0.000036590616,0.000024608471,0.0000103631255,0.00002996347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998282,0.00022177442,0.0009566434,0.00022390486,0.000152578,0.00016308963],"domain_scores_gemma":[0.9990683,0.00021433015,0.0003847243,0.00020883734,0.000049886243,0.00007392344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000906242,0.000079019344,0.000551242,0.00006133045,0.00004772799,8.233154e-7,0.000016473396,0.00003550171,0.000091145586],"category_scores_gemma":[0.0021784625,0.00008189873,0.00004671881,0.00010944328,0.000060016904,0.000015880467,0.000114918024,0.0002442722,3.5074217e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018709814,0.000054773733,0.9909879,0.000031976368,0.00004231339,0.0033266868,0.000027721053,0.000007522857,0.00009929962,0.00002074745,0.00055016036,0.00483221],"study_design_scores_gemma":[0.00015560044,0.00017796947,0.9931537,0.000016911634,0.00003813771,0.00050815294,0.000004575818,0.00014379884,0.00007138249,0.00009921687,0.0055675786,0.00006299028],"about_ca_topic_score_codex":0.9856877,"about_ca_topic_score_gemma":0.9690458,"teacher_disagreement_score":0.01664187,"about_ca_system_score_codex":0.0003442582,"about_ca_system_score_gemma":0.00062309654,"threshold_uncertainty_score":0.33397332},"labels":[],"label_agreement":null},{"id":"W4220972607","doi":"10.1016/j.jhepr.2022.100478","title":"Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Valeant Pharmaceuticals International","keywords":"Zolpidem; Medicine; Deprescribing; Decompensation; Cirrhosis; Benzodiazepine; Internal medicine; Pediatrics; Intensive care medicine; Psychiatry; Polypharmacy","score_opus":0.004356386718543738,"score_gpt":0.21295695695821767,"score_spread":0.20860057023967393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220972607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853355,0.0001936985,0.0000046794266,0.00008623152,0.00006482568,0.00026878965,0.0000061054448,0.000022540384,0.00081957167],"genre_scores_gemma":[0.9994438,0.0000126687,0.00007987431,0.00025863067,0.00002016619,0.000034088716,0.000104622464,0.0000098804685,0.000036222078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992555,0.000023103084,0.00016945029,0.00020386829,0.0002456349,0.00010246483],"domain_scores_gemma":[0.999699,0.000018985045,0.00008213017,0.00011685732,0.000021525362,0.00006152158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009163173,0.00006766847,0.00012209301,0.00008002466,0.000076528144,0.0000099117115,0.0000155777,0.000016899765,0.00009706669],"category_scores_gemma":[0.0000071672207,0.00005495668,0.000019123576,0.00009125233,0.000014193149,0.00008723964,0.000017519602,0.000100797464,4.2511817e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020885273,0.00011383985,0.99640393,0.000028353372,0.00005352749,0.0008042888,0.00073199766,0.000033746877,0.0001475019,0.0000024805222,0.000050618775,0.0014208729],"study_design_scores_gemma":[0.0007128946,0.00013921154,0.9976638,0.00004431758,0.0001473864,0.00007889745,0.00018569376,0.000008273003,0.0007479234,0.00004207566,0.00016055946,0.00006895779],"about_ca_topic_score_codex":0.0001897393,"about_ca_topic_score_gemma":0.000015936246,"teacher_disagreement_score":0.0013519151,"about_ca_system_score_codex":0.000032818127,"about_ca_system_score_gemma":0.000040963405,"threshold_uncertainty_score":0.22410683},"labels":[],"label_agreement":null},{"id":"W4224944802","doi":"10.1016/j.jhepr.2022.100495","title":"Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Radiodensity; Medicine; Cirrhosis; Adipose tissue; Internal medicine; Gastroenterology; Confounding; Hazard ratio; Radiology; Radiography; Confidence interval","score_opus":0.018521804276233678,"score_gpt":0.2741412992779203,"score_spread":0.2556194950016866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224944802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659795,0.00008896559,0.0000018211363,0.000440857,0.00017307843,0.00077258237,0.000031191823,0.000104754385,0.0017888155],"genre_scores_gemma":[0.99615675,0.0000037190634,0.00013110555,0.0026375125,0.00003614965,0.00007264858,0.00030041856,0.000032952084,0.000628771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979435,0.000111975685,0.00046294354,0.0004145741,0.0007423298,0.00032464392],"domain_scores_gemma":[0.99880373,0.00003608777,0.00035487776,0.00043305132,0.00015429228,0.00021797649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004237034,0.00016384834,0.00044548116,0.0001386804,0.00020422983,0.000013523622,0.000043463064,0.00006200768,0.0013550265],"category_scores_gemma":[0.000045783465,0.0001411254,0.00003648254,0.0004422927,0.000047452933,0.00005497897,0.00004253622,0.00038949025,0.000003133975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050517096,0.0008659637,0.9847782,0.00006105231,0.000088396104,0.011080818,0.00020174053,0.000004440734,0.000031242624,0.000004424897,0.0021174997,0.00026100854],"study_design_scores_gemma":[0.0024630213,0.00086977147,0.9903348,0.00012236867,0.00013012574,0.0006502066,0.000022104676,0.000015352065,0.000110137014,0.000036376263,0.00506609,0.0001796663],"about_ca_topic_score_codex":0.0014904329,"about_ca_topic_score_gemma":0.00018219648,"teacher_disagreement_score":0.010430612,"about_ca_system_score_codex":0.000570927,"about_ca_system_score_gemma":0.00016826358,"threshold_uncertainty_score":0.99955785},"labels":[],"label_agreement":null},{"id":"W4251823135","doi":"10.1016/j.jhepr.2019.07.001","title":"Editorial musings","year":2019,"lang":"es","type":"editorial","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Radiation therapy; Medicine; Randomized controlled trial; Hepatocellular carcinoma; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.025328404746769152,"score_gpt":0.25729106091989784,"score_spread":0.2319626561731287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251823135","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017406503,0.002192963,0.00000450489,0.00019591747,0.9595621,0.0020898913,0.00009556129,0.00022841702,0.018224094],"genre_scores_gemma":[0.05059092,0.00064236036,0.00009887684,0.000056757275,0.92363715,0.00014203461,0.00316368,0.00026868423,0.021399524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918823,0.00017264347,0.001783648,0.0018365341,0.003197172,0.001127705],"domain_scores_gemma":[0.9940596,0.0006978077,0.001604289,0.0020434223,0.0009873176,0.0006075393],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001301365,0.0012019573,0.0021235547,0.00040452063,0.00025640344,0.00032239952,0.00026212318,0.0035191323,0.0015384513],"category_scores_gemma":[0.0020300164,0.0010764014,0.0011559168,0.00039307494,0.00017373383,0.0002520108,0.00025829562,0.0018985624,0.0020620625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002754689,0.00035337862,0.14363503,0.0007735747,0.0007035421,0.0074542933,0.00019960714,1.9476145e-7,0.00026488196,0.0000054199436,0.8448014,0.0015331913],"study_design_scores_gemma":[0.0017945359,0.00094755954,0.00046391506,0.0010988225,0.0026794777,0.00025125893,0.000029746669,0.000026501397,0.0005076632,0.00005836643,0.99119145,0.0009507346],"about_ca_topic_score_codex":0.0008699449,"about_ca_topic_score_gemma":0.00000767022,"teacher_disagreement_score":0.14639,"about_ca_system_score_codex":0.000847981,"about_ca_system_score_gemma":0.0031331265,"threshold_uncertainty_score":0.9993743},"labels":[],"label_agreement":null},{"id":"W4280595648","doi":"10.1016/j.jhepr.2022.100498","title":"Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity","year":2022,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Radiation therapy; Cirrhosis; Oncology; Radiofrequency ablation; Radiology; Internal medicine; Ablation","score_opus":0.10344352584465884,"score_gpt":0.32238962160097967,"score_spread":0.21894609575632085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280595648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037689798,0.9516466,0.00001873719,0.00008455111,0.0011399871,0.008530934,0.0001630085,0.00016540647,0.00056095584],"genre_scores_gemma":[0.026410727,0.9602025,0.00037648945,0.00020227229,0.00097406405,0.004536654,0.0062221987,0.00023478639,0.00084031123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959173,0.00022498077,0.0014356636,0.0012299506,0.0006299568,0.0005621082],"domain_scores_gemma":[0.99672055,0.00039668905,0.0010038416,0.0013801233,0.00009203575,0.00040676192],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062080135,0.00077324506,0.0025429148,0.00043169124,0.0002583748,0.000090314556,0.00017184037,0.0004244418,0.0010662448],"category_scores_gemma":[0.00022761074,0.00066517055,0.0014565631,0.0004961315,0.000021246482,0.0001253691,0.00012257324,0.0005522574,0.0000464281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095223055,0.0003431146,0.22023658,0.0041962606,0.0008897651,0.005326274,0.00023754167,1.9496376e-8,0.000004539595,0.000006173839,0.0017437891,0.7669207],"study_design_scores_gemma":[0.0007226585,0.0005331386,0.0030941318,0.0012048208,0.0026613248,0.00068792887,0.0000075921816,0.00004086502,0.000053421027,0.00004820976,0.99035776,0.00058817875],"about_ca_topic_score_codex":0.00048943644,"about_ca_topic_score_gemma":0.000004783497,"teacher_disagreement_score":0.98861396,"about_ca_system_score_codex":0.00057031336,"about_ca_system_score_gemma":0.0008709401,"threshold_uncertainty_score":0.99984694},"labels":[],"label_agreement":null},{"id":"W4281249735","doi":"10.1016/j.jhepr.2022.100508","title":"A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Eastern Health; Université de Lausanne; University of Bern","keywords":"Fibrosis; Biology; DNA damage; Pathology; Cancer research; Senescence; Medicine; Cell biology","score_opus":0.029971465619637292,"score_gpt":0.291080551182611,"score_spread":0.2611090855629737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281249735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416524,0.00013977695,0.0029001902,0.0004090068,0.0007303632,0.0012132063,0.000013240937,0.00013798276,0.00029098935],"genre_scores_gemma":[0.991946,0.0000056979893,0.0018393764,0.0003147515,0.00031108916,0.000089025634,0.00016884619,0.000048376856,0.005276881],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978835,0.00012855597,0.0005680216,0.00044446517,0.00076002884,0.00021545783],"domain_scores_gemma":[0.99812907,0.00008575749,0.00050827046,0.00071410555,0.00010437057,0.00045841825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000290588,0.00017279622,0.0003222906,0.00021404006,0.000183824,0.000022492373,0.00007304985,0.00007107927,0.0004757615],"category_scores_gemma":[0.0007272556,0.00018507782,0.00014753304,0.00023157541,0.00001629062,0.00030184267,0.00005318997,0.00024031143,0.000008643015],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003209391,0.0013055265,0.07144417,0.0006238082,0.00036646155,0.0024615915,0.0030390448,0.30710477,0.5533946,0.0005900285,0.024221921,0.032238662],"study_design_scores_gemma":[0.019318376,0.011138408,0.25370368,0.0003599912,0.0032223656,0.0024038432,0.0008174238,0.65052176,0.03870511,0.014162114,0.0031359992,0.002510904],"about_ca_topic_score_codex":0.00030988024,"about_ca_topic_score_gemma":0.000009145598,"teacher_disagreement_score":0.5146895,"about_ca_system_score_codex":0.00030885366,"about_ca_system_score_gemma":0.0009296453,"threshold_uncertainty_score":0.75472546},"labels":[],"label_agreement":null},{"id":"W4286509886","doi":"10.1016/j.jhepr.2022.100544","title":"Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Liver Centre; University of Alberta","funders":"Novartis Institutes for BioMedical Research; Intercept Pharmaceuticals; Medical Research Council; Merck; Dr. Falk Pharma; GlaxoSmithKline; National Institute for Health and Care Research; Novartis; Pfizer","keywords":"Ursodeoxycholic acid; Tolerability; Placebo; Medicine; Discontinuation; Internal medicine; Obeticholic acid; Adverse effect; Cholestasis; Gastroenterology; Primary biliary cirrhosis; Farnesoid X receptor; Agonist; Receptor; Pathology","score_opus":0.00779975170173277,"score_gpt":0.2178358120458716,"score_spread":0.21003606034413883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286509886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567014,0.00024289566,5.295302e-7,0.00029104252,0.00037839927,0.0023342825,0.000049471917,0.00004293363,0.0009903072],"genre_scores_gemma":[0.9975192,0.000027673093,0.00006956212,0.00040600853,0.000092532384,0.00054162345,0.00085752085,0.000034959474,0.00045092741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793047,0.00020765129,0.00064523536,0.00041432318,0.00050940574,0.00029291405],"domain_scores_gemma":[0.99890375,0.000064620916,0.00027855692,0.00056146894,0.00006139994,0.0001301778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047904014,0.00018593793,0.000519611,0.00022118763,0.00012978178,0.000026786614,0.00008989145,0.000049819635,0.0006000871],"category_scores_gemma":[0.00019284741,0.00015386,0.00014024456,0.00042550484,0.000059968912,0.0001381238,0.0001270904,0.00040148708,0.000005070293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11354382,0.0022079984,0.8766891,0.000061619336,0.000054822693,0.0008377964,0.00026926884,0.000009400431,0.000089365545,6.2923107e-7,0.0012549113,0.0049812975],"study_design_scores_gemma":[0.17597173,0.00094314263,0.8179778,0.00006290279,0.00007107262,0.000041748674,0.00014356407,0.0000036488084,0.000041801097,0.0000090803815,0.0045647807,0.00016875296],"about_ca_topic_score_codex":0.0006654139,"about_ca_topic_score_gemma":0.00001993771,"teacher_disagreement_score":0.062427916,"about_ca_system_score_codex":0.0004378217,"about_ca_system_score_gemma":0.00034575592,"threshold_uncertainty_score":0.65705335},"labels":[],"label_agreement":null},{"id":"W4288058386","doi":"10.1016/j.jhepr.2022.100531","title":"Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centro Hospitalar Universitário do Porto; European Association for the Study of the Liver; Università degli Studi di Salerno; Roche España; University of Nottingham; Queen Elizabeth Hospital Birmingham Charity; Humanitas Research Hospital; Università degli Studi di Napoli Federico II; Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Gilead Sciences; Uniwersytet Medyczny w Bialymstoku; Ankara Universitesi; Faculty of Medicine Siriraj Hospital, Mahidol University; University of Toronto; AbbVie; Università Cattolica del Sacro Cuore; Kocaeli Üniversitesi; Mahidol University; North American Membrane Society","keywords":"Pandemic; Medicine; Hepatitis C; HBsAg; Virology; Viral hepatitis; Hepatitis B; Coronavirus disease 2019 (COVID-19); Family medicine; Hepatitis B virus; Internal medicine; Disease; Virus; Infectious disease (medical specialty)","score_opus":0.08551850487269273,"score_gpt":0.37467653011625196,"score_spread":0.2891580252435592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288058386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976211,0.00015756545,0.0000055554574,0.00048562128,0.00021100501,0.0003635921,0.00007517314,0.000037591402,0.0010427645],"genre_scores_gemma":[0.99847084,0.00010771246,0.000014245811,0.00077899237,0.000043740776,0.000047911406,0.00004944345,0.000015284098,0.00047180228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856853,0.00026104218,0.00033521216,0.00024919902,0.0004420218,0.0001440179],"domain_scores_gemma":[0.99886465,0.00017057521,0.0002681449,0.0004649487,0.000093200666,0.00013848138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010621186,0.00010783211,0.00025873742,0.00006808665,0.00027461076,0.0000075274093,0.000052670704,0.000031880503,0.00035240126],"category_scores_gemma":[0.001708662,0.0000752457,0.00008263144,0.00021637214,0.0000968469,0.00004364421,0.00012894171,0.00017163798,9.4535824e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057726356,0.00011189733,0.9931383,0.00002040822,0.000056749534,0.00025100462,0.00065874076,0.000042244617,0.00016288772,0.000014917035,0.004280968,0.0012041139],"study_design_scores_gemma":[0.00026144704,0.0007188514,0.99436915,0.000009116844,0.000034507044,0.001239019,0.000025203768,0.000043769323,0.000022872633,0.00010914886,0.0030923143,0.000074582116],"about_ca_topic_score_codex":0.033578992,"about_ca_topic_score_gemma":0.010341741,"teacher_disagreement_score":0.02323725,"about_ca_system_score_codex":0.00038673967,"about_ca_system_score_gemma":0.0003853118,"threshold_uncertainty_score":0.97285646},"labels":[],"label_agreement":null},{"id":"W4295007474","doi":"10.1016/j.jhepr.2022.100578","title":"What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association","year":2022,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cancer Research UK","keywords":"Hepatocellular carcinoma; Medicine; Incidence (geometry); Liver cancer; Public health; Cancer; Health care; Family medicine; Environmental health; Political science; Internal medicine; Nursing","score_opus":0.18210931816076126,"score_gpt":0.37645002174293657,"score_spread":0.1943407035821753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295007474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004032616,0.9732065,0.000030881045,0.0147431,0.0060940175,0.004366754,0.0008755619,0.00006754858,0.00021237906],"genre_scores_gemma":[0.0006154407,0.97387314,0.0004327933,0.0016296987,0.0015999185,0.006258436,0.008581185,0.000098107725,0.0069113094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665874,0.00025453797,0.0011886376,0.0007642231,0.0007209941,0.00041288635],"domain_scores_gemma":[0.9969123,0.0007247887,0.0012852099,0.00065965496,0.0001915535,0.00022652124],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012853259,0.00043049044,0.0013639285,0.00018633556,0.00048354536,0.00031390172,0.00023669636,0.00023850707,0.0028237544],"category_scores_gemma":[0.00031788272,0.0003249891,0.0009185661,0.0002992085,0.000017454766,0.00019508564,0.0001817963,0.0004658476,0.000024938716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015949556,0.00012687936,0.0913473,0.0012533673,0.00093948754,0.00028944842,0.0011129929,9.249734e-8,9.432732e-8,0.00003063882,0.1649649,0.7399188],"study_design_scores_gemma":[0.00022363664,0.00011586195,0.0004891592,0.0033654321,0.0015574527,0.00009060933,0.00022812744,0.000048944665,0.0000022424904,0.000044717257,0.9935618,0.00027203324],"about_ca_topic_score_codex":0.0024326018,"about_ca_topic_score_gemma":0.00017311586,"teacher_disagreement_score":0.8285969,"about_ca_system_score_codex":0.0033793524,"about_ca_system_score_gemma":0.0015169667,"threshold_uncertainty_score":0.9999202},"labels":[],"label_agreement":null},{"id":"W4296668671","doi":"10.1016/j.jhepr.2022.100590","title":"ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Pediatric Hepatobiliary Diseases and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gastroenterology; Internal medicine; Medicine; Pathology; Odds ratio","score_opus":0.00605458934532746,"score_gpt":0.21482490478322422,"score_spread":0.20877031543789676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296668671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955425,0.0005076907,0.0000022043705,0.0003851337,0.00022793986,0.001139827,0.00031193497,0.0002256745,0.0016570851],"genre_scores_gemma":[0.9941605,0.00008141404,0.000038220765,0.00095029065,0.00003918731,0.00064217794,0.00085433887,0.00009449384,0.0031393794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959928,0.0001866714,0.0008719622,0.000884717,0.0012599195,0.00080397574],"domain_scores_gemma":[0.99780554,0.00013105647,0.0006406226,0.0008337893,0.00017855548,0.00041043613],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007047597,0.0004624894,0.0009861904,0.0002988706,0.00035125786,0.000047413763,0.00013212499,0.00014217074,0.0011880726],"category_scores_gemma":[0.00020791538,0.0003727703,0.00021280852,0.0014764841,0.00007866855,0.00024459168,0.00015564404,0.0005360354,0.000011214735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036762893,0.0026530167,0.9189011,0.00007110204,0.0006400334,0.0749254,0.0009418678,0.0001032616,0.000004135316,0.000004883924,0.0012831638,0.000104404266],"study_design_scores_gemma":[0.004046028,0.001349229,0.98256946,0.00023099345,0.0007652825,0.008736099,0.00065954786,0.00029074948,0.000033453456,0.000058137044,0.0007542819,0.00050675456],"about_ca_topic_score_codex":0.005987662,"about_ca_topic_score_gemma":0.0007756423,"teacher_disagreement_score":0.066189304,"about_ca_system_score_codex":0.0013978722,"about_ca_system_score_gemma":0.0012084015,"threshold_uncertainty_score":0.99987245},"labels":[],"label_agreement":null},{"id":"W4298625046","doi":"10.1016/j.jhepr.2022.100599","title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Liver transplantation; Primary sclerosing cholangitis; Hazard ratio; Internal medicine; Retrospective cohort study; Transplantation; Gastroenterology; Inflammatory bowel disease; Colectomy; Risk factor; Proportional hazards model; Disease; Surgery; Confidence interval; Ulcerative colitis","score_opus":0.010368161312670553,"score_gpt":0.2796791013966749,"score_spread":0.26931094008400436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298625046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814725,0.00010251417,0.0000014568227,0.000027280224,0.00021994163,0.00045216258,0.00007470242,0.000015001543,0.0009596791],"genre_scores_gemma":[0.9993724,0.000031989854,0.000030042847,0.00005515365,0.000032201395,0.00014764286,0.00021364143,0.0000064323085,0.00011047197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990791,0.000080476086,0.00031399957,0.00016120556,0.00028448203,0.00008073035],"domain_scores_gemma":[0.9994919,0.000020875217,0.00012635396,0.00023515476,0.00006598542,0.000059761565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001565925,0.0000649342,0.00011690887,0.000102863865,0.00005215217,0.0000062542094,0.00005703696,0.000015702077,0.0020446158],"category_scores_gemma":[0.000021197939,0.0000659537,0.000045530003,0.00009082973,0.000026117148,0.00017077033,0.000039074745,0.00014429542,0.0000022811612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036089873,0.0016897931,0.98355913,0.000037750106,0.000044074128,0.0051530767,0.008551741,0.000058833382,0.00022066463,0.000010316117,0.000027468168,0.00028623166],"study_design_scores_gemma":[0.0008880491,0.00022660565,0.9938485,0.000034577675,0.00008777524,0.0003626007,0.0037536586,0.00019227911,0.00007903215,0.000034022607,0.00042808006,0.000064840155],"about_ca_topic_score_codex":0.0002376573,"about_ca_topic_score_gemma":0.00007468045,"teacher_disagreement_score":0.010289326,"about_ca_system_score_codex":0.000066388064,"about_ca_system_score_gemma":0.00010622107,"threshold_uncertainty_score":0.99886763},"labels":[],"label_agreement":null},{"id":"W4309340251","doi":"10.1016/j.jhepr.2022.100626","title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Pediatric Hepatobiliary Diseases and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Bile Salt Export Pump; Genotype; Phenotype; Mutation; Enterohepatic circulation; Internal medicine; Compound heterozygosity; Gastroenterology; Progressive familial intrahepatic cholestasis; Endocrinology; Biology; Medicine; Liver transplantation; Bile acid; Genetics; Transplantation; Gene","score_opus":0.02277527426349955,"score_gpt":0.26818453647062873,"score_spread":0.2454092622071292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309340251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431646,0.00221266,0.000015164504,0.000091510985,0.000114787654,0.00044873467,0.000019412266,0.000034369714,0.0027469082],"genre_scores_gemma":[0.99878097,0.000058597376,0.00047880143,0.000039963157,0.000031805455,0.00011901345,0.00018030847,0.00001700601,0.00029355657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853015,0.000058870693,0.0005980099,0.00030801137,0.00032747278,0.00017748392],"domain_scores_gemma":[0.99912125,0.00009802227,0.00029386848,0.00031637822,0.00005517801,0.00011530695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044857003,0.00010703998,0.00023465692,0.00020073049,0.0001931262,0.00000650263,0.00003293829,0.000037997408,0.00022556457],"category_scores_gemma":[0.00037600624,0.000103166116,0.00006110848,0.0004693479,0.000036129582,0.000077402045,0.00006730883,0.00017875526,0.0000031698046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031034073,0.00040097532,0.99589366,0.000056853525,0.000016481381,0.000876644,0.000420031,0.000121225516,0.00015757377,0.00006346785,0.0001056736,0.0018563847],"study_design_scores_gemma":[0.0005692802,0.0001790767,0.9958921,0.000015504069,0.00015117892,0.00047522242,0.00067582,0.00025728854,0.00005627874,0.0009312425,0.0006900391,0.00010698847],"about_ca_topic_score_codex":0.00032226768,"about_ca_topic_score_gemma":0.000019644349,"teacher_disagreement_score":0.004464496,"about_ca_system_score_codex":0.00013093674,"about_ca_system_score_gemma":0.00039639478,"threshold_uncertainty_score":0.4206992},"labels":[],"label_agreement":null},{"id":"W4318447285","doi":"10.1016/j.jhepr.2023.100689","title":"TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Direction de l’hospitalisation et de l’offre de Soins; Institut National Du Cancer","keywords":"Medicine; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Hazard ratio; Clinical endpoint; Internal medicine; Adverse effect; Population; Randomized controlled trial; Radiation therapy; Gastroenterology; Surgery; Urology; Confidence interval","score_opus":0.03836181107514302,"score_gpt":0.2677111404418221,"score_spread":0.22934932936667907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318447285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797581,0.00242276,0.0002628129,0.0013005508,0.0006447961,0.014527966,0.000010596595,0.00026862117,0.00080380606],"genre_scores_gemma":[0.9888182,0.00026590543,0.00053802994,0.00026117932,0.00058114383,0.0032608097,0.0002711617,0.00007494837,0.005928579],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742955,0.000089783876,0.0009431718,0.0005717417,0.0004010809,0.00056465133],"domain_scores_gemma":[0.9982169,0.00038619916,0.0003908345,0.00050445914,0.00015957118,0.00034200685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013009798,0.0003731864,0.0014689483,0.00023880681,0.00020852803,0.00006935345,0.000058247722,0.00023218058,0.00012438596],"category_scores_gemma":[0.00035115724,0.00029198386,0.00060218235,0.00028335152,0.00009579041,0.0001251389,0.000031775475,0.00015200127,0.000012429968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5862098,0.0003146355,0.3927751,0.00022222605,0.00083762343,0.0064069866,0.0006377054,0.0000012598092,0.0039229384,0.00004214466,0.006979081,0.0016505535],"study_design_scores_gemma":[0.92983234,0.0021569456,0.002936794,0.00004221831,0.0009348323,0.0008471718,0.000062503386,0.024986025,0.005337922,0.00006869161,0.03241732,0.00037726745],"about_ca_topic_score_codex":0.00007570027,"about_ca_topic_score_gemma":0.0000027605327,"teacher_disagreement_score":0.3898383,"about_ca_system_score_codex":0.00008360927,"about_ca_system_score_gemma":0.0002685441,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W4322154777","doi":"10.1016/j.jhepr.2023.100715","title":"A genomic enhancer signature associates with hepatocellular carcinoma prognosis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Medical Research Council; Medical Research Council","keywords":"Hepatocellular carcinoma; Enhancer; Signature (topology); Cancer research; Computational biology; Biology; Genetics; Gene; Gene expression; Mathematics","score_opus":0.009057418960118191,"score_gpt":0.22936931318703072,"score_spread":0.22031189422691252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322154777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996356,0.0019178094,0.00013695183,0.00009426006,0.00015372384,0.00027374612,0.000006019408,0.00004298136,0.0010185189],"genre_scores_gemma":[0.9970078,0.0001761873,0.0002749346,0.000038073136,0.00022779695,0.00008181387,0.00029886529,0.000037159374,0.0018573992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989016,0.000031924923,0.0002218794,0.00041270172,0.00017626205,0.00025560253],"domain_scores_gemma":[0.9993244,0.000008666945,0.00017767269,0.0003157842,0.00010234293,0.0000711592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002577078,0.0001456605,0.0001379575,0.000049517166,0.000089835696,0.000031989697,0.0000697636,0.00017959997,0.000020139238],"category_scores_gemma":[0.0000514081,0.00012455072,0.00007649293,0.00018162667,0.00003162089,0.000002767065,0.000067985166,0.00008314041,0.00001371524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009921425,0.000016775168,0.46738383,0.000009734981,0.000032517823,0.0001241531,0.00003480163,0.000055376484,0.53131914,0.0000023362343,0.00054550695,0.00046588358],"study_design_scores_gemma":[0.0001456736,0.00019033618,0.19973147,0.000009769811,0.000030110581,0.000017755034,0.00002476446,0.00015235954,0.7766553,0.00017453075,0.022647984,0.00021992413],"about_ca_topic_score_codex":0.000032748107,"about_ca_topic_score_gemma":0.000025389618,"teacher_disagreement_score":0.26765236,"about_ca_system_score_codex":0.000021271115,"about_ca_system_score_gemma":0.00009316491,"threshold_uncertainty_score":0.50790304},"labels":[],"label_agreement":null},{"id":"W4324366844","doi":"10.1016/j.jhepr.2023.100727","title":"MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Alberta; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico; National Center for Advancing Translational Sciences; National Institute on Alcohol Abuse and Alcoholism; National Institute of Diabetes and Digestive and Kidney Diseases; Agencia Nacional de Investigación y Desarrollo","keywords":"Renal replacement therapy; Medicine; Intensive care medicine; Alcohol; Internal medicine; Biology","score_opus":0.12744590396310973,"score_gpt":0.3778664451752489,"score_spread":0.2504205412121392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324366844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659073,0.0000902945,0.000003561285,0.00038652227,0.00022999593,0.0015689413,0.000009723403,0.00019512221,0.0009251251],"genre_scores_gemma":[0.99757546,0.00036318213,0.000035442692,0.0008248554,0.000039549574,0.00014067178,0.00033537546,0.00003141815,0.0006540596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975272,0.00009683477,0.00066294364,0.00051927543,0.0007683274,0.0004254431],"domain_scores_gemma":[0.998742,0.000051699593,0.00037373786,0.0004357082,0.0001491621,0.0002477114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010634913,0.00020301412,0.000406999,0.00020433319,0.00011067698,0.000023197175,0.0000352784,0.0001290779,0.00011948448],"category_scores_gemma":[0.00027409266,0.00016337038,0.00004222752,0.0004243014,0.00006537097,0.00013181614,0.00004658778,0.00021479097,0.000016810245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048911496,0.00027491272,0.9942974,0.00007251942,0.00013040885,0.00068796205,0.00023484403,0.0000026364976,0.00006871505,0.0000053569497,0.0019325955,0.0018035274],"study_design_scores_gemma":[0.0054387855,0.0010143302,0.99147767,0.00032015372,0.000044541186,0.000018239447,0.000010667916,0.00013599488,0.00013670378,0.000044468205,0.0012037389,0.00015471868],"about_ca_topic_score_codex":0.0007124355,"about_ca_topic_score_gemma":0.00035788948,"teacher_disagreement_score":0.0049496708,"about_ca_system_score_codex":0.00022713207,"about_ca_system_score_gemma":0.00017222423,"threshold_uncertainty_score":0.66620505},"labels":[],"label_agreement":null},{"id":"W4353096527","doi":"10.1016/j.jhepr.2023.100742","title":"Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Ontario Institute for Cancer Research; Université Laval; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Harvard T.H. Chan School of Public Health; National Institutes of Health; Brigham and Women's Hospital","keywords":"Testosterone (patch); Sex hormone-binding globulin; Internal medicine; Endocrinology; Hormone; Dihydrotestosterone; Dehydroepiandrosterone; Medicine; Odds ratio; Cancer; Androgen","score_opus":0.049954615401715446,"score_gpt":0.2848972761417054,"score_spread":0.23494266073998996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353096527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96838886,0.027914723,8.6157496e-7,0.0003071444,0.00023730408,0.0007063932,0.00017932885,0.00006738784,0.002197978],"genre_scores_gemma":[0.951586,0.045109734,0.0000303634,0.000034641704,0.0007539848,0.000109850625,0.000023623777,0.000024722209,0.0023270948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982492,0.00007024356,0.0004721773,0.0005661533,0.00037464147,0.00026760352],"domain_scores_gemma":[0.99872243,0.00016731679,0.00041759803,0.0004356842,0.00019642586,0.000060540882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052769744,0.00019353697,0.00043413453,0.000067552464,0.00022413382,0.0000136085155,0.000054047207,0.000069191374,0.00001613536],"category_scores_gemma":[0.0003042458,0.00010922141,0.00009692872,0.00026572615,0.00025662463,0.00006916273,0.00016166676,0.00021460745,0.00000285672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043923274,0.000073814634,0.93325615,0.00009264058,0.001325984,0.0026279131,0.023533646,0.00006733639,0.009734391,7.504516e-7,0.0056197243,0.0232284],"study_design_scores_gemma":[0.00048715062,0.00011147334,0.9837903,0.00015286077,0.0005340795,0.00012499989,0.0015812117,0.00015381181,0.007972284,0.000024479385,0.0049196268,0.00014773442],"about_ca_topic_score_codex":0.11703157,"about_ca_topic_score_gemma":0.003006522,"teacher_disagreement_score":0.11402505,"about_ca_system_score_codex":0.000056545854,"about_ca_system_score_gemma":0.00013767529,"threshold_uncertainty_score":0.8888482},"labels":[],"label_agreement":null},{"id":"W4361222909","doi":"10.1016/j.jhepr.2023.100745","title":"An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"European Cooperation in Science and Technology; Roche","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Hepatocellular cancer; Oncology; Gastroenterology","score_opus":0.08080938559773793,"score_gpt":0.3681195761049801,"score_spread":0.28731019050724216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361222909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481577,0.00028093683,0.000045512603,0.00028066948,0.00060693297,0.0011647815,0.000020721924,0.0001023325,0.0026823715],"genre_scores_gemma":[0.9983032,0.000041727482,0.00019921508,0.00003278829,0.00020451401,0.00028657287,0.00055834773,0.000020830146,0.00035282242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987035,0.00002852288,0.00036742998,0.00030610827,0.0004170323,0.00017741231],"domain_scores_gemma":[0.99882585,0.000039000093,0.00018531253,0.00037808882,0.00049601105,0.000075753764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004158722,0.0001386112,0.0002737526,0.00014509643,0.000061321,0.000025744865,0.00004992626,0.00005368414,0.000064782995],"category_scores_gemma":[0.00008228948,0.00011568478,0.00016558825,0.0001484487,0.000035717527,0.00015981191,0.000018798817,0.000035790956,0.000005121663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000332251,0.00036564417,0.9695829,0.00008166486,0.00051881076,0.00022163196,0.002782921,0.0002635168,0.010916477,0.00017540014,0.0010942811,0.013664508],"study_design_scores_gemma":[0.004124304,0.0011855924,0.9457419,0.000054153268,0.0007483828,0.000098313314,0.0028408014,0.03571412,0.0054596,0.00075609447,0.0031067452,0.0001699837],"about_ca_topic_score_codex":0.00018344265,"about_ca_topic_score_gemma":0.000060624698,"teacher_disagreement_score":0.0354506,"about_ca_system_score_codex":0.00024340843,"about_ca_system_score_gemma":0.0003436987,"threshold_uncertainty_score":0.47174883},"labels":[],"label_agreement":null},{"id":"W4361306822","doi":"10.1016/j.jhepr.2023.100743","title":"PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver physiology and pathology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Disease; Medicine; Internal medicine; Oncology","score_opus":0.027491653280472213,"score_gpt":0.33543944693860267,"score_spread":0.30794779365813046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361306822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987303,0.000032543663,0.0000024160877,0.00007489041,0.00024459668,0.00063079235,0.000050295967,0.00003281147,0.00020132899],"genre_scores_gemma":[0.99921405,0.000018998753,0.00009709982,0.00010932586,0.000030906536,0.000039728282,0.00014664316,0.000012694831,0.0003305701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847573,0.0000647705,0.00076319627,0.00031497361,0.00022041026,0.00016094363],"domain_scores_gemma":[0.9987274,0.00014379977,0.00045375057,0.00042750032,0.00012902086,0.000118548414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002646025,0.00011068556,0.0006411263,0.0000851052,0.0000144211945,6.7642156e-7,0.00004078379,0.00009036656,0.00008817024],"category_scores_gemma":[0.00059039705,0.00007473312,0.00011544473,0.00017680453,0.0002103327,0.000048562644,0.0000591107,0.00013804936,0.0000060907296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001111821,0.0006844375,0.99466974,0.00017992481,0.000078283556,0.0018550055,0.00018183581,0.0000030085828,0.000013686287,0.0000061938936,0.00031700815,0.00089906715],"study_design_scores_gemma":[0.0012929458,0.0005475304,0.99742347,0.000107436776,0.00011375536,0.0000084326875,0.000007574934,0.000019692261,0.000043132244,0.00016981602,0.00019720747,0.000069004214],"about_ca_topic_score_codex":0.000022270626,"about_ca_topic_score_gemma":0.000011161903,"teacher_disagreement_score":0.0027537441,"about_ca_system_score_codex":0.0000101629275,"about_ca_system_score_gemma":0.0001488169,"threshold_uncertainty_score":0.30475283},"labels":[],"label_agreement":null},{"id":"W4362640874","doi":"10.1016/j.jhepr.2023.100749","title":"Innovative approaches to the management of ascites in cirrhosis","year":2023,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Ascites; Medicine; Cirrhosis; Paracentesis; Hepatic encephalopathy; Rifaximin; Transjugular intrahepatic portosystemic shunt; Intensive care medicine; Internal medicine; Portal hypertension; Gastroenterology; Surgery; Antibiotics","score_opus":0.2959458255951879,"score_gpt":0.365538782188307,"score_spread":0.06959295659311909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362640874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042514567,0.9908183,0.000021944072,0.00012932067,0.0001716262,0.002456201,0.000026043257,0.000035260302,0.0059161657],"genre_scores_gemma":[0.0011645101,0.99701625,0.00013535227,0.00003125672,0.00005758644,0.00044469273,0.00033680923,0.000028011327,0.00078551786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986614,0.000035455887,0.00064218603,0.00028137042,0.0002591682,0.00012039536],"domain_scores_gemma":[0.9992155,0.000046058187,0.0002873685,0.00037530015,0.000036586865,0.000039185776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037584643,0.00015686182,0.0006797455,0.00026376962,0.000017341536,0.000007651694,0.00006452263,0.000068307396,0.000015440059],"category_scores_gemma":[0.000006502517,0.00009510082,0.00014627766,0.0013471275,0.000018794073,0.000025446607,0.000041298088,0.00012301106,0.000028853361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021155964,0.00015883468,0.0019821653,0.1269623,0.0033257839,0.0049802754,0.0009013616,0.0000034099517,1.0508033e-7,0.0008388971,0.0005293302,0.86029637],"study_design_scores_gemma":[0.00034114067,0.0001122098,0.025787853,0.09694923,0.01088313,0.00033759375,0.0005217922,0.0000029389696,0.000012802373,0.0003249215,0.8643033,0.00042309088],"about_ca_topic_score_codex":0.000041067,"about_ca_topic_score_gemma":0.000008422309,"teacher_disagreement_score":0.86377394,"about_ca_system_score_codex":0.00005267302,"about_ca_system_score_gemma":0.00010552193,"threshold_uncertainty_score":0.3878099},"labels":[],"label_agreement":null},{"id":"W4362699996","doi":"10.1016/j.jhepr.2023.100753","title":"Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bijzonder Onderzoeksfonds UGent; Universiteit Antwerpen; Fonds Wetenschappelijk Onderzoek; Canadian Association for the Study of the Liver","keywords":"Medicine; Transient elastography; Fatty liver; Internal medicine; Gastroenterology; Diabetes mellitus; Metabolic syndrome; Cohort; Type 2 diabetes; Nonalcoholic fatty liver disease; Prospective cohort study; Magnetic resonance elastography; Epidemiology; Disease; Liver fibrosis; Elastography; Fibrosis; Ultrasound; Radiology; Obesity; Endocrinology","score_opus":0.014253847980743476,"score_gpt":0.27791890511913186,"score_spread":0.2636650571383884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362699996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795413,0.00057068607,5.552253e-7,0.00006113301,0.000086107095,0.0011729336,0.00004902057,0.000030335064,0.00007512476],"genre_scores_gemma":[0.99813163,0.0013170968,0.00006363322,0.000019238423,0.000026727846,0.00026146302,0.00008587755,0.000018820627,0.00007551487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990987,0.0000130555545,0.00025134152,0.0002801229,0.00016324075,0.00019351474],"domain_scores_gemma":[0.99734193,0.0019686846,0.00021982155,0.0002516398,0.000106036416,0.00011187777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110616966,0.00013357963,0.00030501606,0.000115439376,0.00003621012,0.000009463949,0.000023967335,0.00004153341,0.000020900556],"category_scores_gemma":[0.0026045844,0.00008884953,0.000053441032,0.0002925902,0.000038197097,0.00007334795,0.000029008937,0.000048915266,0.000002808463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003048788,0.00026132542,0.99700576,0.0005804095,0.00012287068,0.00031040332,0.00044539687,0.000014931761,0.00009309541,0.000001524474,0.0006737286,0.00046009175],"study_design_scores_gemma":[0.0006854537,0.00066575065,0.99333394,0.00052045134,0.0004108068,0.000009885638,0.00012521469,0.000040135477,0.003997863,0.00007567029,0.000042356965,0.000092492955],"about_ca_topic_score_codex":0.00022393039,"about_ca_topic_score_gemma":0.0001411106,"teacher_disagreement_score":0.0039047676,"about_ca_system_score_codex":0.000033707758,"about_ca_system_score_gemma":0.00015386722,"threshold_uncertainty_score":0.36231786},"labels":[],"label_agreement":null},{"id":"W4366754899","doi":"10.1016/j.jhepr.2023.100778","title":"Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Autoimmune hepatitis; Internal medicine; Gastroenterology; Fatty liver; Liver biopsy; Cirrhosis; Steatohepatitis; Metabolic syndrome; Diabetes mellitus; Hepatitis; Disease; Obesity; Biopsy; Endocrinology","score_opus":0.010239327133959907,"score_gpt":0.2627745757340412,"score_spread":0.2525352486000813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366754899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772984,0.00089629076,1.606704e-7,0.00028259677,0.000046213572,0.0008452544,0.00007840259,0.00003217998,0.00008908893],"genre_scores_gemma":[0.99827063,0.00087906583,0.000051019462,0.000051833813,0.000008140947,0.00013120369,0.00010987002,0.00001706722,0.0004811469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990058,0.000029718873,0.0002733911,0.00030288042,0.00022259822,0.000165604],"domain_scores_gemma":[0.999217,0.000110632434,0.0001339674,0.00030247527,0.00005260227,0.00018336337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005643736,0.0001763214,0.00042574183,0.00014800813,0.000044030392,0.000014218092,0.000015603659,0.00003528639,0.000013766891],"category_scores_gemma":[0.00006653104,0.0001105024,0.00005992114,0.00012538685,0.00008772622,0.000062272025,0.000039854986,0.00003706942,0.0000016369453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006445634,0.00084730756,0.9877856,0.00007502626,0.00023476213,0.0053340574,0.00038594747,9.0894105e-7,0.000012033432,0.000008928635,0.00007130257,0.004599593],"study_design_scores_gemma":[0.0032674582,0.00079103926,0.9950564,0.00016177841,0.00033811017,0.000024611229,0.000026017573,0.000017505476,0.00012858814,0.0000129330865,0.000069641785,0.00010592698],"about_ca_topic_score_codex":0.0013106575,"about_ca_topic_score_gemma":0.000098023105,"teacher_disagreement_score":0.007270821,"about_ca_system_score_codex":0.00008466148,"about_ca_system_score_gemma":0.000097319535,"threshold_uncertainty_score":0.4506157},"labels":[],"label_agreement":null},{"id":"W4367397117","doi":"10.1016/j.jhepr.2023.100782","title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Biodel","keywords":"Medicine; Cohort; Internal medicine; Adverse effect; Placebo; Clinical endpoint; Cholestasis; Gastroenterology; Clinical trial; Pathology","score_opus":0.07938823805219147,"score_gpt":0.3582880309852884,"score_spread":0.2788997929330969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367397117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935225,0.00007544614,0.000016529233,0.00039075356,0.0013011652,0.0018218681,0.000055060173,0.00014052866,0.0026760993],"genre_scores_gemma":[0.99694175,0.000042873027,0.0009966175,0.00009512489,0.00029706964,0.000119027674,0.0007302894,0.000053338164,0.0007239132],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967319,0.00007768731,0.001491557,0.00073561096,0.00056424394,0.0003990013],"domain_scores_gemma":[0.99805367,0.000072611874,0.00067242584,0.00086729566,0.00013074155,0.00020325037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008898179,0.00026321283,0.0008213806,0.00027624195,0.000056730813,0.00005084331,0.00023892242,0.00019937236,0.000066812194],"category_scores_gemma":[0.00040120998,0.00022148946,0.0000913444,0.000625112,0.000119002965,0.00017929246,0.00010715337,0.0002750567,0.000009939456],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29027718,0.04076254,0.037122075,0.0011341147,0.00094183563,0.103950374,0.022746658,0.00008062696,0.17462897,0.00020065144,0.004393126,0.32376185],"study_design_scores_gemma":[0.48316824,0.033679795,0.16127293,0.012565624,0.001567229,0.00064768613,0.008066894,0.0023975219,0.27216762,0.008483933,0.013051526,0.0029310149],"about_ca_topic_score_codex":0.00086915225,"about_ca_topic_score_gemma":0.00090486737,"teacher_disagreement_score":0.32083085,"about_ca_system_score_codex":0.0001174017,"about_ca_system_score_gemma":0.00028186213,"threshold_uncertainty_score":0.9032078},"labels":[],"label_agreement":null},{"id":"W4368340905","doi":"10.1016/j.jhepr.2023.100785","title":"Use of albumin infusion for cirrhosis-related complications: An international position statement","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","keywords":"Cirrhosis; Albumin; Position statement; Medicine; Statement (logic); Gastroenterology; Internal medicine; Intensive care medicine; Philosophy; Family medicine; Epistemology","score_opus":0.05821377306093508,"score_gpt":0.3460671124270163,"score_spread":0.28785333936608126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368340905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974624,0.000009451099,0.00063988403,0.00068946497,0.00019358406,0.0005899246,0.000076792494,0.000081535945,0.0002569945],"genre_scores_gemma":[0.99269366,0.00008057603,0.0006098276,0.00010806589,0.000026970682,0.00008534409,0.0061567533,0.000010084174,0.00022873377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991922,0.000012240221,0.0003756528,0.00016008782,0.00018580574,0.000074049676],"domain_scores_gemma":[0.9993637,0.000036184505,0.00017448186,0.00018147303,0.00018579359,0.000058372603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013404577,0.000054920627,0.000090534486,0.00013299269,0.000040471936,0.000011683094,0.000022276954,0.00003461434,0.000047400084],"category_scores_gemma":[0.000016282871,0.00005207491,0.0000529003,0.00012104694,0.00001582939,0.00024872896,0.000008284657,0.00002770354,0.00000833743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010399014,0.0016011449,0.7184498,0.00071397395,0.0013439681,0.0007402617,0.0034117452,0.00086756446,0.24817091,0.0035215355,0.006214629,0.01392457],"study_design_scores_gemma":[0.0006500557,0.00018835133,0.9813168,0.00015351373,0.0003098301,0.000098904435,0.000070594906,0.003691247,0.010380474,0.00095736416,0.002106472,0.00007640773],"about_ca_topic_score_codex":0.00007866178,"about_ca_topic_score_gemma":0.000005912037,"teacher_disagreement_score":0.26286697,"about_ca_system_score_codex":0.00003992462,"about_ca_system_score_gemma":0.00004807429,"threshold_uncertainty_score":0.21235532},"labels":[],"label_agreement":null},{"id":"W4379745482","doi":"10.1016/j.jhepr.2023.100809","title":"Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Ministero dell’Istruzione, dell’Università e della Ricerca; Ministero della Salute","keywords":"Medicine; Decompensation; Internal medicine; Gastroenterology; Hazard ratio; Hepatocellular carcinoma; Esophageal varices; Fatty liver; Cirrhosis; Liver disease; Proportional hazards model; Portal vein thrombosis; Alcoholic liver disease; Varices; Portal hypertension; Confidence interval; Disease","score_opus":0.01942429766806594,"score_gpt":0.28729180521498704,"score_spread":0.2678675075469211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379745482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960879,0.00017570658,0.000113325455,0.00029954847,0.00014855246,0.0007530963,0.000049902796,0.00025297876,0.0021189882],"genre_scores_gemma":[0.9975099,0.0001565516,0.00012247842,0.00022954066,0.00006657635,0.00013573992,0.0014859701,0.000020305783,0.0002729423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987543,0.000026235342,0.00036184362,0.00035414702,0.00027591293,0.00022753174],"domain_scores_gemma":[0.9991129,0.000054049375,0.00011541481,0.00038132194,0.00007717702,0.00025910683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012117057,0.00012923867,0.0002022251,0.0002019333,0.000082209735,0.00001634773,0.00005023767,0.000045505643,0.00007763263],"category_scores_gemma":[0.00001724735,0.00012063337,0.00007823071,0.00053251174,0.000043819353,0.00016243602,0.000022212887,0.00011400586,0.00014416034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015116934,0.0002646134,0.98488754,0.00024738253,0.000096264994,0.011421856,0.00049411325,0.00033797364,0.0010396045,0.00004855065,0.0003364074,0.0006745153],"study_design_scores_gemma":[0.00080862135,0.000036749065,0.9942057,0.00014208865,0.00027133484,0.00010088279,0.000032492084,0.0036865445,0.00025603405,0.0001790604,0.00017417618,0.00010633183],"about_ca_topic_score_codex":0.00016095847,"about_ca_topic_score_gemma":0.000030151441,"teacher_disagreement_score":0.011320972,"about_ca_system_score_codex":0.000049014412,"about_ca_system_score_gemma":0.00014382075,"threshold_uncertainty_score":0.4919286},"labels":[],"label_agreement":null},{"id":"W4381252706","doi":"10.1016/j.jhepr.2023.100817","title":"Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"Vir Biotechnology; Janssen Pharmaceuticals; Gilead Research Scholars; Gilead Sciences; GlaxoSmithKline","keywords":"Biology; Virology; RNA; Viral replication; Deep sequencing; Hepatitis B virus; Viral load; HBx; Virus; Transcription (linguistics); Gene; Genome; Genetics","score_opus":0.10564410419906027,"score_gpt":0.3653618667268447,"score_spread":0.2597177625277844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381252706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846375,0.00022459778,0.000060265975,0.00007123666,0.00028798074,0.00039601512,0.000007903126,0.00010980879,0.00037842747],"genre_scores_gemma":[0.9982268,0.00021131465,0.0010275107,0.000054298896,0.0002221891,0.000013683014,0.000015177126,0.00003339096,0.0001955985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989122,0.000029983687,0.00037641398,0.00027307047,0.00020060138,0.00020774326],"domain_scores_gemma":[0.9992163,0.00013336097,0.00023854602,0.00022631449,0.0001288969,0.000056553865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019375872,0.00015356371,0.00037309516,0.00016001092,0.00012798539,0.000023805553,0.000022725517,0.00004619416,0.00004830266],"category_scores_gemma":[0.00020368528,0.000120149954,0.000059593505,0.00033200043,0.00011024889,0.00014508876,0.00005423751,0.000115315685,0.0000055854266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067147607,0.00024064838,0.6607451,0.00010778361,0.00037775165,0.001472773,0.0024956302,0.000039483522,0.32809472,0.000012770605,0.00045930257,0.005282608],"study_design_scores_gemma":[0.0018754861,0.00061114575,0.9125893,0.00043693633,0.00016078375,0.00043566094,0.00017422732,0.00084386097,0.07994272,0.000017019433,0.0026533958,0.0002594601],"about_ca_topic_score_codex":0.0023795262,"about_ca_topic_score_gemma":0.00048854825,"teacher_disagreement_score":0.25184426,"about_ca_system_score_codex":0.000031803116,"about_ca_system_score_gemma":0.00008250437,"threshold_uncertainty_score":0.4899573},"labels":[],"label_agreement":null},{"id":"W4384129505","doi":"10.1016/j.jhepr.2023.100847","title":"Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Hepatocellular carcinoma; Medicine; Internal medicine; Incidence (geometry); Gastroenterology; Hepatitis B; Hepatitis B virus; Tenofovir; Chronic hepatitis; Lower risk; Randomized controlled trial; Viral load; Immunology; Confidence interval; Human immunodeficiency virus (HIV); Virus","score_opus":0.011186443526818185,"score_gpt":0.23660211977195797,"score_spread":0.22541567624513978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384129505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969428,0.00070324546,0.0000065525333,0.00029510606,0.00015656494,0.0011452513,0.00001864601,0.00010997993,0.0006218383],"genre_scores_gemma":[0.99829113,0.00048178536,0.00013922977,0.00006124059,0.00006595335,0.0001369987,0.00008256604,0.0000616306,0.0006794365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971737,0.000062246036,0.00087740977,0.0006689882,0.0006783065,0.00053933426],"domain_scores_gemma":[0.99837554,0.000070366885,0.00043440927,0.00068533106,0.00025710723,0.00017724374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045330633,0.00031084512,0.0007463218,0.0003462861,0.00010909689,0.000017110602,0.00008174986,0.00011792628,0.000035071167],"category_scores_gemma":[0.00035426262,0.0002549686,0.00006807798,0.0008284019,0.0003014822,0.00021210722,0.00021828419,0.00024648383,0.000020046387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010315928,0.00012928995,0.9917436,0.00034610584,0.00006244106,0.0035277929,0.0004834458,0.000013631321,0.0011105789,0.0000133967005,0.00044745853,0.0020190456],"study_design_scores_gemma":[0.0011199197,0.0007979058,0.9936742,0.0004902391,0.000076679695,0.00013643922,0.000021699834,0.0006504333,0.0021967571,0.00011856951,0.00045189972,0.00026522516],"about_ca_topic_score_codex":0.013277842,"about_ca_topic_score_gemma":0.0053862934,"teacher_disagreement_score":0.007891549,"about_ca_system_score_codex":0.00030715024,"about_ca_system_score_gemma":0.00042001455,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W4386572320","doi":"10.1016/j.jhepr.2023.100901","title":"Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"University of Birmingham; National Institute for Health and Care Research","keywords":"Medicine; Disease; Liver disease; Autoimmune disease; Autoimmune hepatitis; Clinical disease; Pediatrics; Immunology; Internal medicine","score_opus":0.011287669819765445,"score_gpt":0.2762524490524886,"score_spread":0.26496477923272316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386572320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930045,0.0031859525,0.0000023167809,0.0011094759,0.0006108559,0.0013034302,0.00004306715,0.0004456721,0.000294742],"genre_scores_gemma":[0.99636734,0.000575994,0.000088901885,0.0002737944,0.00015348887,0.00023409717,0.0008580127,0.00006631916,0.0013820672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737346,0.00013569342,0.0006618759,0.0006494335,0.0006661588,0.0005133696],"domain_scores_gemma":[0.99749935,0.000053868673,0.0002311467,0.0012881028,0.00011965354,0.00080788386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042317982,0.000306962,0.00043931356,0.00030780156,0.00019817827,0.00004571131,0.00014117219,0.00010153265,0.00062322256],"category_scores_gemma":[0.0008738205,0.00025611342,0.00033011555,0.0007594779,0.000103404374,0.00023898033,0.00032874523,0.00035344248,0.0002801701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088213506,0.0014378399,0.9585591,0.00047696612,0.00008756336,0.018464293,0.0011203971,0.000005221517,0.00008582072,0.000014827985,0.007786119,0.011079731],"study_design_scores_gemma":[0.0018820381,0.00015535863,0.9914036,0.0011475657,0.0002765972,0.00006575014,0.00024885172,0.00031618465,0.000028828668,0.0006898325,0.003487618,0.00029782366],"about_ca_topic_score_codex":0.00026303637,"about_ca_topic_score_gemma":0.000008041262,"teacher_disagreement_score":0.032844465,"about_ca_system_score_codex":0.0001549247,"about_ca_system_score_gemma":0.0008123717,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W4386597720","doi":"10.1016/j.jhepr.2023.100904","title":"Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Hepatic encephalopathy; Oxidative stress; Internal medicine; Righting reflex; Endocrinology; Proinflammatory cytokine; Hippocampus; Hyperammonemia; Medicine; Encephalopathy; Pathology; Inflammation; Reflex","score_opus":0.01743909350003489,"score_gpt":0.2572460670616742,"score_spread":0.2398069735616393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386597720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984479,0.00006689978,0.000005203188,0.00011130839,0.00022895134,0.00063845114,0.000013093394,0.00011166972,0.00037653823],"genre_scores_gemma":[0.9992646,0.000078352714,0.00005414898,0.000049008733,0.00006105575,0.000059112135,0.00020967273,0.000025483367,0.00019858307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984287,0.00005459388,0.00056327163,0.00035050305,0.00035326966,0.0002496314],"domain_scores_gemma":[0.99918324,0.00009116763,0.0002097663,0.00030083896,0.00008962975,0.00012535276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002381555,0.00014783724,0.000303573,0.00023076069,0.0000342005,0.000008536481,0.00004670375,0.00007284987,0.000027069655],"category_scores_gemma":[0.000057855963,0.00013124141,0.0000966457,0.0005349287,0.000042228152,0.00011999662,0.00001933168,0.00013408747,0.000031924028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015035136,0.00026063577,0.79108113,0.00047846828,0.000033389788,0.008252693,0.0008781836,0.00006349267,0.19833465,0.0000018697492,0.000037386002,0.00042772427],"study_design_scores_gemma":[0.00076860486,0.00014807461,0.6844272,0.00017179703,0.00012734115,0.00012325696,0.00006962962,0.000864003,0.31309196,0.00008439436,0.000018057242,0.00010563792],"about_ca_topic_score_codex":0.00048110876,"about_ca_topic_score_gemma":0.000079003774,"teacher_disagreement_score":0.11475732,"about_ca_system_score_codex":0.000033131022,"about_ca_system_score_gemma":0.00021467253,"threshold_uncertainty_score":0.53518695},"labels":[],"label_agreement":null},{"id":"W4386989422","doi":"10.1016/j.jhepr.2023.100911","title":"Cardiomyopathy in cirrhosis: From pathophysiology to clinical care","year":2023,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Transjugular intrahepatic portosystemic shunt; Cirrhosis; Hepatorenal syndrome; Cardiology; Hyperdynamic circulation; Pathophysiology; Cardiomyopathy; Internal medicine; Heart failure; Liver disease; Ejection fraction; Portal hypertension; Intensive care medicine","score_opus":0.09798074427274693,"score_gpt":0.43468699937544253,"score_spread":0.3367062551026956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386989422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005722987,0.9906367,0.0000032477933,0.000016737124,0.0015705982,0.0013368744,0.00018543706,0.00010749995,0.0004199296],"genre_scores_gemma":[0.001444144,0.9937043,0.000057487527,0.00016834975,0.0010788849,0.00033714992,0.0030433082,0.00006926664,0.00009707429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972248,0.00020468766,0.0013098789,0.0007865593,0.00023518775,0.00023885776],"domain_scores_gemma":[0.9985124,0.00017406541,0.0003055492,0.0006940896,0.00006899174,0.00024491578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002589045,0.00028686321,0.0021727246,0.00024500152,0.000022889415,0.000010825765,0.00007342494,0.00041647803,0.000034049746],"category_scores_gemma":[0.00006546544,0.00023430801,0.00080820883,0.00035312548,0.000023002694,0.000028568798,0.00005103424,0.00038512103,0.00034730122],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006342499,0.00010388949,0.020453136,0.0241285,0.0011339998,0.067605965,0.0006383383,9.374693e-7,9.030495e-7,0.0000023641587,0.0008614251,0.88500714],"study_design_scores_gemma":[0.0005932396,0.00027798605,0.07502916,0.042829018,0.012696385,0.00030278123,0.00018618694,5.0149106e-7,7.389561e-7,0.00019961853,0.86729,0.00059433747],"about_ca_topic_score_codex":0.0004350744,"about_ca_topic_score_gemma":0.00005119102,"teacher_disagreement_score":0.88441277,"about_ca_system_score_codex":0.00011510707,"about_ca_system_score_gemma":0.0005819647,"threshold_uncertainty_score":0.9554804},"labels":[],"label_agreement":null},{"id":"W4387534095","doi":"10.1016/j.jhepr.2023.100928","title":"Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk Fonden","keywords":"Steatosis; Histology; Nonalcoholic fatty liver disease; Fatty liver; Magnetic resonance imaging; Internal medicine; Pathology; Medicine; Chemistry; Gastroenterology; Radiology; Disease","score_opus":0.052701769997514546,"score_gpt":0.2842468748987557,"score_spread":0.23154510490124117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387534095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799036,0.016120797,0.00001700422,0.0015538592,0.00015134725,0.0013272585,0.00002296741,0.00013767234,0.00076549075],"genre_scores_gemma":[0.9934769,0.00067763176,0.00007973466,0.00039165295,0.000039215513,0.000931882,0.00017857515,0.000019918643,0.004204454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976462,0.00016845507,0.0005666456,0.0007389661,0.00054531574,0.00033442295],"domain_scores_gemma":[0.9985169,0.0001225745,0.0002408311,0.00077433436,0.00014155508,0.00020376706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000289823,0.00025626065,0.0011999077,0.00031174673,0.00008113662,0.000021425054,0.00006107248,0.00013969159,0.0016246133],"category_scores_gemma":[0.0001759618,0.00019828377,0.000758016,0.0008778361,0.00007014477,0.00006233455,0.00006159125,0.00016709801,0.000074868134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024551243,0.00068336615,0.9585126,0.00006866949,0.009270582,0.0151609015,0.00013458967,0.0000029194712,0.00022181854,0.000006396068,0.0123411715,0.003351474],"study_design_scores_gemma":[0.00053867284,0.00015850978,0.9324258,0.000011631826,0.05523199,0.000100331956,0.000022038676,0.00017620609,0.00088501984,0.000117266165,0.010156601,0.0001759413],"about_ca_topic_score_codex":0.001561499,"about_ca_topic_score_gemma":0.00047113418,"teacher_disagreement_score":0.045961406,"about_ca_system_score_codex":0.00029756664,"about_ca_system_score_gemma":0.000058492646,"threshold_uncertainty_score":0.999288},"labels":[],"label_agreement":null},{"id":"W4388736488","doi":"10.1016/j.jhepr.2023.100965","title":"Transplant oncology – Current indications and strategies to advance the field","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Context (archaeology); Liver transplantation; Intensive care medicine; General surgery; Transplantation; Surgery; Oncology","score_opus":0.01750327538876078,"score_gpt":0.375293624284298,"score_spread":0.35779034889553724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388736488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9036872,0.00086716836,0.010804897,0.07144238,0.00080431905,0.0012918096,0.000022610104,0.00068470574,0.010394951],"genre_scores_gemma":[0.99569297,0.002015152,0.00045460812,0.0012553629,0.00005692117,0.00006232388,0.00002663945,0.000007578816,0.00042844715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994449,0.000011244482,0.00019241482,0.00013991237,0.000102657825,0.00010885152],"domain_scores_gemma":[0.9995675,0.000116861585,0.00005211822,0.0001760245,0.000021920683,0.00006557757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013698617,0.000060317307,0.0001137144,0.000069685884,0.00007385631,0.000013365972,0.000030237014,0.00003700916,0.00004960793],"category_scores_gemma":[0.00003310598,0.00003917912,0.000028155971,0.0001754961,0.000025458818,0.000040600942,0.000008705388,0.000110814835,0.000013062363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027486446,0.00033484658,0.58508134,0.0013738822,0.00015769662,0.0058341403,0.019606039,0.00003588724,0.0071255425,0.01921447,0.096806444,0.26415482],"study_design_scores_gemma":[0.00024216928,0.00035571304,0.535861,0.0001203022,0.00012388879,0.0011406904,0.0005575553,0.00001351758,0.007935175,0.0027007428,0.45081392,0.00013532395],"about_ca_topic_score_codex":0.000019295843,"about_ca_topic_score_gemma":0.00004033229,"teacher_disagreement_score":0.35400745,"about_ca_system_score_codex":0.000013174711,"about_ca_system_score_gemma":0.00008610974,"threshold_uncertainty_score":0.15976782},"labels":[],"label_agreement":null},{"id":"W4389166622","doi":"10.1016/j.jhepr.2023.100977","title":"Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Social Fund; European Regional Development Fund; Instituto de Salud Carlos III; European Commission","keywords":"Cirrhosis; Medicine; Etiology; Intervention (counseling); Cardiology; Internal medicine; Psychiatry","score_opus":0.004369320110496301,"score_gpt":0.21893224146349796,"score_spread":0.21456292135300167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389166622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993321,0.000049795603,0.000009242427,0.00000830151,0.00007877537,0.00032011277,0.0000065889735,0.000038575614,0.00015651545],"genre_scores_gemma":[0.9995911,0.000006017608,0.000013768834,0.000006171212,0.000012096477,0.000009908497,0.0002456331,0.000007274752,0.00010802855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921656,0.00002532826,0.0002917722,0.00017530363,0.00019532953,0.00009569364],"domain_scores_gemma":[0.99968547,0.000017808432,0.00012212353,0.000100070574,0.00003143713,0.00004311432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016421273,0.000066660396,0.00017473173,0.00013081398,0.000016071048,0.0000037625891,0.000011416031,0.000051299736,0.00003679806],"category_scores_gemma":[0.000014207745,0.000052094325,0.000055792316,0.00015976105,0.0000134761485,0.00007653678,0.000009210367,0.00004394859,0.000005540026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027627515,0.000092159,0.9955955,0.000117762545,0.000057033514,0.0030148174,0.00009578306,0.000008196324,0.00053086464,0.0000023096666,0.000012941536,0.00019636203],"study_design_scores_gemma":[0.001051059,0.0002421913,0.99751586,0.00046449061,0.00019915673,0.00023139745,0.000025950094,0.00012536395,0.000048301943,0.000039886116,0.000002473403,0.000053901913],"about_ca_topic_score_codex":0.00013167312,"about_ca_topic_score_gemma":0.000018359246,"teacher_disagreement_score":0.00278342,"about_ca_system_score_codex":0.000063989544,"about_ca_system_score_gemma":0.000021430464,"threshold_uncertainty_score":0.21243449},"labels":[],"label_agreement":null},{"id":"W4389166630","doi":"10.1016/j.jhepr.2023.100975","title":"Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Calgary; Toronto General Hospital; University of Toronto","funders":"Eisai; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; HBeAg; Tenofovir alafenamide; Clinical endpoint; Pharmacodynamics; HBsAg; Adverse effect; Gastroenterology; Placebo; Hepatitis B virus; Viral load; Immunology; Clinical trial; Pharmacokinetics; Virus; Pathology","score_opus":0.008844287842600385,"score_gpt":0.2697018624479435,"score_spread":0.2608575746053431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389166630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813396,0.00007185297,0.000031979234,0.00005987394,0.00022488553,0.00059013703,0.00002839041,0.00010373282,0.00075518776],"genre_scores_gemma":[0.99679404,0.0029056969,0.000027074066,0.000021088816,0.00004994832,0.000029829109,0.00005029176,0.000030112022,0.00009191787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862784,0.00004704316,0.0003993491,0.0003366235,0.00031687217,0.00027228423],"domain_scores_gemma":[0.9992975,0.00004426381,0.00026770594,0.0002243219,0.000105790416,0.00006038873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024353934,0.0001714041,0.00043758898,0.00025567517,0.00006852918,0.000007232859,0.00002056041,0.00007358188,0.000016837965],"category_scores_gemma":[0.00010789675,0.00015283874,0.00004339429,0.00050967216,0.00011897298,0.00019426421,0.000085930056,0.00018707442,0.0000065921163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013985223,0.0001686323,0.9765339,0.00018520745,0.00007874171,0.0004585414,0.00017586754,0.000018809831,0.0065255375,0.0000027224878,0.00009880715,0.01561337],"study_design_scores_gemma":[0.0011528516,0.00036037524,0.9915584,0.00021251084,0.00006641236,0.000049706057,0.0000012870668,0.0011993529,0.004898104,0.000024988518,0.00033207398,0.00014398615],"about_ca_topic_score_codex":0.030085964,"about_ca_topic_score_gemma":0.055155538,"teacher_disagreement_score":0.025069574,"about_ca_system_score_codex":0.00030177843,"about_ca_system_score_gemma":0.0001320729,"threshold_uncertainty_score":0.9763728},"labels":[],"label_agreement":null},{"id":"W4389978485","doi":"10.1016/j.jhepr.2023.100985","title":"Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sarcopenia; Medicine; Cirrhosis; Grip strength; Internal medicine; Malnutrition; Multivariate analysis; Physical therapy; Gerontology","score_opus":0.04033695668467189,"score_gpt":0.34255018510859553,"score_spread":0.3022132284239236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389978485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920619,0.00017639651,0.000070662034,0.0034380273,0.00018605115,0.00042209268,0.000013254823,0.000105055886,0.003526554],"genre_scores_gemma":[0.99797624,0.00031749802,0.00020321629,0.0008253514,0.000109729204,0.00006311454,0.00010921237,0.0000147518995,0.0003808777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988033,0.000054417487,0.00044035073,0.00024608505,0.00023539035,0.00022043422],"domain_scores_gemma":[0.99942756,0.00018160466,0.00012998137,0.00014752569,0.000030046293,0.000083255385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010151461,0.00010128015,0.00018684471,0.00010014703,0.00019860572,0.00003743161,0.000023646777,0.000056234367,0.000099046214],"category_scores_gemma":[0.0000989046,0.00007062326,0.000026780477,0.00019593406,0.00002955182,0.000063344174,0.000016871769,0.00036444058,0.0000040672426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008295161,0.00014052482,0.8811042,0.00071712304,0.00003494026,0.0024133937,0.0042598145,0.00000414174,0.0789845,0.00043713136,0.016630845,0.01519049],"study_design_scores_gemma":[0.0021450713,0.0005741235,0.84730154,0.010686054,0.0001124256,0.001921097,0.005116411,0.055658463,0.043834396,0.00056397193,0.031610668,0.0004758024],"about_ca_topic_score_codex":0.0005704649,"about_ca_topic_score_gemma":0.00037280182,"teacher_disagreement_score":0.05565432,"about_ca_system_score_codex":0.00012978801,"about_ca_system_score_gemma":0.00008061048,"threshold_uncertainty_score":0.2879933},"labels":[],"label_agreement":null},{"id":"W4391037932","doi":"10.1016/j.jhepr.2024.101011","title":"Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Newcastle University; Shionogi; European Commission; Novo Nordisk; National Institute for Health and Care Research; Intercept Pharmaceuticals; Arrowhead Pharmaceuticals; Medpace; European Federation of Pharmaceutical Industries and Associations; Genentech; Valeant Pharmaceuticals International; LG Chem; CymaBay Therapeutics; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; Gilead Sciences; Amgen; National Heart, Lung, and Blood Institute; NGM Biopharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Fibrosis; Internal medicine; Cohort; Confounding; Gastroenterology; Steatohepatitis; Liver biopsy; Liver disease; Fatty liver; Disease; Biopsy","score_opus":0.0335086251453721,"score_gpt":0.3358556132995721,"score_spread":0.30234698815419997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391037932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336094,0.005327743,0.000005481285,0.00002099865,0.000045335808,0.0010566723,0.0000963527,0.000006191602,0.00008031641],"genre_scores_gemma":[0.9994162,0.00035538286,0.000013593465,0.000009272302,0.000036580055,0.00011018906,0.000010639004,0.000011706751,0.000036465546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932307,0.00002486001,0.00020295868,0.00017409949,0.0002140838,0.000060913215],"domain_scores_gemma":[0.99918836,0.0002454455,0.00017723624,0.00020544541,0.00011366539,0.000069827496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027148903,0.000082574545,0.00015729929,0.000053906206,0.000028894934,0.0000060090865,0.00000983848,0.000026868003,0.00003271416],"category_scores_gemma":[0.00021432403,0.00004757575,0.00012588747,0.000053968983,0.00005453669,0.000027503056,0.000014890744,0.000025608762,2.972836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035225172,0.0005997637,0.9698015,0.00055537676,0.0013767023,0.00022268364,0.00057211315,0.000040836396,0.009159264,0.000007460435,0.0001370788,0.017174963],"study_design_scores_gemma":[0.0007812299,0.00080384326,0.97215796,0.00031014736,0.0055682333,0.000035075867,0.000014624894,0.0008226318,0.019228147,0.0002218217,0.000016216536,0.000040075818],"about_ca_topic_score_codex":0.00041063302,"about_ca_topic_score_gemma":0.00008023588,"teacher_disagreement_score":0.017134888,"about_ca_system_score_codex":0.000047049096,"about_ca_system_score_gemma":0.000115675604,"threshold_uncertainty_score":0.19400828},"labels":[],"label_agreement":null},{"id":"W4391065196","doi":"10.1016/j.jhepr.2023.100999","title":"Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society of Intestinal Research; Toronto Liver Centre; University of Toronto","funders":"Eisai; Celgene; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Surrogate endpoint; Adverse effect; Internal medicine; Placebo; Pharmacodynamics; Gastroenterology; Clinical trial; Pharmacokinetics; Pathology","score_opus":0.0613409017301175,"score_gpt":0.3808454877862025,"score_spread":0.319504586056085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391065196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719796,0.018752856,0.00016561766,0.001671818,0.0011737328,0.0020331098,0.000030043688,0.0002114089,0.003981774],"genre_scores_gemma":[0.9713412,0.0076711252,0.0002425854,0.00014948206,0.000477825,0.00042048175,0.000054255754,0.000047996153,0.019595075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863595,0.00003069661,0.00043753514,0.0004879702,0.00015066791,0.0002571664],"domain_scores_gemma":[0.9991651,0.00016566877,0.00009172105,0.00038036643,0.0000833161,0.00011381237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032825972,0.00020007395,0.00040515087,0.000101605445,0.00020893014,0.0001067246,0.00003063038,0.000081416714,0.00010429665],"category_scores_gemma":[0.00020721802,0.00015621443,0.000063554966,0.00013634277,0.00008108101,0.0001617376,0.00013033817,0.00008622613,0.000024678076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008219081,0.00043604913,0.6979884,0.00083269674,0.0008248124,0.008519688,0.0004959117,9.7461e-7,0.0018520709,0.0002209165,0.0056690364,0.28233755],"study_design_scores_gemma":[0.0017320606,0.0024340353,0.58404285,0.00060373,0.0004026101,0.003213924,0.000004173344,0.00009960771,0.0016905068,0.00013367021,0.4054244,0.00021846847],"about_ca_topic_score_codex":0.00073404715,"about_ca_topic_score_gemma":0.002748909,"teacher_disagreement_score":0.39975536,"about_ca_system_score_codex":0.00061845477,"about_ca_system_score_gemma":0.0004529241,"threshold_uncertainty_score":0.637024},"labels":[],"label_agreement":null},{"id":"W4391066052","doi":"10.1016/j.jhepr.2024.101008","title":"Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"AI in cancer detection","field":"Computer Science","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Assistance publique-Hôpitaux de Paris","keywords":"Artificial intelligence; Hepatocellular carcinoma; Liver cancer; Cluster analysis; Intrahepatic Cholangiocarcinoma; Computer science; Medicine; Cancer; Pathology; Biopsy; Convolutional neural network; Pattern recognition (psychology); Radiology; Internal medicine","score_opus":0.03249325826326052,"score_gpt":0.2709599125736169,"score_spread":0.23846665431035638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391066052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5505118,0.004281464,0.43895575,0.00044899233,0.0035989506,0.00020896878,0.0000024257752,0.00082169316,0.0011699738],"genre_scores_gemma":[0.98008597,0.00011987077,0.018615242,0.00009129966,0.00062597235,0.00003796868,0.00001630309,0.000032075768,0.00037527588],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980234,0.0000784504,0.00043070773,0.0007902804,0.00041216594,0.00026500772],"domain_scores_gemma":[0.9990322,0.000065502594,0.00020802807,0.000508496,0.00010042091,0.000085377666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036280756,0.00017645047,0.00018222652,0.0001456972,0.0001878455,0.00037233692,0.0002393118,0.00010696122,0.00011263833],"category_scores_gemma":[0.000036083522,0.0001751386,0.00009231422,0.0005822897,0.000035695906,0.0008526077,0.0001731846,0.0003209698,0.00003390927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000197082,0.000065686254,0.032768074,0.0001779334,0.00013974505,0.0028669867,0.0031280934,0.0051034023,0.46116674,0.00045079045,0.0007984514,0.4933144],"study_design_scores_gemma":[0.00007786748,0.000027152983,0.09466978,0.00017591465,0.000044195887,0.0005458408,0.00004271469,0.88767874,0.0074750506,0.0005695777,0.008375536,0.00031759863],"about_ca_topic_score_codex":0.0016770388,"about_ca_topic_score_gemma":0.000049500348,"teacher_disagreement_score":0.8825754,"about_ca_system_score_codex":0.00069276296,"about_ca_system_score_gemma":0.00026970461,"threshold_uncertainty_score":0.7141945},"labels":[],"label_agreement":null},{"id":"W4391255691","doi":"10.1016/j.jhepr.2024.101020","title":"Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Alcohol use disorder; Medicine; Population; Alcoholic liver disease; Disease burden; Epidemiology; Burden of disease; Environmental health; Alcohol; Gerontology; Cirrhosis; Internal medicine","score_opus":0.07368375262630074,"score_gpt":0.3643857920519022,"score_spread":0.29070203942560147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391255691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875221,0.0075801727,0.0000069718158,0.0037997584,0.000110532805,0.00059309695,0.000011723764,0.00004261113,0.0003330203],"genre_scores_gemma":[0.9979883,0.00078316394,0.000030271229,0.0006306351,0.000063808104,0.000031460433,0.000033290744,0.000010761762,0.00042833798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988107,0.000079941696,0.00032965347,0.0002964734,0.0003006375,0.00018260039],"domain_scores_gemma":[0.9992765,0.00018180882,0.00009547419,0.00022527957,0.000054454835,0.00016646215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045666698,0.000121018114,0.0002184383,0.00007370364,0.000055250333,0.000046039924,0.000027630324,0.000082441504,0.000039543633],"category_scores_gemma":[0.00031873147,0.000083823026,0.000055759203,0.00021638456,0.00012521654,0.00011653299,0.000032683747,0.0001491355,0.0000028953234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014879371,0.00013068863,0.9762687,0.0005398508,0.00008875637,0.0053715096,0.0009130864,0.0000035621556,0.000049646897,0.00071273907,0.0062287804,0.009543868],"study_design_scores_gemma":[0.0005878925,0.00012333402,0.9835469,0.00039673038,0.00015352885,0.0007159246,0.00007012239,0.0006713796,6.293774e-7,0.00040613074,0.013241619,0.000085778054],"about_ca_topic_score_codex":0.0011160851,"about_ca_topic_score_gemma":0.00023255011,"teacher_disagreement_score":0.010466158,"about_ca_system_score_codex":0.000054463962,"about_ca_system_score_gemma":0.00017369352,"threshold_uncertainty_score":0.3418204},"labels":[],"label_agreement":null},{"id":"W4391293858","doi":"10.1016/j.jhepr.2024.101021","title":"A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis","keywords":"Hepatocellular carcinoma; Internal medicine; Medicine; Phase (matter); Gastroenterology; Oncology; Chemistry","score_opus":0.03161021835078301,"score_gpt":0.26121888789108116,"score_spread":0.22960866954029815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391293858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923845,0.001045667,0.000019100555,0.00012306264,0.00045781586,0.0038369107,0.000052868832,0.00018241294,0.0018976412],"genre_scores_gemma":[0.9971475,0.000016900865,0.00017153514,0.000027097454,0.00014448866,0.0003442553,0.0009711983,0.000104499595,0.0010725225],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962162,0.00010633056,0.0013018958,0.00086227065,0.0009591193,0.000554224],"domain_scores_gemma":[0.9981943,0.00005711568,0.00036440566,0.0008864061,0.00019860001,0.00029918688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039917332,0.00050068676,0.0011606362,0.0004868573,0.00009012603,0.00005470014,0.00009711669,0.00024742883,0.0003385457],"category_scores_gemma":[0.00009293123,0.0003873448,0.00032043518,0.0008154903,0.00013105568,0.0002181092,0.00007916853,0.00029165752,0.000020380527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033336446,0.0043177083,0.93332416,0.00057746517,0.0004531298,0.023095679,0.001337283,0.0000019294223,0.00020032561,0.000032128315,0.0005617127,0.0027620392],"study_design_scores_gemma":[0.6376828,0.07208219,0.16538084,0.0039867302,0.0052495827,0.002330799,0.00020093331,0.030010113,0.06897656,0.00018981505,0.011467873,0.0024417588],"about_ca_topic_score_codex":0.0006739972,"about_ca_topic_score_gemma":0.000049592352,"teacher_disagreement_score":0.7679433,"about_ca_system_score_codex":0.00034957647,"about_ca_system_score_gemma":0.0006471909,"threshold_uncertainty_score":0.99985784},"labels":[],"label_agreement":null},{"id":"W4392723785","doi":"10.1016/j.jhepr.2024.101056","title":"Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Stiftung Professor Dr. Max Cloëtta; Université de Genève; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Hepatocellular carcinoma; Microbiome; Gut microbiome; Transmission (telecommunications); Obesity; Medicine; Gut flora; Biology; Bioinformatics; Internal medicine; Immunology; Computer science","score_opus":0.00938645713190321,"score_gpt":0.24928992069549444,"score_spread":0.23990346356359124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392723785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942969,0.004669073,0.00027143807,0.000110389454,0.0001888436,0.0002607839,0.0000634774,0.000009890352,0.0001291868],"genre_scores_gemma":[0.99884504,0.0003727711,0.0002556114,0.000060245486,0.00014514598,0.000006052715,0.00008911191,0.00001781495,0.00020819486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988744,0.00014153343,0.0004178068,0.00029093734,0.00010515603,0.00017014671],"domain_scores_gemma":[0.9990879,0.000014500219,0.00021422104,0.0005797789,0.000058675843,0.000044891334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003966817,0.00013179891,0.00017087023,0.000021222982,0.000108313405,0.000020595928,0.00017344362,0.00010670357,0.000037760943],"category_scores_gemma":[0.000014060154,0.000072470466,0.00016024442,0.000083807194,0.00014195807,0.0000061812125,0.00006477979,0.00011033602,0.0000013324764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036340094,0.000078310346,0.069448054,0.00015922498,0.000057032223,0.0000605282,0.00032021003,0.0000064525507,0.9286509,0.00001464809,0.0007506473,0.00041764154],"study_design_scores_gemma":[0.00012058888,0.00020294944,0.15587115,0.00006752529,0.00010144387,0.0008002199,0.00008733693,0.000115689094,0.8131041,0.00025414702,0.029161993,0.000112881266],"about_ca_topic_score_codex":0.0033646368,"about_ca_topic_score_gemma":0.00006299684,"teacher_disagreement_score":0.11554683,"about_ca_system_score_codex":0.000008197,"about_ca_system_score_gemma":0.00015357832,"threshold_uncertainty_score":0.5086347},"labels":[],"label_agreement":null},{"id":"W4395085455","doi":"10.1016/j.jhepr.2024.101075","title":"Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"National Cancer Institute","keywords":"Hepatocellular carcinoma; Metabolic syndrome; Medicine; Resection; Internal medicine; Oncology; Gastroenterology; Surgery; Obesity","score_opus":0.01739564781100721,"score_gpt":0.2195542655477571,"score_spread":0.20215861773674987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395085455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901228,0.008404706,0.0000036614106,0.00004098596,0.00017001816,0.0008062076,0.000007326537,0.000043109118,0.00040121176],"genre_scores_gemma":[0.99944866,0.000042077463,0.000105288054,0.000011609076,0.000014776854,0.00010523647,0.000068564346,0.0000315393,0.00017227721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984812,0.00004868076,0.0004799236,0.00044794718,0.00032316902,0.00021908038],"domain_scores_gemma":[0.9993588,0.000024262861,0.00010730552,0.00030578775,0.00008608858,0.00011779418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025351357,0.00019250766,0.00041350772,0.00031910438,0.00002476878,0.000022230097,0.000023720433,0.00008549646,0.00008321573],"category_scores_gemma":[0.00003139207,0.00014381365,0.0000794736,0.00047711164,0.000055991077,0.00014509272,0.000030157882,0.00019300343,0.0000055239016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001956859,0.00015499534,0.98110384,0.00025541655,0.00010322129,0.016896544,0.00023162828,2.1794034e-7,0.000039843162,0.000022648468,0.000012174283,0.0009837818],"study_design_scores_gemma":[0.0006813587,0.00081409095,0.99348855,0.00052551576,0.00029350098,0.0015149943,0.000009705089,0.0006520292,0.0013962984,0.000091863025,0.00038888017,0.00014318529],"about_ca_topic_score_codex":0.00029665045,"about_ca_topic_score_gemma":0.00001322624,"teacher_disagreement_score":0.0153815495,"about_ca_system_score_codex":0.000058772966,"about_ca_system_score_gemma":0.000109324574,"threshold_uncertainty_score":0.58645505},"labels":[],"label_agreement":null},{"id":"W4396900414","doi":"10.1016/j.jhepr.2024.101071","title":"Corrigendum to ‘Transplant oncology – Current indications and strategies to advance the field’ [JHEP Reports 6 (2024) 100965]","year":2024,"lang":"en","type":"erratum","venue":"JHEP Reports","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Current (fluid); Internal medicine; Medical physics; Oncology; Engineering","score_opus":0.02904277933730917,"score_gpt":0.3921160128786347,"score_spread":0.3630732335413255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396900414","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004569747,0.07268568,0.033300146,0.076522164,0.57166845,0.0093961395,0.00053056504,0.0009860364,0.23034108],"genre_scores_gemma":[0.035039943,0.019420594,0.017875519,0.013333905,0.01028737,0.0021039739,0.0026020315,0.00039704272,0.8989396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961496,0.00011315253,0.0013681292,0.0011750121,0.0006647596,0.00052931986],"domain_scores_gemma":[0.9973253,0.00027274995,0.0005381277,0.0011944924,0.00019184077,0.00047746958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086664606,0.000538438,0.0009947902,0.00040760386,0.00025235562,0.00015672357,0.00016485664,0.0005089289,0.00033112217],"category_scores_gemma":[0.00034102448,0.00037315016,0.00024027147,0.00051195006,0.000101061996,0.00011229505,0.000087390974,0.0016673005,0.000043463082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077981706,0.00009266125,0.0036823084,0.0011234634,0.0002084895,0.015689759,0.0026650706,0.0000058887863,0.000076011434,0.00049710326,0.94462025,0.031261027],"study_design_scores_gemma":[0.000111689835,0.0004274816,0.018146122,0.0013012885,0.00092844217,0.009464062,0.0002858786,0.0000046014115,0.0000802947,0.0022040103,0.9666439,0.00040217978],"about_ca_topic_score_codex":0.00021137063,"about_ca_topic_score_gemma":0.0009205704,"teacher_disagreement_score":0.66859853,"about_ca_system_score_codex":0.00017904518,"about_ca_system_score_gemma":0.0019296446,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W4399366014","doi":"10.1016/j.jhepr.2024.101129","title":"Reply to: Correspondence on “Cardiomyopathy in cirrhosis: From pathophysiology to clinical care”","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cirrhosis; Cardiology; Cardiomyopathy; Internal medicine; Heart failure","score_opus":0.019974811309292514,"score_gpt":0.3429103905674008,"score_spread":0.3229355792581083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399366014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431777,0.0006065742,0.00008067005,0.00097116135,0.0020731601,0.00046480703,0.0000314325,0.00010096283,0.0013534582],"genre_scores_gemma":[0.9921141,0.000072269395,0.00016597849,0.0067306245,0.00051521737,0.00007652223,0.00010583493,0.00001907692,0.00020037925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838936,0.000081612474,0.00049309677,0.00062969077,0.00023396355,0.0001722726],"domain_scores_gemma":[0.99904287,0.00016885385,0.000040318,0.00046384268,0.000052847638,0.00023126112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026876904,0.000119020166,0.000303716,0.00016980393,0.000019847796,0.00002046071,0.00004406563,0.000081931474,0.000073624426],"category_scores_gemma":[0.0001001018,0.000102984144,0.00014275631,0.00026221137,0.000016634216,0.000050089835,0.000023428893,0.00018901986,0.00034803804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036784264,0.0003235653,0.7652459,0.00034931902,0.00034506764,0.14650156,0.008409855,0.000141649,0.009495283,0.000077517056,0.014727503,0.05070432],"study_design_scores_gemma":[0.00032038358,0.00072996266,0.9838818,0.0008785645,0.00027127753,0.000108209526,0.0002189251,0.000028857792,0.001169529,0.00044024055,0.011795399,0.00015688327],"about_ca_topic_score_codex":0.00045249896,"about_ca_topic_score_gemma":0.000018824589,"teacher_disagreement_score":0.21863583,"about_ca_system_score_codex":0.00007370822,"about_ca_system_score_gemma":0.00019147266,"threshold_uncertainty_score":0.4473441},"labels":[],"label_agreement":null},{"id":"W4399389397","doi":"10.1016/j.jhepr.2024.101132","title":"Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Grifols; Ipsen; ZonMw; Vir Biotechnology; Amsterdam University Medical Centers; Intercept Pharmaceuticals; Gilead Sciences; GlaxoSmithKline","keywords":"Incidence (geometry); Medicine; Cohort; Population; Cohort study; Internal medicine; Pediatrics; Environmental health","score_opus":0.011974765544751612,"score_gpt":0.2785950898333813,"score_spread":0.2666203242886297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399389397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925701,0.0038698614,0.0000034837562,0.00014895585,0.00008758108,0.0006907824,0.0000037717807,0.0000205693,0.0026048808],"genre_scores_gemma":[0.99899495,0.00031157234,0.000019767442,0.00011478404,0.00003799496,0.000044644858,0.0000079121955,0.0000060527486,0.00046231315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915564,0.000066852044,0.0002515086,0.00017838662,0.00027459013,0.00007299451],"domain_scores_gemma":[0.9994422,0.00010827745,0.000055615736,0.00032299687,0.000041529704,0.000029377492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085674744,0.000061971565,0.00013976281,0.000064959335,0.00002629865,0.000021313957,0.00004714534,0.000023806173,0.000044847533],"category_scores_gemma":[0.00014573243,0.00003902991,0.000033222463,0.00019079362,0.00004609054,0.000118883996,0.000046387715,0.00012782933,0.0000010007998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015656828,0.00018190277,0.99474144,0.00041052667,0.00003248037,0.0013147247,0.0013296709,5.299646e-7,0.00013442112,0.0000047267245,0.00030313924,0.0015307704],"study_design_scores_gemma":[0.00012441605,0.00016342523,0.9980859,0.00022116465,0.00013528866,0.00057706045,0.00024722447,0.00004352572,0.000024322251,0.000112844566,0.00022371812,0.000041074498],"about_ca_topic_score_codex":0.00041905788,"about_ca_topic_score_gemma":0.000016292439,"teacher_disagreement_score":0.0064248447,"about_ca_system_score_codex":0.00002734366,"about_ca_system_score_gemma":0.00012038896,"threshold_uncertainty_score":0.15915936},"labels":[],"label_agreement":null},{"id":"W4400408647","doi":"10.1016/j.jhepr.2024.101168","title":"Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Dalhousie University; University of British Columbia; University of Calgary; University of Ottawa; Western University; University of Toronto; Université de Sherbrooke; Queen's University; Toronto General Hospital; University Health Network; Université de Montréal; University of Saskatchewan; St. Michael's Hospital","funders":"Allergan; Grifols; Ipsen; Novo Nordisk; Swedish Orphan Biovitrum; European Association for the Study of the Liver; Vir Biotechnology; Intercept Pharmaceuticals; Pfizer; Incyte; Bristol-Myers Squibb; Dr. Falk Pharma; CSL Behring; Ultragenyx Pharmaceutical; Canadian Liver Foundation; Celgene; PSC Partners Seeking a Cure; Gilead Sciences; American Association for the Study of Liver Diseases; Kowa Company; Sanofi; Genesis Pharma; LifeArc; Falk Foundation","keywords":"Ursodeoxycholic acid; Medicine; Internal medicine; Liver transplantation; Primary biliary cirrhosis; Gastroenterology; Alkaline phosphatase; Liver disease; Cohort; Bilirubin; Transplantation; Biology","score_opus":0.00515738763793972,"score_gpt":0.23015237871998198,"score_spread":0.22499499108204227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400408647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797136,0.00041655498,2.2073317e-7,0.00020434517,0.00008302753,0.00036581594,0.000055203687,0.00007412009,0.0008293717],"genre_scores_gemma":[0.99558234,0.00001351199,0.000054049473,0.0000942215,0.000018297918,0.000010815301,0.000297665,0.000026089929,0.0039029783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987821,0.000058898633,0.0003857316,0.00028427146,0.00029864506,0.00019037836],"domain_scores_gemma":[0.99911714,0.00010951134,0.00009217835,0.0004770305,0.00008029979,0.00012384677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020380582,0.00014593039,0.0003513783,0.00015788106,0.000022854401,0.000010951889,0.00003739478,0.0000825714,0.00025756407],"category_scores_gemma":[0.00015773396,0.000101025136,0.000110944944,0.00028522752,0.00009734183,0.0000878936,0.00008934618,0.00014682958,0.000028249719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016639644,0.00048269378,0.9836813,0.00015462458,0.00011977777,0.0047353376,0.00012116829,3.5970817e-7,0.0068349163,3.2174148e-7,0.0019852773,0.00022021195],"study_design_scores_gemma":[0.0006925047,0.00023979343,0.99434346,0.00039008682,0.000128758,0.00021212902,0.000008290977,0.000009136812,0.00294894,0.000007790096,0.00090445724,0.00011463574],"about_ca_topic_score_codex":0.00013819274,"about_ca_topic_score_gemma":0.0000019473352,"teacher_disagreement_score":0.010662131,"about_ca_system_score_codex":0.00021663247,"about_ca_system_score_gemma":0.00015657973,"threshold_uncertainty_score":0.41196853},"labels":[],"label_agreement":null},{"id":"W4401502546","doi":"10.1016/j.jhepr.2024.101183","title":"A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessness","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gilead Sciences; National Health Service Corps; Sussex Area Community Foundation","keywords":"Virology; Hepatitis C virus; Medicine; Psychology; Virus","score_opus":0.08672675441603818,"score_gpt":0.3989720492196257,"score_spread":0.31224529480358754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401502546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720317,0.00033422848,0.023568502,0.00016467995,0.0011995017,0.00078705116,0.000041567753,0.00022580517,0.0016469482],"genre_scores_gemma":[0.9956433,0.00012608588,0.0007399441,0.00007999612,0.00014916317,0.0008523947,0.000035505935,0.000044090222,0.0023294834],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99765277,0.000096099546,0.0008350168,0.00053394336,0.0003617448,0.0005204408],"domain_scores_gemma":[0.9990723,0.0001721331,0.00012561871,0.00031280753,0.00015758855,0.0001595219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000751104,0.00019250641,0.0005073309,0.00028649534,0.00034548005,0.00006622881,0.00009129312,0.00020236192,0.00011499106],"category_scores_gemma":[0.00022047755,0.00018732614,0.00007629846,0.00062498054,0.000019521134,0.0004909282,0.00012532476,0.00036041395,0.000088503824],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018657509,0.00010110963,0.14875822,0.0005262693,0.000015148865,0.0005377448,0.8222657,0.0022077523,0.007770805,0.0014443822,0.000069501766,0.016284734],"study_design_scores_gemma":[0.0007236018,0.00010198611,0.6401871,0.0021426522,0.0000419683,0.000011494039,0.22311315,0.12009157,0.0014627512,0.002151775,0.008684945,0.0012870427],"about_ca_topic_score_codex":0.051401038,"about_ca_topic_score_gemma":0.2914782,"teacher_disagreement_score":0.5991525,"about_ca_system_score_codex":0.00047670616,"about_ca_system_score_gemma":0.00025556385,"threshold_uncertainty_score":0.95491576},"labels":[],"label_agreement":null},{"id":"W4401821832","doi":"10.1016/j.jhepr.2024.101193","title":"Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek","keywords":"Medicine; Internal medicine; National Health and Nutrition Examination Survey; Metabolic syndrome; Hypertriglyceridemia; Population; Diabetes mellitus; Obesity; Fatty liver; Disease; Endocrinology; Triglyceride; Cholesterol; Environmental health","score_opus":0.0066326780088731,"score_gpt":0.21899860921976935,"score_spread":0.21236593121089625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401821832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963075,0.002382033,0.0000053481617,0.00002902167,0.00019033435,0.0008587786,0.000026851469,0.000043133372,0.00015701712],"genre_scores_gemma":[0.9994384,0.000108383596,0.000052344807,0.0000106971875,0.000020774916,0.000089692825,0.00008074008,0.000019386172,0.00017957331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884576,0.000020088217,0.00027438422,0.00033511868,0.00037851074,0.0001461708],"domain_scores_gemma":[0.9994042,0.000040020514,0.00010135622,0.00023937646,0.00006144778,0.00015360359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000396247,0.00014697829,0.00030623362,0.00007928567,0.000029507537,0.000026057241,0.000023583354,0.00003568269,0.0001152604],"category_scores_gemma":[0.000023394814,0.00009544839,0.00006923376,0.0000966881,0.000082608996,0.00009675757,0.00004031189,0.000063630265,0.0000034266393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003366367,0.00074985594,0.99471134,0.00080448523,0.0004546497,0.0025253086,0.000083876155,8.3754765e-7,0.000023190743,0.00007291905,0.000044592798,0.000495261],"study_design_scores_gemma":[0.0005442387,0.00030712574,0.9955911,0.001127033,0.0016460187,0.00023741803,0.00000316558,0.000075772004,0.00026108098,0.00003763363,0.00007710997,0.000092273935],"about_ca_topic_score_codex":0.00006931804,"about_ca_topic_score_gemma":0.0000011129881,"teacher_disagreement_score":0.003130925,"about_ca_system_score_codex":0.000017346449,"about_ca_system_score_gemma":0.000044800887,"threshold_uncertainty_score":0.38922724},"labels":[],"label_agreement":null},{"id":"W4401823402","doi":"10.1016/j.jhepr.2024.101188","title":"Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nutrition Society; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Deoxycholic acid; Primary sclerosing cholangitis; Feces; Gastroenterology; Internal medicine; Primary (astronomy); Microbiology; Bilirubin; Bile acid; Medicine; Chemistry; Food science; Biology; Disease","score_opus":0.009069113485443007,"score_gpt":0.23338089201275775,"score_spread":0.22431177852731474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401823402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266183,0.00527065,0.0000070525534,0.00023113,0.00012570902,0.00023221536,0.000009281684,0.000095712916,0.0013663875],"genre_scores_gemma":[0.9988962,0.000091353606,0.00033354326,0.00016357214,0.0001010449,0.000014513043,0.000084617954,0.000018389186,0.00029677377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990042,0.000029046108,0.0002613324,0.00030550055,0.00017145868,0.00022849687],"domain_scores_gemma":[0.9995387,0.00005265954,0.0000615929,0.00017996147,0.00004144808,0.00012561282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002178389,0.00014268859,0.00024260393,0.00008294448,0.00005944669,0.00010556357,0.000025165382,0.00006242386,0.000047769878],"category_scores_gemma":[0.000081402155,0.00010070849,0.00005927982,0.00019332478,0.0000661125,0.00018470104,0.00007496469,0.00030610847,0.0000053048316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000168979,0.00022226541,0.92520225,0.00030130145,0.000081010854,0.006123045,0.0003464303,7.1411597e-7,0.05514034,0.0000039184647,0.0005630954,0.011846624],"study_design_scores_gemma":[0.00036255724,0.00034556366,0.9909487,0.001160293,0.000093137845,0.0046636644,0.000057083504,0.00004210783,0.0015055013,0.000029669902,0.0006519198,0.00013980226],"about_ca_topic_score_codex":0.00043009873,"about_ca_topic_score_gemma":0.00003059828,"teacher_disagreement_score":0.06574642,"about_ca_system_score_codex":0.00018757857,"about_ca_system_score_gemma":0.00015050679,"threshold_uncertainty_score":0.41067728},"labels":[],"label_agreement":null},{"id":"W4402469356","doi":"10.1016/j.jhepr.2024.101216","title":"Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Key Research and Development Program of China","keywords":"Observational study; Internal medicine; Hepatocellular carcinoma; Medicine; Oncology; Overall survival","score_opus":0.0739277514550694,"score_gpt":0.28716219601485354,"score_spread":0.21323444455978413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402469356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605167,0.00005417036,0.00012020075,0.00021846853,0.0004953547,0.0021953932,0.000077226796,0.00021231297,0.00057517743],"genre_scores_gemma":[0.99430585,0.0000018179089,0.000743554,0.000027356362,0.00045075998,0.00053864357,0.0025527608,0.000051065817,0.0013282086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983459,0.000026165928,0.00034894992,0.000520069,0.0005708221,0.00018806517],"domain_scores_gemma":[0.9990304,0.000045080942,0.00012302354,0.00027875797,0.00039475702,0.0001279422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021775533,0.00020666906,0.00024823984,0.00012866686,0.00008759742,0.00009972398,0.000047947062,0.000049758055,0.00007829503],"category_scores_gemma":[0.000041775165,0.00013676827,0.00007029372,0.00018981719,0.000032648753,0.00038485095,0.000018473347,0.000098952674,0.0000036852775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006718584,0.00066658255,0.9928046,0.00006580434,0.00059234916,0.001232605,0.00033166376,0.0000045144798,0.00016885472,0.000019631781,0.00018456497,0.003257013],"study_design_scores_gemma":[0.0019138388,0.0037735684,0.98527837,0.00010812004,0.00055952684,0.00013700785,0.00010319874,0.0033530367,0.0002979035,0.000038032013,0.00427704,0.00016037212],"about_ca_topic_score_codex":0.00013155169,"about_ca_topic_score_gemma":0.000045871853,"teacher_disagreement_score":0.0075262026,"about_ca_system_score_codex":0.00013770667,"about_ca_system_score_gemma":0.00019531557,"threshold_uncertainty_score":0.55772483},"labels":[],"label_agreement":null},{"id":"W4403154199","doi":"10.1016/j.jhepr.2024.101231","title":"Progressive systemic inflammation precedes decompensation in compensated cirrhosis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Instituto de Salud Carlos III; European Regional Development Fund; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ministerio de Ciencia e Innovación","keywords":"Decompensation; Systemic inflammation; Cirrhosis; Inflammation; Medicine; Systemic circulation; Immunology; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.010649512540929277,"score_gpt":0.28283360698341603,"score_spread":0.27218409444248676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403154199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954003,0.0010828227,0.00011396924,0.00018152199,0.0003085866,0.000752547,0.0000030228955,0.00019863552,0.0019585812],"genre_scores_gemma":[0.9991577,0.000047133475,0.00010301003,0.000017682476,0.00011790313,0.00009516343,0.00033948076,0.000015836134,0.0001060847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.000037051163,0.00040119034,0.00024779676,0.00021213453,0.000120622775],"domain_scores_gemma":[0.9995811,0.000041393465,0.00009220492,0.00014920122,0.00007527421,0.000060821123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018937493,0.000097312026,0.00016046819,0.00020309101,0.00002833761,0.000050793595,0.000017536408,0.00006640465,0.00009969992],"category_scores_gemma":[0.000014642365,0.000084803236,0.000052946813,0.0002461454,0.000016844584,0.00022533233,0.000005948857,0.000091970134,0.000042922675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034835882,0.00017239817,0.8816668,0.0056940247,0.0006193455,0.03141948,0.0063160355,0.00026921733,0.05521509,0.0009949134,0.00024354026,0.017040838],"study_design_scores_gemma":[0.0009025404,0.00014606089,0.94084704,0.0057809507,0.0008705432,0.008335189,0.00032078897,0.007851615,0.033460442,0.00089327357,0.0002951614,0.00029642016],"about_ca_topic_score_codex":0.00006099977,"about_ca_topic_score_gemma":0.000018091929,"teacher_disagreement_score":0.059180252,"about_ca_system_score_codex":0.00012018733,"about_ca_system_score_gemma":0.00012887693,"threshold_uncertainty_score":0.34581757},"labels":[],"label_agreement":null},{"id":"W4403312140","doi":"10.1016/j.jhepr.2024.101232","title":"Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"European Association for the Study of the Liver; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Research UK","keywords":"Atezolizumab; Bevacizumab; Oncology; Medicine; Internal medicine; Cancer; Nivolumab; Chemotherapy; Immunotherapy","score_opus":0.030543782792304238,"score_gpt":0.3042937490793094,"score_spread":0.27374996628700515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403312140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378496,0.0026391065,0.0000036057918,0.00084138307,0.00030551458,0.0010284854,0.000017381159,0.00013474733,0.0012448371],"genre_scores_gemma":[0.9951851,0.00020266553,0.00015485258,0.0001092447,0.000079187856,0.0005280724,0.000099471996,0.000043383236,0.003598043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984466,0.000031437463,0.00043166432,0.00057041715,0.0002346897,0.00028518017],"domain_scores_gemma":[0.9993376,0.00005064048,0.00006632376,0.000366797,0.000022470203,0.00015615493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011024084,0.00028852862,0.000464834,0.00021227243,0.00003441051,0.00004862967,0.000019634997,0.00011353509,0.0004642489],"category_scores_gemma":[0.000018531435,0.00018699425,0.00015283513,0.00012334264,0.00002510446,0.00010269019,0.000029018847,0.00013354162,0.000030290135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025391966,0.00033624738,0.8412343,0.00017236214,0.000094786235,0.03500357,0.00034534954,2.7821366e-7,0.00014471947,0.000007174199,0.000025339958,0.122381926],"study_design_scores_gemma":[0.00228167,0.0028532527,0.9610141,0.0010917097,0.00023299393,0.0013560727,0.00004853732,0.00041186583,0.012611355,0.00012385141,0.017648693,0.0003258838],"about_ca_topic_score_codex":0.00005609589,"about_ca_topic_score_gemma":0.00015261689,"teacher_disagreement_score":0.12205604,"about_ca_system_score_codex":0.00026514466,"about_ca_system_score_gemma":0.000080053054,"threshold_uncertainty_score":0.7625404},"labels":[],"label_agreement":null},{"id":"W4404185764","doi":"10.1016/j.jhepr.2024.101263","title":"Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Ipsen; Eisai; Bayer HealthCare; FibroGen; EA Pharma Co., Ltd.; Gilead Sciences; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Stage (stratigraphy); Algorithm; Oncology; Internal medicine; Medicine; Computer science; Biology","score_opus":0.0700108056272081,"score_gpt":0.43591009182488194,"score_spread":0.36589928619767387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404185764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99058056,0.0015952034,0.0044876956,0.0002058495,0.0008037312,0.0015872319,0.0000026601188,0.000047520014,0.0006895441],"genre_scores_gemma":[0.99631053,0.000026197975,0.0027545833,0.000028527402,0.00012621787,0.0002480967,0.000008412132,0.000016438375,0.00048097732],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99867076,0.00006265067,0.0004299471,0.00031079727,0.0003844549,0.00014137589],"domain_scores_gemma":[0.99914503,0.00015891998,0.00013659542,0.00014124616,0.0003747259,0.000043457563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017434476,0.000108058724,0.00034877984,0.00016401129,0.000036112244,0.000016334845,0.000019206609,0.00004606229,0.000022378877],"category_scores_gemma":[0.0009952085,0.00008521364,0.00008900507,0.00016840672,0.00008050943,0.000100347635,0.000019503354,0.00022081846,0.0000016138218],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011448644,0.0011327915,0.4780164,0.0029672363,0.0025363471,0.0013485037,0.051181916,0.00429612,0.046782542,0.000087739696,0.0014485135,0.40905702],"study_design_scores_gemma":[0.0015651194,0.00021121262,0.21617602,0.00056973496,0.0003004033,0.0000759816,0.0009557845,0.7659528,0.012375809,0.00036874198,0.0013341829,0.000114194685],"about_ca_topic_score_codex":0.00011869572,"about_ca_topic_score_gemma":0.000032861266,"teacher_disagreement_score":0.7616567,"about_ca_system_score_codex":0.00025610486,"about_ca_system_score_gemma":0.000086028536,"threshold_uncertainty_score":0.34749115},"labels":[],"label_agreement":null},{"id":"W4404289263","doi":"10.1016/j.jhepr.2024.101265","title":"Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"RWTH Aachen University; Deutsche Krebshilfe; Universitat de Barcelona; Medizinischen Hochschule Hannover; Università degli Studi di Milano-Bicocca; Deutsche Forschungsgemeinschaft; Yale University; National Institute for Health and Care Research; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Dipartimenti di Eccellenza; Falk Foundation","keywords":"Autoimmune hepatitis; Medicine; Hepatitis; Status quo; Group (periodic table); Virology; Immunology; Political science; Chemistry","score_opus":0.0830393063897963,"score_gpt":0.40301383828835297,"score_spread":0.3199745318985567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404289263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061070145,0.97365093,0.000004764814,0.00047695445,0.0077488464,0.0019016429,0.00024554017,0.00012041105,0.015240193],"genre_scores_gemma":[0.0014161401,0.8958171,0.000063471285,0.000057293255,0.0006198616,0.00030809487,0.0011767335,0.00014864885,0.100392655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99382204,0.00057826616,0.0022195408,0.0009030588,0.0018533771,0.0006237336],"domain_scores_gemma":[0.9952966,0.00037218357,0.0009672959,0.0026425037,0.00051646493,0.00020493616],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001911035,0.00062956545,0.0021584833,0.00063864514,0.00027552043,0.00016975433,0.00083810475,0.00053768465,0.002242885],"category_scores_gemma":[0.00089887145,0.0004115616,0.0018981653,0.0015046775,0.0005042701,0.00020234904,0.0017099989,0.0025737733,0.0001482004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005386334,0.0010132575,0.011913338,0.036737084,0.0041030203,0.0061347303,0.00036812658,6.45049e-7,0.000009026545,0.0009100286,0.238241,0.70051587],"study_design_scores_gemma":[0.0001646622,0.000104289924,0.020831116,0.049392063,0.0021531798,0.0013261983,0.000042837964,0.00004269564,0.0000011309712,0.00024395651,0.92535675,0.000341148],"about_ca_topic_score_codex":0.0064265556,"about_ca_topic_score_gemma":0.00013397193,"teacher_disagreement_score":0.70017475,"about_ca_system_score_codex":0.00087798224,"about_ca_system_score_gemma":0.0018398503,"threshold_uncertainty_score":0.99983364},"labels":[],"label_agreement":null},{"id":"W4404353474","doi":"10.1016/j.jhepr.2024.101271","title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; University of Alberta Hospital; University of Alberta; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Natural Science Basic Research Program of Shaanxi Province; Scientific Research Plan Projects of Shaanxi Education Department; College of Medicine, Seoul National University; Alnylam Pharmaceuticals; AstraZeneca; Genentech; LG Chem; Ipsen; National Key Research and Development Program of China; Sun Pharma; Key Science and Technology Program of Shaanxi Province; Siemens Healthineers; Yakult Bio-Science Foundation; Intercept Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Education Department of Shaanxi Province; Universidade de Lisboa; Universidad Nacional Autónoma de México; Faculty of Medicine, Chulalongkorn University; National and Kapodistrian University of Athens; Daewoong Pharmaceutical Company; Universiti Malaya; Novo Nordisk; Helwan University; Yonsei University; Eisai; National Natural Science Foundation of China; Pfizer; Consejo Nacional de Investigaciones Científicas y Técnicas; Institut National de la Santé et de la Recherche Médicale; Royal College of Surgeons in Ireland; Universidad de Sevilla; Chulalongkorn University; McGill University Health Centre; Regeneron Pharmaceuticals; Bristol-Myers Squibb; Chinese University of Hong Kong; Eli Lilly and Company; CSL Behring; Yonsei University College of Medicine; McGill University; Universitas Indonesia; Amsterdam University Medical Centers; Gilead Sciences; Seoul National University; Inventiva Pharma; Kowa Company; Sanofi","keywords":"Burden of disease; Medicine; Disease; Liver dysfunction; Intensive care medicine; Environmental health; Internal medicine","score_opus":0.011524808326253818,"score_gpt":0.2642028400749321,"score_spread":0.2526780317486783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404353474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745502,0.018856667,0.00001790591,0.0011583032,0.0013861842,0.00068724714,0.00012312637,0.00008743385,0.0031329615],"genre_scores_gemma":[0.99449337,0.00028976108,0.00004460518,0.00013407505,0.00026521314,0.000092551425,0.00014008615,0.0000186328,0.0045217113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985357,0.000027895047,0.00036876916,0.00041476838,0.00043752955,0.0002153408],"domain_scores_gemma":[0.9988439,0.00003789746,0.00008669422,0.000424122,0.00015319421,0.00045415474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011798852,0.00016893657,0.00034868284,0.000091528054,0.000039165814,0.000036403508,0.000035557074,0.000057037454,0.001357865],"category_scores_gemma":[0.00015954823,0.00013359367,0.00026646635,0.0004487289,0.000027465909,0.00008216761,0.000050734212,0.00005763849,0.00020145075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117736854,0.0011183132,0.9076322,0.0002554967,0.0018817756,0.01959207,0.00025456442,0.00011586476,0.000061182654,0.0007319953,0.05457474,0.013664064],"study_design_scores_gemma":[0.00032413178,0.0001142025,0.97417325,0.00036669592,0.0021920009,0.00009010358,0.000035489193,0.00017114857,0.00011185113,0.00019231721,0.022097854,0.00013093003],"about_ca_topic_score_codex":0.0010844375,"about_ca_topic_score_gemma":0.00003818467,"teacher_disagreement_score":0.066541076,"about_ca_system_score_codex":0.00014952308,"about_ca_system_score_gemma":0.00034499523,"threshold_uncertainty_score":0.99955505},"labels":[],"label_agreement":null},{"id":"W4404844276","doi":"10.1016/j.jhepr.2024.101290","title":"Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biliary tract cancer; Meta-analysis; Randomized controlled trial; Medicine; Systemic therapy; Oncology; Internal medicine; Biliary tract; Overall survival; Cancer; Gemcitabine; Breast cancer","score_opus":0.2097868775859035,"score_gpt":0.44038850796007784,"score_spread":0.23060163037417433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404844276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013634823,0.98760843,0.000010668751,0.00015361229,0.00058806664,0.0107111,0.00078947836,0.00007122457,0.000053761036],"genre_scores_gemma":[0.0000385437,0.99530405,0.00023162444,0.00012348701,0.00011315065,0.0031401063,0.0007295721,0.00010420906,0.00021526503],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938437,0.00037434947,0.0031887966,0.001714298,0.00046345455,0.00041544903],"domain_scores_gemma":[0.9949809,0.0003834677,0.0020312208,0.002213239,0.0002488764,0.00014229467],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002027997,0.0008643099,0.015716799,0.0005875879,0.000081261525,0.000062958796,0.00026461977,0.00021748833,0.00007100088],"category_scores_gemma":[0.00048769166,0.0005143079,0.002114816,0.0017355507,0.00007379914,0.0002647951,0.00017394031,0.00043688022,0.0000011446323],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011409517,0.000039105464,0.00007383431,0.8296697,0.08976722,0.0005056005,0.00003758677,7.9234024e-7,2.1424357e-7,7.4520744e-7,0.00015378928,0.07974002],"study_design_scores_gemma":[0.00016795413,0.000038558897,0.0000037100067,0.13517235,0.7035623,0.0026680403,0.000050169023,0.000013377979,1.1533044e-7,0.00000604917,0.15793325,0.00038408558],"about_ca_topic_score_codex":0.00008248375,"about_ca_topic_score_gemma":0.00027637937,"teacher_disagreement_score":0.69449735,"about_ca_system_score_codex":0.00043653496,"about_ca_system_score_gemma":0.00083132513,"threshold_uncertainty_score":0.9997308},"labels":[],"label_agreement":null},{"id":"W4404885936","doi":"10.1016/j.jhepr.2024.101272","title":"Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; SickKids Foundation; University of Toronto; Toronto General Hospital; Queen's University; Women's College Hospital; Public Health Ontario","funders":"University Health Network Foundation; Canadian Institutes of Health Research; PSC Partners Seeking a Cure","keywords":"Primary sclerosing cholangitis; Inflammatory bowel disease; Epidemiology; Medicine; Sequence (biology); Disease; Internal medicine; Gastroenterology; Biology","score_opus":0.07122271235830462,"score_gpt":0.36948930689861803,"score_spread":0.2982665945403134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404885936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763452,0.022108246,0.00002181532,0.00015839594,0.00024746198,0.00031387783,0.000060963954,0.00009681553,0.00064725586],"genre_scores_gemma":[0.99797535,0.0013690223,0.00006454605,0.00014592666,0.0001525868,0.000016850281,0.00012628152,0.000022533382,0.00012692498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867326,0.00008517947,0.000513412,0.0003211072,0.00016975371,0.00023726307],"domain_scores_gemma":[0.9983126,0.0006201732,0.0001540788,0.00050319656,0.000060849008,0.0003491177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006247126,0.00015604371,0.00034499468,0.00008078221,0.000058861788,0.000023211298,0.00004268171,0.00006561315,0.000100225945],"category_scores_gemma":[0.0020596753,0.000121715784,0.00024108139,0.00009728369,0.00024279709,0.00021754726,0.00010353142,0.00019099089,0.000004672907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025495887,0.00006520815,0.99036986,0.0009999637,0.0001917291,0.003493238,0.000054151362,0.000013980411,0.0017476846,0.00006354381,0.0012242737,0.0017508989],"study_design_scores_gemma":[0.00012281352,0.000089028676,0.99619824,0.0010648748,0.00036924917,0.00058347505,0.000009642974,0.00024212342,0.000041475952,0.00096572324,0.00019723542,0.00011612977],"about_ca_topic_score_codex":0.00061128964,"about_ca_topic_score_gemma":0.0000018566928,"teacher_disagreement_score":0.02163016,"about_ca_system_score_codex":0.00015022075,"about_ca_system_score_gemma":0.0004906785,"threshold_uncertainty_score":0.49634257},"labels":[],"label_agreement":null},{"id":"W4405259999","doi":"10.1016/j.jhepr.2024.101300","title":"Non-invasive assessment of portal hypertension: Liver stiffness and beyond","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ludwig Boltzmann Gesellschaft; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Portal hypertension; Medicine; Internal medicine; Cardiology; Cirrhosis","score_opus":0.03439928864060379,"score_gpt":0.3336309422470708,"score_spread":0.299231653606467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405259999","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028506762,0.9908829,0.000004133365,0.0000139383465,0.000541748,0.0008816661,0.000057169884,0.000031936863,0.004735874],"genre_scores_gemma":[0.01629631,0.9819861,0.00009428933,0.000040953695,0.00019517585,0.000055422846,0.00077335176,0.000044434608,0.00051396375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982835,0.000019572157,0.00071802706,0.00047586867,0.0003653983,0.00013763913],"domain_scores_gemma":[0.99893457,0.000058354606,0.00037499008,0.00035581872,0.00011809918,0.00015817164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012897768,0.00028936303,0.0013043057,0.00017765227,0.000029571935,0.00001866873,0.000030736275,0.00019298331,0.0000896663],"category_scores_gemma":[0.000007364579,0.000199477,0.000352793,0.00015508453,0.00006040315,0.000064119915,0.000037749654,0.00023681046,0.000009693359],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025210711,0.000362113,0.0010501132,0.3286235,0.0045735105,0.31327757,0.0002792662,1.7772676e-7,0.000022798757,0.00016001849,0.0035155308,0.3481102],"study_design_scores_gemma":[0.0014218127,0.0005222722,0.031446543,0.16460602,0.21751676,0.1455489,0.00021236017,0.00005040667,0.00004153609,0.00024665293,0.4368275,0.0015592076],"about_ca_topic_score_codex":0.000030449904,"about_ca_topic_score_gemma":0.0000042243955,"teacher_disagreement_score":0.433312,"about_ca_system_score_codex":0.000037420235,"about_ca_system_score_gemma":0.0010047974,"threshold_uncertainty_score":0.8134436},"labels":[],"label_agreement":null},{"id":"W4405741174","doi":"10.1016/j.jhepr.2024.101311","title":"Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"National Institute of Allergy and Infectious Diseases; Japan Society for the Promotion of Science; National Institutes of Health; United States-Israel Binational Science Foundation; Japan Agency for Medical Research and Development","keywords":"cccDNA; Virology; Hepatitis B virus; Primary (astronomy); Kinetics; Virus; Biology; Chemistry; Physics; HBsAg","score_opus":0.06270405028205692,"score_gpt":0.3445699201040431,"score_spread":0.28186586982198614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405741174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377495,0.003060961,0.00023110863,0.00007076024,0.000096301585,0.00029887946,0.000006346183,0.000040592957,0.002420128],"genre_scores_gemma":[0.9978784,0.00090918667,0.000987597,0.000030961874,0.00005326555,0.000015729787,0.000025364325,0.000022090448,0.000077448545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863267,0.000016888804,0.00073385047,0.00023316339,0.0002566666,0.00012673943],"domain_scores_gemma":[0.9994995,0.000036091144,0.00011437484,0.00021207459,0.00009797827,0.000039960592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027356576,0.000111697205,0.00039414922,0.00019919874,0.00002090131,0.0000085059955,0.000020554222,0.000071957445,0.000024841136],"category_scores_gemma":[0.00008343549,0.0001053512,0.00005411747,0.00016685438,0.00006180297,0.000087623026,0.00006436096,0.000105370214,8.2855723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010726715,0.000085512795,0.95199496,0.0008026119,0.00004967897,0.0005866648,0.0006644169,0.00033964036,0.041630562,0.00009796098,0.000067753936,0.0036694931],"study_design_scores_gemma":[0.00027090826,0.00023623141,0.93563503,0.0011338842,0.00011134853,0.0001683028,0.000014005626,0.04575919,0.015226856,0.0010572595,0.00024536683,0.00014162781],"about_ca_topic_score_codex":0.011459043,"about_ca_topic_score_gemma":0.0035637605,"teacher_disagreement_score":0.045419548,"about_ca_system_score_codex":0.000091873175,"about_ca_system_score_gemma":0.00006366665,"threshold_uncertainty_score":0.99512374},"labels":[],"label_agreement":null},{"id":"W4406283509","doi":"10.1016/j.jhepr.2024.101325","title":"Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Agència de Gestió d'Ajuts Universitaris i de Recerca; Boston Scientific Corporation; Generalitat de Catalunya; European Commission; Mallinckrodt Pharmaceuticals","keywords":"Terlipressin; Octreotide; Portal hypertension; Medicine; Cirrhosis; Hemodynamics; Internal medicine; Portal venous pressure; Randomized controlled trial; Cardiology; Gastroenterology; Somatostatin; Hepatorenal syndrome","score_opus":0.015727796399592046,"score_gpt":0.2790695597728927,"score_spread":0.2633417633733007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406283509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721164,0.00017693892,0.000019667588,0.000078993246,0.00014353896,0.001455066,0.000006844649,0.000012581097,0.0008947116],"genre_scores_gemma":[0.9993445,0.00003182472,0.0002711676,0.00007987128,0.000026151034,0.000034727014,0.00011159935,0.000007529696,0.00009260464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987018,0.0000715565,0.0006727859,0.0002829299,0.0001739005,0.000097034965],"domain_scores_gemma":[0.999307,0.00014937925,0.00022716452,0.00016590916,0.0000796766,0.00007087591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034675762,0.00010354263,0.0005784922,0.000121858066,0.000021324624,0.000010267948,0.000013406763,0.000069828995,0.00001329277],"category_scores_gemma":[0.00007885983,0.000071879076,0.000066075605,0.000101278514,0.00013732899,0.000082630875,0.000014084437,0.00009152451,1.5865518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34199548,0.00061172066,0.6539807,0.00015012843,0.00019227926,0.0007440242,0.000058350284,2.560749e-7,0.00003397032,0.0000076117144,0.000021263066,0.00220423],"study_design_scores_gemma":[0.44467258,0.00041536358,0.55312,0.00040967847,0.0009370422,0.00008919293,0.0000203371,0.00009923223,0.00009195559,0.0000711558,0.000005877571,0.000067565015],"about_ca_topic_score_codex":0.00006515528,"about_ca_topic_score_gemma":0.00001887121,"teacher_disagreement_score":0.10267709,"about_ca_system_score_codex":0.00000900393,"about_ca_system_score_gemma":0.000103077124,"threshold_uncertainty_score":0.29311436},"labels":[],"label_agreement":null},{"id":"W4406980504","doi":"10.1016/j.jhepr.2025.101338","title":"Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkers","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Deutsche Forschungsgemeinschaft","keywords":"Proteomics; Computational biology; Medicine; Liver failure; Bioinformatics; Intensive care medicine; Biology; Internal medicine; Genetics","score_opus":0.004320680443534701,"score_gpt":0.21839591755306287,"score_spread":0.21407523710952817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406980504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962408,0.00024313101,0.0009523263,0.00015348202,0.000046741145,0.0017524728,0.000016111644,0.00004087419,0.0005540452],"genre_scores_gemma":[0.99735755,0.000088887144,0.0022112166,0.00004948851,0.000014985893,0.00009380451,0.0000584809,0.000011463674,0.00011413265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916303,0.000019653517,0.0002380006,0.0002882407,0.00017512644,0.00011594957],"domain_scores_gemma":[0.99936014,0.00004497291,0.00017285676,0.0001771131,0.00016671827,0.00007817412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053385153,0.00012951544,0.0002154799,0.00011696138,0.00005942407,0.000013311572,0.000021273785,0.00006781924,0.000008455597],"category_scores_gemma":[0.000021568934,0.00009381974,0.00003605307,0.00016923937,0.0000701894,0.00013876354,0.0000130895005,0.00008083703,8.177846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011788488,0.0011776548,0.8626764,0.010449318,0.00967145,0.036558382,0.008796957,0.000006719359,0.05178066,0.001588783,0.00023920024,0.00526598],"study_design_scores_gemma":[0.0031999175,0.0011990529,0.85474914,0.003987905,0.007426214,0.002347721,0.0010371985,0.0005420757,0.12358933,0.001502389,0.00009573155,0.00032334874],"about_ca_topic_score_codex":0.00008505682,"about_ca_topic_score_gemma":0.00007343833,"teacher_disagreement_score":0.07180867,"about_ca_system_score_codex":0.000027570473,"about_ca_system_score_gemma":0.0002818068,"threshold_uncertainty_score":0.3825858},"labels":[],"label_agreement":null},{"id":"W4407588098","doi":"10.1016/j.jhepr.2025.101354","title":"Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; McMaster University Medical Centre","funders":"McMaster University; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Sorafenib","score_opus":0.007376531883041114,"score_gpt":0.24222326125277627,"score_spread":0.23484672936973516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407588098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919087,0.0027388937,0.00007633386,0.00018346995,0.0030913623,0.0003753571,0.0000076241195,0.000009463656,0.0016087837],"genre_scores_gemma":[0.99690455,0.00017923572,0.00008081762,0.00020473088,0.0011420086,0.000031809443,0.000036383582,0.000016140366,0.00140432],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875385,0.00004962806,0.00049061945,0.00036565866,0.00011730957,0.00022291306],"domain_scores_gemma":[0.99897516,0.00001736873,0.0002395852,0.0006621231,0.00006888842,0.00003685853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027997463,0.0001485778,0.00026697328,0.0000647132,0.000050847964,0.000014165194,0.00015441324,0.00009473953,0.000009278651],"category_scores_gemma":[0.00015707467,0.00011594193,0.0001409246,0.00016036353,0.00010557214,0.000003611973,0.00013403568,0.00010397407,9.3523323e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004084511,0.00007291402,0.20740733,0.000044737255,0.000037653495,0.0000074227223,0.000073003706,0.00003461186,0.7858472,0.00010490846,0.0047955704,0.0015338261],"study_design_scores_gemma":[0.0007009023,0.000058792364,0.40660873,0.000040860246,0.000041391293,0.000053762244,0.00006544891,0.00014230552,0.2450434,0.00010049131,0.34695977,0.00018415427],"about_ca_topic_score_codex":0.00028882816,"about_ca_topic_score_gemma":0.00006189853,"teacher_disagreement_score":0.5408038,"about_ca_system_score_codex":0.000012324422,"about_ca_system_score_gemma":0.00023259666,"threshold_uncertainty_score":0.47279748},"labels":[],"label_agreement":null},{"id":"W4408303709","doi":"10.1016/j.jhepr.2025.101332","title":"Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Sir Jules Thorn Charitable Trust; European Association for the Study of the Liver; Canadian Institutes of Health Research; Canadian Liver Foundation; Medical Research Foundation; Medical Research Council; Soy Nutrition Institute; Queen Elizabeth Hospital Birmingham Charity","keywords":"Medicine; Cholestatic hepatitis; Liver transplantation; Autoimmune hepatitis; Transplantation; Hepatitis; Gastroenterology; Immunology; Internal medicine","score_opus":0.0076581597323133995,"score_gpt":0.24070584910694526,"score_spread":0.23304768937463186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408303709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552387,0.0024429427,0.00019978826,0.00010604801,0.00036379186,0.00038908873,0.000022118693,0.00002371164,0.00092864176],"genre_scores_gemma":[0.9978278,0.0015842014,0.00020250701,0.00008543778,0.000006298257,0.000034396584,0.00004793198,0.0000075294847,0.00020385675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910635,0.00006535891,0.00031199504,0.00020095283,0.00018862239,0.00012671597],"domain_scores_gemma":[0.9993634,0.00006630058,0.00014418516,0.00028350673,0.00008000077,0.00006259281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120524805,0.00011385265,0.00026883572,0.00009010393,0.0000449949,0.0000134036845,0.000025219535,0.000047190104,0.00008059579],"category_scores_gemma":[0.00006376941,0.00009831492,0.0000679752,0.00014373421,0.00007435174,0.000100807025,0.000028426863,0.0000950167,0.0000013081705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003997856,0.0006107597,0.94670826,0.0032117993,0.00024531604,0.01286234,0.002398059,0.0000036444376,0.0006480342,0.00020343959,0.0002680417,0.032440506],"study_design_scores_gemma":[0.00040893984,0.00025251813,0.9960293,0.000896837,0.0003315272,0.0007665529,0.00005584535,0.00011797614,0.0006886396,0.00012249923,0.00023931258,0.00009000519],"about_ca_topic_score_codex":0.0007828845,"about_ca_topic_score_gemma":0.000023986284,"teacher_disagreement_score":0.049321074,"about_ca_system_score_codex":0.000029949535,"about_ca_system_score_gemma":0.00011284118,"threshold_uncertainty_score":0.40091664},"labels":[],"label_agreement":null},{"id":"W4409670273","doi":"10.1016/j.jhepr.2025.101431","title":"Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Imperial Experimental Cancer Medicine Centre; European Association for the Study of the Liver; Associazione Italiana per la Ricerca sul Cancro; Foundation for Liver Research; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Treatment and Research Trust; Cancer Research UK; Wellcome Trust; F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Bevacizumab; Medicine; Internal medicine; Oncology; Nivolumab; Cancer; Chemotherapy","score_opus":0.15455715574314444,"score_gpt":0.3669817862430308,"score_spread":0.21242463049988636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409670273","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2668521,0.70822346,0.0004010092,0.0023378378,0.00009498171,0.015255667,0.000064142754,0.000093551294,0.006677272],"genre_scores_gemma":[0.98529905,0.0031419252,0.00048045843,0.00012433516,0.000006411562,0.0006090417,0.00005403985,0.000014688763,0.010270077],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974009,0.0001299485,0.001517683,0.0004234803,0.0003301958,0.00019780245],"domain_scores_gemma":[0.99695307,0.0007159319,0.0008763467,0.0009831112,0.00038141833,0.00009013486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011883551,0.00022097038,0.0039733355,0.00060802395,0.000049440205,0.00001211475,0.00007891406,0.00006724524,0.00014454752],"category_scores_gemma":[0.0011958468,0.00015054378,0.00138466,0.0016931257,0.00005956819,0.00007787735,0.000055001514,0.00006620478,7.928983e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003426246,0.00033094065,0.07489268,0.6566621,0.2650158,0.00038993428,0.00020118516,0.000009970263,0.00026929798,0.00067849,0.0011137617,0.00009317451],"study_design_scores_gemma":[0.0005660219,0.00018031974,0.00422547,0.008347375,0.9833783,0.000043152308,0.000012540681,0.0004274269,0.0025407055,0.00005697981,0.00009801974,0.00012371942],"about_ca_topic_score_codex":0.000513864,"about_ca_topic_score_gemma":0.00010035303,"teacher_disagreement_score":0.7184469,"about_ca_system_score_codex":0.00010866779,"about_ca_system_score_gemma":0.00024561945,"threshold_uncertainty_score":0.6138997},"labels":[],"label_agreement":null},{"id":"W4410221646","doi":"10.1016/j.jhepr.2025.101451","title":"SBRT for bridging and downstaging HCC before transplant","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bridging (networking); Medicine; Oncology; Computer science","score_opus":0.025146067120193957,"score_gpt":0.26103194842607785,"score_spread":0.2358858813058839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410221646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868614,0.0010224432,0.001586447,0.0015325038,0.00019768758,0.00074122404,0.000006220792,0.00008016155,0.007971911],"genre_scores_gemma":[0.9953339,0.000028845172,0.0008609616,0.00030267058,0.00008001705,0.00009158553,0.00008154548,0.000012742217,0.0032076999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991944,0.000007535408,0.00024874252,0.0002648907,0.00009309885,0.00019133193],"domain_scores_gemma":[0.9996101,0.000026445196,0.00005471759,0.00019182402,0.000038899358,0.0000779596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019067222,0.00011512483,0.00024476476,0.000098773,0.00010198952,0.000022951926,0.000016546277,0.0000578096,0.000020672798],"category_scores_gemma":[0.000025289402,0.000094562754,0.00010370897,0.00009134972,0.000026430405,0.00004543203,0.000011817977,0.00006326052,0.000001163262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042373536,0.00003827708,0.96176016,0.00025229147,0.000098114426,0.0013837023,0.00024991645,1.05213864e-7,0.0007652428,0.00011677019,0.000895559,0.03439748],"study_design_scores_gemma":[0.0046622227,0.0007126623,0.6695009,0.001832085,0.0026171182,0.004488602,0.00019940271,0.0070501594,0.049480207,0.0019085878,0.25694174,0.00060634734],"about_ca_topic_score_codex":0.00004052149,"about_ca_topic_score_gemma":0.0000106924845,"teacher_disagreement_score":0.29225928,"about_ca_system_score_codex":0.000041994896,"about_ca_system_score_gemma":0.00006871527,"threshold_uncertainty_score":0.3856157},"labels":[],"label_agreement":null},{"id":"W4410708099","doi":"10.1016/j.jhepr.2025.101455","title":"Type II fibre atrophy and nuclear disruption in decompensated cirrhosis","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"Institute of Nutrition, Metabolism and Diabetes; Faculty of Medicine and Dentistry, University of Alberta; University Hospital Foundation; Canada Foundation for Innovation; Canadian Institutes of Health Research; Canadian Liver Foundation; University of Alberta; Canadian Association for the Study of the Liver; Canadian Donation and Transplantation Research Program","keywords":"Atrophy; Cirrhosis; Medicine; Internal medicine","score_opus":0.01631844964273129,"score_gpt":0.33084914662329834,"score_spread":0.31453069698056707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410708099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805258,0.00045483722,0.000004019189,0.0038300029,0.00028785746,0.00020784863,4.1658927e-7,0.000058503498,0.014630728],"genre_scores_gemma":[0.9966868,0.00020640463,0.0006970782,0.0014650914,0.000041907104,0.0000045081965,0.00001338251,0.000008155195,0.0008766476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933696,0.000014275284,0.00027455675,0.00017837688,0.0000761398,0.00011969728],"domain_scores_gemma":[0.999657,0.000012497755,0.00006252036,0.00015483455,0.000047626767,0.00006554516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001343025,0.000060259328,0.00016451694,0.00014379037,0.00008953317,0.000010275398,0.000012115145,0.00006124899,0.0001915231],"category_scores_gemma":[0.000061006493,0.000057680856,0.000022571021,0.00024215985,0.000022433624,0.0000351722,0.000032889195,0.00012199536,0.0000063147736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044478988,0.00039663282,0.9283145,0.0012242326,0.000047247697,0.0023448945,0.00090424425,0.0000019748172,0.013544394,0.0027277104,0.017052008,0.03299735],"study_design_scores_gemma":[0.0009028797,0.00016416964,0.845502,0.0007058445,0.000034580677,0.00044600273,0.00011263022,0.000313252,0.00016962868,0.0014834192,0.15006758,0.000098025244],"about_ca_topic_score_codex":0.00007038326,"about_ca_topic_score_gemma":0.000012341976,"teacher_disagreement_score":0.13301557,"about_ca_system_score_codex":0.000064300206,"about_ca_system_score_gemma":0.00004584766,"threshold_uncertainty_score":0.23521571},"labels":[],"label_agreement":null},{"id":"W4410893913","doi":"10.1016/j.jhepr.2025.101465","title":"Modelling the liver’s regenerative capacity across different clinical conditions","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver physiology and pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; University of British Columbia; University Health Network","funders":"University Health Network; Scheme for Promotion of Academic and Research Collaboration; Hospital for Sick Children; Stem Cell Network; Natural Sciences and Engineering Research Council of Canada; University Health Network Foundation","keywords":"Regeneration (biology); Liver regeneration; Biology; Transcriptome; Fibrosis; Computational biology; Bioinformatics; Medicine; Pathology; Cell biology; Gene; Gene expression; Genetics","score_opus":0.10681498027195654,"score_gpt":0.3974263234288321,"score_spread":0.29061134315687553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410893913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906763,0.00025848087,0.0030403554,0.00097642455,0.0009827485,0.00028558652,0.000011758557,0.000044363263,0.003724011],"genre_scores_gemma":[0.9950239,0.00009735199,0.00017171563,0.0014086935,0.00024593368,0.00003873188,0.000046835,0.000005307615,0.002961516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988549,0.00017082768,0.0004120239,0.00029942085,0.000078257086,0.00018458116],"domain_scores_gemma":[0.99899405,0.00024189764,0.00014024704,0.00046507618,0.00010367369,0.00005507746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003742901,0.00010591883,0.00029959824,0.00002066805,0.00030883218,0.000008354387,0.000051732386,0.00016581858,0.0000719997],"category_scores_gemma":[0.000119765304,0.00006347036,0.00015578925,0.00007370208,0.00039452294,0.000031477324,0.000066146706,0.00041122048,0.000013748975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078992476,0.003021259,0.81872046,0.0003049737,0.0022190656,0.0096715465,0.010860923,0.010174324,0.0097985035,0.05177584,0.07885119,0.0038120167],"study_design_scores_gemma":[0.0018653465,0.0006707403,0.8848827,0.00027593397,0.00083923026,0.0028859454,0.00071229093,0.031046066,0.011907804,0.04539393,0.01905941,0.00046061343],"about_ca_topic_score_codex":0.00007496447,"about_ca_topic_score_gemma":0.000023325176,"teacher_disagreement_score":0.06616226,"about_ca_system_score_codex":0.000028300237,"about_ca_system_score_gemma":0.00008106714,"threshold_uncertainty_score":0.25882465},"labels":[],"label_agreement":null},{"id":"W4411103641","doi":"10.1016/j.jhepr.2025.101472","title":"Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Novartis Pharma; Bausch Health; Novo Nordisk; Intercept Pharmaceuticals; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Gilead Foundation; Alnylam Pharmaceuticals; Janssen Pharmaceuticals; Gilead Sciences; Medpace; Arrowhead Pharmaceuticals; GlaxoSmithKline; Amgen; NGM Biopharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Post-hoc analysis; Post hoc; Histology; Medicine; Computer science; Internal medicine","score_opus":0.008694000275621356,"score_gpt":0.27642456383699926,"score_spread":0.2677305635613779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411103641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710464,0.0005602555,0.0000013476234,0.00037488109,0.00018326816,0.0009000012,0.000019872838,0.000008778581,0.0008469245],"genre_scores_gemma":[0.998805,0.000051629817,0.000024860208,0.00039240043,0.000009933762,0.00020581536,0.00005478263,0.0000072224,0.00044839754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853206,0.000064007385,0.0006016009,0.00035121216,0.00023880188,0.00021229144],"domain_scores_gemma":[0.9989057,0.000081645005,0.00030508224,0.00054338877,0.00010941083,0.000054745753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021905049,0.00013943025,0.00058002997,0.00025041806,0.00003520437,0.00000851536,0.000057339683,0.00006931654,0.00005026618],"category_scores_gemma":[0.0000958023,0.00008622971,0.00023991581,0.0008353961,0.00010113798,0.000034257726,0.00007830442,0.00009127963,6.357001e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051668882,0.0018099843,0.98546076,0.00005045858,0.0017910304,0.0025514886,0.00041483,0.000026090176,0.00009792269,0.00006232905,0.00009584498,0.0024723692],"study_design_scores_gemma":[0.012513223,0.0004910916,0.9837116,0.00013360231,0.002164759,0.000017624418,0.00017630466,0.00007588117,0.00040183013,0.000017124714,0.00022146829,0.000075471035],"about_ca_topic_score_codex":0.004993661,"about_ca_topic_score_gemma":0.014109481,"teacher_disagreement_score":0.00911582,"about_ca_system_score_codex":0.00034374336,"about_ca_system_score_gemma":0.0002994803,"threshold_uncertainty_score":0.7873422},"labels":[],"label_agreement":null},{"id":"W4411964743","doi":"10.1016/j.jhepr.2025.101508","title":"Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLD","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Horizon 2020 Framework Programme; National Cancer Institute; Erasmus Universitair Medisch Centrum Rotterdam; Universidad San Francisco de Quito; Pontificia Universidad Católica de Chile; Fondo Nacional de Desarrollo Científico y Tecnológico; Universidad de Navarra; University of Toronto; Euskal Herriko Unibertsitatea; Stichting voor Lever- en Maag-Darm Onderzoek; University of Minnesota","keywords":"Cirrhosis; Internal medicine; Immune system; Medicine; Oncology; Hepatocellular carcinoma; Framingham Risk Score; Immunology; Disease","score_opus":0.004282798868604924,"score_gpt":0.20263247802064335,"score_spread":0.19834967915203844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411964743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917898,0.0070064384,0.00001752125,0.000050660874,0.000030727202,0.0007179818,0.000007223803,0.000015152041,0.00036446613],"genre_scores_gemma":[0.99500316,0.0021048367,0.0025066338,0.000017675944,0.0000048207635,0.0001389019,0.00001650353,0.000012749422,0.00019471048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990238,0.00002224443,0.00034686492,0.000309128,0.00015906541,0.00013888453],"domain_scores_gemma":[0.9992791,0.00004916669,0.0002647224,0.0002528559,0.000073170304,0.0000809733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011872705,0.00014812057,0.00033829603,0.000103992075,0.00005589226,0.000011402713,0.000017754346,0.000048354017,0.000020800806],"category_scores_gemma":[0.00003661535,0.00009604367,0.000021988253,0.00016104893,0.00007024952,0.000032557517,0.000041860854,0.00009764778,4.974241e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017974996,0.00033061192,0.9872061,0.00018498067,0.0004606251,0.0007720619,0.00038325848,0.000010686873,0.000019798617,0.000008999646,0.000057549416,0.010385557],"study_design_scores_gemma":[0.0014065041,0.00030672387,0.9938508,0.0008592735,0.000871052,0.00013722836,0.0001185183,0.00006816169,0.0020539835,0.000038966267,0.00018762164,0.00010116274],"about_ca_topic_score_codex":0.0005960286,"about_ca_topic_score_gemma":0.00021025675,"teacher_disagreement_score":0.010284395,"about_ca_system_score_codex":0.00006352355,"about_ca_system_score_gemma":0.0002340212,"threshold_uncertainty_score":0.39165473},"labels":[],"label_agreement":null},{"id":"W4412049501","doi":"10.1016/j.jhepr.2025.101510","title":"Improving risk stratification and detection of early HCC using ultrasound-based deep learning models","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Centre Hospitalier Régional Universitaire de Montpellier; Centre National de la Recherche Scientifique; Eisai; Université de Strasbourg; Assistance publique-Hôpitaux de Paris; AstraZeneca; Agence Nationale de la Recherche; Institut National de la Santé et de la Recherche Médicale; European Commission; Bristol-Myers Squibb","keywords":"Risk stratification; Ultrasound; Artificial intelligence; Deep learning; Medicine; Computer science; Radiology; Internal medicine","score_opus":0.03914402113417043,"score_gpt":0.24861898286194228,"score_spread":0.20947496172777186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412049501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943008,0.000593185,0.055504,0.000009309576,0.00006599739,0.00033980183,7.4886833e-7,0.000046557714,0.0004324129],"genre_scores_gemma":[0.9976367,0.000021089812,0.00219009,0.0000075519056,0.000022646342,0.00001727455,0.000018104833,0.000011588538,0.00007499017],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99912155,0.00005293273,0.00033420254,0.00024244937,0.00013471507,0.000114172246],"domain_scores_gemma":[0.9992824,0.000068035064,0.00029875452,0.00019594797,0.00010720861,0.000047612877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029782738,0.00010083668,0.00019617498,0.0001385092,0.00012743652,0.000026425167,0.0000137777515,0.00008942443,0.0000062473964],"category_scores_gemma":[0.00015162316,0.000094776544,0.000069321366,0.00018084483,0.00003448545,0.000105708255,0.000008215094,0.00013571333,2.7559167e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041307827,0.00003816989,0.74536914,0.00009158272,0.00004039278,0.000043361466,0.00011911232,0.00026682985,0.22190769,0.000008849681,2.5308051e-7,0.032073334],"study_design_scores_gemma":[0.00065895566,0.00032132422,0.18178725,0.00014801067,0.0007703465,0.00012826336,0.0001382357,0.45831043,0.35695451,0.0006004102,0.000031727202,0.00015053179],"about_ca_topic_score_codex":0.0010950795,"about_ca_topic_score_gemma":0.000029512245,"teacher_disagreement_score":0.5635819,"about_ca_system_score_codex":0.000064921005,"about_ca_system_score_gemma":0.000092890165,"threshold_uncertainty_score":0.38648754},"labels":[],"label_agreement":null},{"id":"W4413384329","doi":"10.1016/j.jhepr.2025.101560","title":"Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Vlaamse regering; Faculty of Medicine, Prince of Songkla University; Ipsen; National and Kapodistrian University of Athens; Prince of Songkla University; Norgine; Fonds Wetenschappelijk Onderzoek; Chinese University of Hong Kong; Maastricht Universitair Medisch Centrum; Rijksuniversiteit Groningen; Janssen Pharmaceuticals; Amsterdam University Medical Centers; Gilead Sciences; University of Toronto; Amgen; Universiteit Maastricht; GlaxoSmithKline; Universitair Medisch Centrum Groningen; Bristol-Myers Squibb; Novo Nordisk; Abbott Laboratories","keywords":"Hepatocellular carcinoma; Medicine; Chronic hepatitis; Fibrosis; Liver fibrosis; Gastroenterology; Internal medicine; Carcinoma; Oncology; Immunology; Virus","score_opus":0.004282488972549752,"score_gpt":0.1985558713954053,"score_spread":0.19427338242285552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413384329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996838,0.0015543356,0.000008699544,0.00001809813,0.000044500957,0.0013686726,0.000027537224,0.000011073753,0.00012913211],"genre_scores_gemma":[0.9993875,0.00009150423,0.00017617785,0.000015551355,0.000007369701,0.00015352732,0.000067002395,0.000016269933,0.00008509486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985928,0.000019200368,0.00045139014,0.00037105707,0.00036746892,0.00019808653],"domain_scores_gemma":[0.9986963,0.00002516475,0.00041842688,0.0005167179,0.0002520432,0.00009133291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007573276,0.00018742013,0.0004491639,0.00014290345,0.00002706123,0.000005041608,0.00004150301,0.00004426442,0.000036106612],"category_scores_gemma":[0.000016450347,0.00012659063,0.00013724314,0.00024548676,0.00007354416,0.00006362127,0.000044137276,0.00007266887,4.8520366e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009580427,0.0018116839,0.98356336,0.0006325545,0.0004641993,0.00038674544,0.00020498109,0.000107933345,0.000353748,0.000005117775,0.0000139354215,0.011497723],"study_design_scores_gemma":[0.0044611935,0.0028070074,0.97770834,0.0010236979,0.001077212,0.0000036882298,0.000067041205,0.00010574892,0.012579565,0.0000041652343,0.00004783626,0.000114510854],"about_ca_topic_score_codex":0.0009666511,"about_ca_topic_score_gemma":0.000070791204,"teacher_disagreement_score":0.012225816,"about_ca_system_score_codex":0.0003384734,"about_ca_system_score_gemma":0.00025478986,"threshold_uncertainty_score":0.5162216},"labels":[],"label_agreement":null},{"id":"W4413788159","doi":"10.1016/j.jhepr.2025.101566","title":"Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies","year":2025,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"Incyte; Roche; AstraZeneca; Servier; MSD","keywords":"Liver transplantation; Observational study; Meta-analysis; Medicine; Internal medicine; Transplantation; Oncology","score_opus":0.3662705535403707,"score_gpt":0.38299568102747755,"score_spread":0.01672512748710686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413788159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001179432,0.99185455,0.00009699405,0.00008657756,0.000016057134,0.0077741877,0.00010060036,0.00001625627,0.000042985186],"genre_scores_gemma":[0.00006562243,0.99204093,0.0010520732,0.00014165124,0.00000973746,0.003987763,0.0015915157,0.00002062415,0.0010900795],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973975,0.00017940899,0.0014625557,0.0004753441,0.00036614496,0.0001190825],"domain_scores_gemma":[0.99724364,0.0005771945,0.0011413392,0.0005468063,0.0004342378,0.000056763984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009219485,0.00037651949,0.009976137,0.00032995758,0.000053291697,0.000010772275,0.000044176388,0.00012380366,0.000051150728],"category_scores_gemma":[0.00025123276,0.00020161644,0.0031248287,0.00080171204,0.000042457337,0.00005024281,0.000016586577,0.00007912847,5.2403493e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003826937,0.00003197749,0.00017644028,0.69529647,0.3031766,0.00060980185,0.00003408609,5.4953237e-8,1.0917222e-8,0.000014734137,0.000058468886,0.00059748994],"study_design_scores_gemma":[0.000094902694,0.0000798459,0.000015170286,0.1148262,0.8780267,0.000600498,0.000005916051,0.000004076554,0.0000014166212,0.000004950546,0.006202194,0.00013808323],"about_ca_topic_score_codex":0.000010335094,"about_ca_topic_score_gemma":0.00001678324,"teacher_disagreement_score":0.58047026,"about_ca_system_score_codex":0.000053745167,"about_ca_system_score_gemma":0.00026884477,"threshold_uncertainty_score":0.82216793},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":["metaepi_broad"],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4413847639","doi":"10.1016/j.jhepr.2025.101570","title":"Time for a globally unified chronic HBV terminology?","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Gilead Sciences; Grifols; GlaxoSmithKline","keywords":"Terminology; Virology; Medicine; Computer science; Linguistics; Philosophy","score_opus":0.015833899807558924,"score_gpt":0.305834603299202,"score_spread":0.29000070349164303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413847639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7973815,0.0028975883,0.00048074595,0.007942091,0.001370744,0.002221263,0.000014405532,0.00044573707,0.18724588],"genre_scores_gemma":[0.9421256,0.00006636066,0.00074844767,0.0012673658,0.00020599176,0.0001678895,0.00003415211,0.000016892727,0.055367272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882984,0.000013637983,0.0003990052,0.00032455937,0.00013668777,0.00029628948],"domain_scores_gemma":[0.9991609,0.000060845225,0.00012379778,0.0004532351,0.0001438256,0.000057389712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020553383,0.0001339737,0.00037251698,0.00009211888,0.00010132044,0.00001147433,0.00005564826,0.00011076024,0.0001207077],"category_scores_gemma":[0.0005455252,0.00011842161,0.000113638955,0.0001500533,0.00011004544,0.00003496954,0.00008509048,0.000089691195,0.00006062911],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028798764,0.00043377152,0.3335485,0.00096971047,0.001191741,0.0067792553,0.00029772765,0.000010367202,0.019005442,0.0021965196,0.5584086,0.07687037],"study_design_scores_gemma":[0.0011613795,0.00044581952,0.19496448,0.0003048418,0.00033815883,0.00072838226,0.000012432383,0.00029019034,0.0033875825,0.0021706203,0.7959813,0.00021482342],"about_ca_topic_score_codex":0.0001643923,"about_ca_topic_score_gemma":0.00028886102,"teacher_disagreement_score":0.23757266,"about_ca_system_score_codex":0.00028136262,"about_ca_system_score_gemma":0.00051818904,"threshold_uncertainty_score":0.48290932},"labels":[],"label_agreement":null},{"id":"W4414440271","doi":"10.1016/j.jhepr.2025.101596","title":"Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluation","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Gilead Sciences; GlaxoSmithKline","keywords":"HBx; cccDNA; Hepatitis B virus; Antiviral drug; Drug development; Cell culture; DNA; Chronic hepatitis","score_opus":0.023942647351603355,"score_gpt":0.3257353504875284,"score_spread":0.30179270313592504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414440271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609084,0.0005871381,0.0007320643,0.00025961126,0.00083535543,0.002787405,0.000010754435,0.00009826527,0.03378097],"genre_scores_gemma":[0.97594064,0.000011748569,0.013258519,0.00009762775,0.00008719428,0.00044914975,0.000082630395,0.00002141573,0.01005107],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973363,0.00008423318,0.0012372334,0.00048028392,0.00060854695,0.00025339957],"domain_scores_gemma":[0.9973889,0.000072679104,0.00077224843,0.00051771494,0.0011902415,0.000058224265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014399034,0.00020522422,0.0005956318,0.00018756246,0.00017223324,0.000014853846,0.000050908224,0.000116281735,0.000014912098],"category_scores_gemma":[0.0008791026,0.00017007682,0.00015976722,0.0002428405,0.000052258685,0.00007682212,0.00008371376,0.00010463677,0.0000048056195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014893007,0.0008677131,0.55683315,0.007921508,0.001771716,0.0034632767,0.037672453,0.000029689574,0.18768798,0.00030558277,0.1799798,0.021977816],"study_design_scores_gemma":[0.0036223633,0.00032787336,0.21769007,0.0039035648,0.0018750345,0.0005576072,0.004866483,0.0009354653,0.49908656,0.00023041053,0.2662153,0.0006892694],"about_ca_topic_score_codex":0.000085258594,"about_ca_topic_score_gemma":0.00027855276,"teacher_disagreement_score":0.3391431,"about_ca_system_score_codex":0.00046132779,"about_ca_system_score_gemma":0.0011764868,"threshold_uncertainty_score":0.6935531},"labels":[],"label_agreement":null},{"id":"W4414979676","doi":"10.1016/j.jhepr.2025.101619","title":"From model to man: Understanding Tregs' dual role in MASLD","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Horizon 2020 Framework Programme; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Immune system; Complement (music); Steatohepatitis; Acquired immune system; Translation (biology); Dual (grammatical number); Constraint (computer-aided design); Complement system","score_opus":0.03497788461030359,"score_gpt":0.30180014939867816,"score_spread":0.26682226478837456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414979676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95328826,0.0006935699,0.000357696,0.002897583,0.00018691493,0.00047082375,0.000013232848,0.000050020735,0.042041916],"genre_scores_gemma":[0.99676645,0.00002217338,0.00037909273,0.000802832,0.000055136195,0.000079172256,0.00004759267,0.000010649188,0.0018368951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990603,0.000009839859,0.00025970538,0.00032613825,0.00017414942,0.00016986745],"domain_scores_gemma":[0.9994481,0.00003111477,0.000045257428,0.0003264732,0.000017895014,0.0001311641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006744116,0.00011051415,0.00022592848,0.00013944057,0.00003398259,0.000020325278,0.00002167476,0.000051215247,0.00010008486],"category_scores_gemma":[0.000026645512,0.0000957038,0.000076844924,0.00015652612,0.000010862371,0.000046779598,0.000045156296,0.000061797145,0.000013889084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824905,0.0016213623,0.9450851,0.0000686934,0.00042997315,0.014816271,0.0020528995,0.0014776011,0.0007166858,0.0030167578,0.026062187,0.0043699853],"study_design_scores_gemma":[0.0062082727,0.000366011,0.84767413,0.0021120727,0.001457111,0.00014146365,0.007065303,0.0148033835,0.008211327,0.1017426,0.0094495,0.00076882023],"about_ca_topic_score_codex":0.000583286,"about_ca_topic_score_gemma":0.00012980921,"teacher_disagreement_score":0.09872584,"about_ca_system_score_codex":0.00045482998,"about_ca_system_score_gemma":0.00013852397,"threshold_uncertainty_score":0.39026877},"labels":[],"label_agreement":null},{"id":"W4415069879","doi":"10.1016/j.jhepr.2025.101630","title":"Navigating second-line therapy after immunotherapy in advanced HCC☆","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Immunotherapy; Hepatocellular carcinoma; Clinical trial; Sorafenib; Disease; Systemic therapy; Tyrosine kinase; Therapeutic approach","score_opus":0.009116866115393253,"score_gpt":0.31641623419048914,"score_spread":0.3072993680750959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415069879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774215,0.015049063,0.000040482533,0.0012805264,0.0006750042,0.000636918,0.0000024477645,0.000082454186,0.004811571],"genre_scores_gemma":[0.99005026,0.0009769469,0.0005275,0.004448673,0.00008287231,0.00018521541,0.000019183353,0.000029605106,0.0036797242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838483,0.000032462343,0.00070311717,0.00039350253,0.00019240599,0.0002936957],"domain_scores_gemma":[0.99909,0.000042450596,0.0001852952,0.00057183043,0.00006696013,0.000043471144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004197949,0.00020444187,0.00040260967,0.00008833343,0.000052875865,0.000025740228,0.00006168272,0.00012419395,0.0011778488],"category_scores_gemma":[0.000028354447,0.00017170724,0.00017942753,0.0004661024,0.000067956884,0.00010941205,0.000020358171,0.00034552813,0.0000042572865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070402795,0.000405974,0.16859636,0.000102348306,0.00025171513,0.0017064301,0.0007768317,0.000005548826,0.17887853,0.000010917986,0.0005340038,0.6416911],"study_design_scores_gemma":[0.0076163895,0.00047563098,0.6597312,0.0014354115,0.000019819476,0.0004988309,0.0002512614,0.00004145798,0.0817659,0.00057728484,0.24717836,0.00040845812],"about_ca_topic_score_codex":0.00012589281,"about_ca_topic_score_gemma":0.00008610089,"teacher_disagreement_score":0.6412826,"about_ca_system_score_codex":0.00017235882,"about_ca_system_score_gemma":0.0001844481,"threshold_uncertainty_score":0.99973524},"labels":[],"label_agreement":null},{"id":"W4415304935","doi":"10.1016/j.jhepr.2025.101640","title":"MELD 3.i and the case for continuous updating in liver allocation","year":2025,"lang":"en","type":"letter","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences","keywords":"Liver transplantation; Liver disease; Liver failure; Waiting list; Disease; Transplantation","score_opus":0.011349507147428668,"score_gpt":0.2575242420283196,"score_spread":0.24617473488089092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415304935","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15201478,0.004045125,0.00085272227,0.8206742,0.0012766785,0.0077889175,0.000108159,0.00013316021,0.013106247],"genre_scores_gemma":[0.68384206,0.00029741408,0.000273565,0.30792904,0.001330884,0.0004274263,0.0017545397,0.000029578197,0.004115473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991111,0.000043728818,0.00034615086,0.00026446924,0.00010929289,0.00012527045],"domain_scores_gemma":[0.9992168,0.0002694299,0.0001874149,0.0002250761,0.000079757985,0.000021511176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003029567,0.00012185966,0.0002815373,0.0000897259,0.000057747864,0.00002621806,0.000020356943,0.00020268226,0.000015820278],"category_scores_gemma":[0.000056101635,0.00008501277,0.000076702134,0.000058501828,0.00004531397,0.000047505368,0.000010592672,0.00031826893,7.7231357e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005223681,0.000054322674,0.008330758,0.005041406,0.0006762205,0.34578848,0.0019422102,0.000002174022,0.000018218985,0.00026366682,0.6291699,0.008190309],"study_design_scores_gemma":[0.02410242,0.00039713763,0.019408822,0.006905354,0.02313259,0.14475942,0.0016244825,0.0029080822,0.00097444735,0.005521407,0.7686845,0.0015813499],"about_ca_topic_score_codex":0.0008323202,"about_ca_topic_score_gemma":0.000105469284,"teacher_disagreement_score":0.5318273,"about_ca_system_score_codex":0.000031300464,"about_ca_system_score_gemma":0.00011059357,"threshold_uncertainty_score":0.346672},"labels":[],"label_agreement":null},{"id":"W4415756350","doi":"10.1016/j.jhepr.2025.101658","title":"Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib – A phase II trial (PEMRAD)","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Merck Canada; Princess Margaret Cancer Foundation; Merck","keywords":"Pembrolizumab; Sorafenib; Hepatocellular carcinoma; Clinical trial; Radiation therapy; Hepatocellular cancer; Stereotactic radiotherapy","score_opus":0.02267633328266469,"score_gpt":0.28418463771258057,"score_spread":0.2615083044299159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415756350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892504,0.0039728046,0.000028460376,0.0012913157,0.0005506858,0.0033167168,0.0000070332467,0.00011544705,0.0014671339],"genre_scores_gemma":[0.99645215,0.00011997893,0.0002636099,0.0003726383,0.000111427646,0.0003421047,0.00015169627,0.000051064395,0.002135315],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973601,0.00013304167,0.00093260326,0.0007736024,0.00032935792,0.0004712801],"domain_scores_gemma":[0.99850374,0.000095154974,0.000282952,0.00075422286,0.00012314624,0.00024078898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040484578,0.0004107551,0.0009310654,0.00047590508,0.00018852053,0.000055284858,0.000077701756,0.00021624491,0.00013721803],"category_scores_gemma":[0.0001514889,0.00037214055,0.00024540297,0.000486744,0.00009285437,0.00018628557,0.0000737255,0.00030218236,0.000002946086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04429711,0.002920217,0.913114,0.00019905667,0.00027099482,0.017040858,0.00044678655,1.6807263e-7,0.013462666,0.000110984474,0.00020297442,0.0079341475],"study_design_scores_gemma":[0.6898968,0.03198191,0.20577748,0.0007713765,0.0016695672,0.003677093,0.00028473287,0.012023534,0.029328816,0.00089226535,0.02214371,0.0015527162],"about_ca_topic_score_codex":0.000289283,"about_ca_topic_score_gemma":0.000020441277,"teacher_disagreement_score":0.70733654,"about_ca_system_score_codex":0.00026578587,"about_ca_system_score_gemma":0.00044682206,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W4415901190","doi":"10.1016/j.jhepr.2025.101635","title":"Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Cilag; Horizon 2020 Framework Programme; Ipsen; Servier; Deutsche Krebshilfe; Eisai; LEO Pharma; European Cooperation in Science and Technology; Incyte; Deutsche Bahn; Les Laboratories Pierre Fabre; Eli Lilly and Company; AstraZeneca; Celgene; Daiichi Sankyo Europe; Sanofi; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung; Amgen","keywords":"Observational study; Clinical Practice; Clinical trial; Profiling (computer programming); Biliary tract; Precision medicine; Randomized controlled trial; Biomarker","score_opus":0.24815108010042666,"score_gpt":0.4805192816871646,"score_spread":0.23236820158673796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415901190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895952,0.0017426407,0.000008720833,0.0033901017,0.00015937207,0.00051260315,0.00000422535,0.000020772084,0.0045664036],"genre_scores_gemma":[0.9978916,0.00007544946,0.0012422638,0.0005038714,0.000059546208,0.00009298495,0.000009169608,0.000006253452,0.000118840704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987076,0.000057551148,0.0006896471,0.00031228276,0.00013387391,0.00009904947],"domain_scores_gemma":[0.99860054,0.00053575216,0.00023848865,0.00030789172,0.00026829273,0.000049047507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008032132,0.00008053895,0.00027821874,0.000096473355,0.000051980816,0.000008601821,0.000029703802,0.00004436359,0.000007581275],"category_scores_gemma":[0.0018322737,0.000070287104,0.000036129088,0.00040308113,0.00006142092,0.00013613373,0.000047506797,0.00012880475,1.19067394e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051001254,0.0010315815,0.957199,0.000038133978,0.000092185,0.00016627973,0.00025778566,0.0000011631988,0.00027821393,0.000018055454,0.0007404452,0.04012616],"study_design_scores_gemma":[0.0005398597,0.00016949755,0.99601454,0.00007588845,0.00019097017,0.00013953252,0.0006554023,0.00004440837,0.000011125683,0.00013209508,0.0019712774,0.000055395663],"about_ca_topic_score_codex":0.0013919071,"about_ca_topic_score_gemma":0.00040705584,"teacher_disagreement_score":0.040070765,"about_ca_system_score_codex":0.000046554072,"about_ca_system_score_gemma":0.0003743269,"threshold_uncertainty_score":0.2866225},"labels":[],"label_agreement":null},{"id":"W4416023742","doi":"10.1016/j.jhepr.2025.101671","title":"Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European AIDS Treatment Network; Swiss HIV Cohort Research Foundation; Schweizerische Akademie der Medizinischen Wissenschaften; Gottfried und Julia Bangerter-Rhyner-Stiftung; Danmarks Grundforskningsfond; MSD Sharp and Dohme; Agence Nationale de la Recherche; FP7 Coordination of Research Activities; Inselspital, Universitätsspital Bern; Janssen Scientific Affairs; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Gilead Sciences; Sidaction; Bristol-Myers Squibb","keywords":"HBsAg; Hepatitis B virus; Human immunodeficiency virus (HIV); Hepatitis B; Antigen; RNA; Antibody; Transmission (telecommunications)","score_opus":0.01569297630744075,"score_gpt":0.28605223645782385,"score_spread":0.2703592601503831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416023742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861918,0.00071389,0.0000044723333,0.0001613431,0.00008791485,0.00042242734,0.000004285852,0.00002839734,0.012385443],"genre_scores_gemma":[0.99836886,0.000426823,0.00020577367,0.0000950645,0.000010369355,0.000017515335,0.0000064839287,0.00002119469,0.00084789615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843436,0.00004060789,0.00069306523,0.00035672155,0.00021648599,0.00025875296],"domain_scores_gemma":[0.99918216,0.00006566151,0.00026721123,0.00028702818,0.0001378933,0.00006006979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031176273,0.00016174086,0.000549813,0.000266852,0.000052754924,0.000009369337,0.000035558212,0.000079925245,0.000023314824],"category_scores_gemma":[0.0008222461,0.00014150678,0.00003015342,0.00070595444,0.00015562108,0.00007966113,0.00008118346,0.00019121103,0.0000027082442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030604573,0.00007290384,0.97151744,0.00015140149,0.00004448411,0.022576353,0.0015012902,0.0000070668284,0.0011601114,0.000019328554,0.000083943305,0.0028350526],"study_design_scores_gemma":[0.0007151701,0.00011598457,0.9946869,0.0015489238,0.00004407017,0.00093151134,0.00007520153,0.0004352098,0.0009750119,0.00006013269,0.00028640623,0.00012548344],"about_ca_topic_score_codex":0.011502992,"about_ca_topic_score_gemma":0.011313094,"teacher_disagreement_score":0.023169434,"about_ca_system_score_codex":0.00007967165,"about_ca_system_score_gemma":0.0002303819,"threshold_uncertainty_score":0.9950795},"labels":[],"label_agreement":null},{"id":"W4416713291","doi":"10.1016/j.jhepr.2025.101683","title":"External beam radiation for HCC: Ready for incorporation into guidelines?","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"External beam radiation; Radiation therapy; Beam (structure); External beam radiotherapy; Clinical trial; Clinical Practice","score_opus":0.11159624147511966,"score_gpt":0.361849546685738,"score_spread":0.25025330521061834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416713291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88480294,0.001927212,0.10226065,0.003923469,0.0012095838,0.00415799,0.000016003487,0.0001468912,0.0015552754],"genre_scores_gemma":[0.9676554,0.000031604417,0.024369435,0.00060305285,0.0004938287,0.0008895656,0.0010022711,0.000020039877,0.0049347803],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988308,0.000010510126,0.00057991425,0.0002927928,0.00013977583,0.00014623706],"domain_scores_gemma":[0.9989134,0.00006286555,0.0002546422,0.0002807724,0.00042185813,0.00006642723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046444908,0.00012601276,0.00025093448,0.00013037215,0.00011125441,0.000029094199,0.000027941609,0.00011094803,0.000015982689],"category_scores_gemma":[0.00047344997,0.00011026724,0.0001513853,0.00012363226,0.0000151045115,0.000096966076,0.000013161831,0.000042337113,0.0000033126041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030660728,0.00015936604,0.8205555,0.0002857799,0.00012768804,0.00013559069,0.00009911274,0.0000050038807,0.010250795,0.0006432164,0.042383987,0.12504736],"study_design_scores_gemma":[0.0052475976,0.0014173281,0.06076496,0.0004929369,0.0015527012,0.0002901236,0.00007325901,0.022230484,0.20174251,0.029048176,0.6766398,0.0005001487],"about_ca_topic_score_codex":0.000092122405,"about_ca_topic_score_gemma":0.00001429942,"teacher_disagreement_score":0.75979054,"about_ca_system_score_codex":0.00013512881,"about_ca_system_score_gemma":0.00022963247,"threshold_uncertainty_score":0.44965675},"labels":[],"label_agreement":null},{"id":"W4416910545","doi":"10.1016/j.jhepr.2025.101597","title":"PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Health, University of Sydney; Klinisk Institut, Syddansk Universitet; School of Medicine, Stanford University; European Regional Development Fund; Norgine; Grifols; Syddansk Universitet; Università di Bologna; Instituto de Salud Carlos III; Universitat de Barcelona; Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk; Aarhus Universitet; KU Leuven; Universidad Complutense de Madrid; Institut National de la Santé et de la Recherche Médicale; Università degli Studi di Torino; University College London; Amsterdam University Medical Centers; Novo Nordisk Fonden; Universiteit van Amsterdam; Instituto de Investigación Sanitaria Gregorio Marañón; Centres de Recerca de Catalunya; Mallinckrodt Pharmaceuticals; Hospital Clínic de Barcelona; Pfizer; Odense Universitetshospital; Universitat Autònoma de Barcelona; Boston Scientific Corporation; European Commission; Ministero della Salute","keywords":"Immune system; Biomarker; Chronic liver disease; Disease; Risk factor; Immune Dysfunction; Liver dysfunction","score_opus":0.0022983704790313967,"score_gpt":0.23725592358288544,"score_spread":0.23495755310385405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416910545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915063,0.00006719448,0.000017126302,0.000007611796,0.00021766774,0.00045946563,0.000009639794,0.0000026371035,0.000068012276],"genre_scores_gemma":[0.99962276,0.00011545233,0.000014915913,0.0000169291,0.000053065854,0.000018520786,0.000109787616,0.0000040490295,0.000044511475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994396,0.000067069115,0.0001846213,0.0001861951,0.000056160687,0.00006634229],"domain_scores_gemma":[0.9995922,0.0000052510636,0.00012791502,0.00019644374,0.00005825378,0.000019953728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001466577,0.00006069772,0.000092799215,0.000032838834,0.000036957448,0.000012153381,0.00003511083,0.000036276942,0.000010364833],"category_scores_gemma":[0.00004401707,0.00004012169,0.00001998797,0.000036654725,0.000054409127,0.0000057601424,0.000053887758,0.000044827997,1.2207781e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004557089,0.00034379453,0.99726206,0.000011843902,0.000061356885,0.0000034922869,0.000075266566,0.000014461541,0.0010265228,0.0000030142478,0.0000246865,0.00071779406],"study_design_scores_gemma":[0.0018772089,0.00030715487,0.9968304,0.000011476271,0.000042662672,0.0000022708407,0.000012322043,0.000022389944,0.00024584524,0.0000059835743,0.0006000104,0.000042248914],"about_ca_topic_score_codex":0.0008246692,"about_ca_topic_score_gemma":0.0017410798,"teacher_disagreement_score":0.0014215,"about_ca_system_score_codex":0.00001842274,"about_ca_system_score_gemma":0.00008555689,"threshold_uncertainty_score":0.1636115},"labels":[],"label_agreement":null},{"id":"W4417515877","doi":"10.1016/j.jhepr.2025.101714","title":"A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Cilag; Fondation contre le Cancer; Vlaamse regering; Stichting Tegen Kanker; Fonds Wetenschappelijk Onderzoek; Universiteit Antwerpen; Vlaams Supercomputer Centrum; Gilead Sciences","keywords":"Hepatocellular carcinoma; Liver cancer; Viral hepatitis; Gene signature; Liver biopsy; Transcriptome; Hepatitis C; Cancer; Antibody","score_opus":0.011786665702950389,"score_gpt":0.2993961855991077,"score_spread":0.2876095198961573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417515877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887596,0.0035412407,0.000190443,0.0005845643,0.00073024596,0.0017737277,0.000056402132,0.00010577409,0.004258041],"genre_scores_gemma":[0.9833145,0.007094405,0.0010807827,0.0010087937,0.00040922704,0.0004369586,0.000035206092,0.00005781362,0.006562299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966353,0.00016627338,0.00083899207,0.00084209646,0.00073892233,0.00077842496],"domain_scores_gemma":[0.99816173,0.00014748338,0.00020721558,0.0008609008,0.00026005195,0.0003625993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005734834,0.00033342637,0.00065921084,0.0006292935,0.000115913506,0.000058820144,0.00018085407,0.0005833356,0.0014051136],"category_scores_gemma":[0.00053707924,0.0003168332,0.00016671476,0.0009446453,0.000101865,0.00014291181,0.00024060013,0.0016452909,0.0001901884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022938458,0.00031068551,0.7334959,0.000653406,0.00028078275,0.030224107,0.0011084109,0.0008400528,0.030977985,0.00002317404,0.031700388,0.17015572],"study_design_scores_gemma":[0.0030021432,0.0011382898,0.60498565,0.002388684,0.00042712493,0.00026362887,0.000029289451,0.04772553,0.17300068,0.00022806285,0.16576058,0.0010503684],"about_ca_topic_score_codex":0.03557302,"about_ca_topic_score_gemma":0.02334021,"teacher_disagreement_score":0.16910535,"about_ca_system_score_codex":0.0020899184,"about_ca_system_score_gemma":0.0018330235,"threshold_uncertainty_score":0.99992836},"labels":[],"label_agreement":null}]}